Mitochondrial Dynamics and Neurodegeneration
Bingwei Lu Editor
Mitochondrial Dynamics and Neurodegeneration
Editor Bingwei Lu Department of Pathology Stanford University School of Medicine 825 Allardice Way Stanford, CA 94305 USA
[email protected]
ISBN 978-94-007-1290-4 e-ISBN 978-94-007-1291-1 DOI 10.1007/978-94-007-1291-1 Springer Dordrecht Heidelberg London New York Library of Congress Control Number: 2011929228 © Springer Science+Business Media B.V. 2011 No part of this work may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording or otherwise, without written permission from the Publisher, with the exception of any material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com)
Preface
Ever since the ancient bacteria entered a primitive eukaryotic host cell billions of years ago, the proto-mitochondrion and its host cells have entered into an intricate symbiosis relationship that has been constantly evolving. Mitochondria and their host cells depend on each other for maintenance and survival. For example, the majority of the components of the mitochondrial proteome are encoded by host nuclear DNA. On the other hand, mitochondria are essential for such diverse functions as energy metabolism, reactive oxygen species production, calcium buffering, and cell death control. As the name implied (mito and chondrion means threaded and grain, respectively, in Greek), the morphology of mitochondrion is dynamic, constantly undergoing fission and fusion processes in vivo, and these morphological changes are believed to be important for the essential mitochondrial functions mentioned above. Given the critical roles of mitochondria for the normal physiology and life and death decisions of its host cells throughout the body of a multicellular organism, it is not surprising that defects in mitochondrial dynamics are linked to human diseases. What is surprising is the relatively selective vulnerability of neurons to defective mitochondrial dynamics. This has fueled considerable efforts in neurodegenerative disease field to use mitochondrial dynamics as a new experimental paradigm for disease mechanism investigation. Although many reviews and books have been written on the contribution of mitochondrial dysfunction to human diseases, this is the first book that integrates diverse topics such as the genetic control of mitochondrial dynamics, the relationship between mitochondrial dynamics and bioenergetics, the roles of mitochondrial dynamics in apoptosis, axonal transport, mitochondrial quality control, and the contribution of defective mitochondrial dynamics to the pathogenesis of neuro degenerative diseases. Focusing on the theme of mitochondrial dynamics and its role in neurodegeneration, this book brings together leading scientists and clinicians from around the world to deliver a comprehensive treatise on all aspects of mitochondrial dynamics. In Chap. 1, Dr. McQuibban and his colleagues present a comprehensive historical account of key discoveries in mitochondria research and those that lead to the identification of key molecular players involved in mitochondrial dynamics. They especially emphasize the role played by model organism genetics in these latter discoveries. In Chap. 2, Dr. Rossignol and colleagues describe the funda mental mechanisms by which mitochondrial dynamics and cellular energy status v
vi
Preface
can reciprocally regulate each other. Many thought-provoking hypotheses are proposed. In Chap. 3, Dr. Shirihai and colleagues discuss the regulation and interdependence of mitochondrial dynamics and mitochondrial autophagy (mitophagy) in mitochondrial quality control. This is a very timely topic as mitophagy is currently one of the heavily studied areas in neurodegenerative disease research. In Chap. 4, Dr. Youle and colleague highlights the importance of mitochondrial dynamics in the timely execution of apoptosis, one of the fundamental processes involved in neurodegeneration. In Chap. 5, Dr. Sheng and colleague discuss the molecular processes that lead to the transport and distribution of mitochondria to neuronal axons and synapses, arguably one of the most important aspects of neuronal physiology. Although disease relevance is not the main focus of this chapter, understanding the relationships among mitochondrial dynamics, transport, and neuronal plasticity will shed important insights into the disease conditions. In Chap. 6, Dr. Reynier and colleagues presents recent findings on the clinical diversity of diseases caused by mutations in the mitochondrial fusion machinery, the spectrum of mutations in the mitochondrial fusion genes and the corresponding pathophysiology, and the therapeutic perspectives. In Chap. 7, Dr. Chu and colleague summarize a rapidly growing body of literature focusing on the role of mitochondrial dynamics in the pathogenesis of Parkinson’s disease, and they discuss unresolved controversies in the field in the context of a dynamic network of compensatory responses to mitochondrial stress, dysfunction and injury. In Chap. 8, Dr. Lipton and colleagues highlight the role of aberrant mitochondrial dynamics in the pathogenesis of Alzheimer’s disease, and offer a molecular mechanism connecting disease-causing insults and post-translational modification of the mitochondrial fission machinery component Drp1. In Chap. 9, Dr. Monteiro and colleagues discuss the published literature linking mitochondrial dysfunction in Huntington’s disease, focusing on the role that defects in mitochondrial dynamics might play in disease pathogenesis. These chapters discuss the central problems associated with the nascent but rapidly growing research field of mitochondrial dynamics in neurodegeneration. They should serve as an excellent reference book for students, clinicians, and researchers engaged or interested in mitochondria biology, neurobiology, and mechanisms of neurodegenerative diseases. I want to thank all of our authors for their hard work and Thijs van Vlijmen and Sara Huisman of Springer for their excellent help in making this book a reality. Associate Professor Stanford University School of Medicine Stanford, CA 94305 USA
Bingwei Lu, Ph.D.
Contents
1 The Genetics of Mitochondrial Fusion and Fission................................ Eliana Y. L. Chan, Jarungjit Rujiviphat, and G. Angus McQuibban 2 Relationships Between Mitochondrial Dynamics and Bioenergetics....................................................................................... Giovanni Benard, Nadège Bellance, Caroline Jose, and Rodrigue Rossignol 3 Mitochondrial Dynamics and Autophagy................................................ Linsey Stiles, Andrew Ferree, and Orian Shirihai
1
47
69
4 Mitochondrial Dynamics and Apoptosis.................................................. 109 Megan M. Cleland and Richard J. Youle 5 Mitochondrial Dynamics and Axonal Transport.................................... 139 Qian Cai and Zu-Hang Sheng 6 Neurological Diseases Associated with Mutations in the Mitochondrial Fusion Machinery.................................................. 169 Guy Lenaers, Dominique Bonneau, Cécile Delettre, Patrizia Amati-Bonneau, Emmanuelle Sarzi, Dan Miléa, Christophe Verny, Vincent Procaccio, Christian Hamel, and Pascal Reynier 7 Mitochondrial Fission-Fusion and Parkinson’s Disease: A Dynamic Question of Compensatory Networks.................................. 197 Charleen T. Chu and Sarah B. Berman 8 Role of the Mitochondrial Fission Protein Drp1 in Synaptic Damage and Neurodegeneration.............................................................. 215 Tomohiro Nakamura, Dong-Hyung Cho, and Stuart A. Lipton
vii
viii
Contents
9 Mitochondrial Dynamics and Huntington’s Disease: A Dance of Fate.......................................................................................... 235 Hongmin Wang, Mariusz Karbowski, and Mervyn J. Monteiro Index.................................................................................................................. 259
Contributors
Patrizia Amati-Bonneau UMR CNRS 6214 - Inserm U771, Angers, France and Département de Biochimie et Génétique, Centre Hospitalier Universitaire, Angers, France Nadège Bellance Laboratoire “MRGM” EA4576 (Maladies Rares: Génétique et Métabolisme), Université de Bordeaux, Bordeaux, France Giovanni Benard Laboratoire “MRGM” EA4576 (Maladies Rares: Génétique et Métabolisme), Université de Bordeaux, Bordeaux, France Sarah B. Berman Department of Neurology, University of Pittsburgh School of Medicine, 3501 Fifth Avenue, BST3, Room 7037, Pittsburgh, PA 15213, USA and The Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA Dominique Bonneau UMR CNRS 6214 - Inserm U771, Angers, France and Département de Biochimie et Génétique, Centre Hospitalier Universitaire, Angers, France Qian Cai Synaptic Function Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Building 35, Room 2B-215, 35 Convent Drive, Bethesda, MD 20892–3706, USA Eliana Y.L. Chan Department of Biochemistry, University of Toronto, Toronto, ON, Canada
ix
x
Contributors
Dong-Hyung Cho Graduate School of East-West Medical Science, Kyung Hee University, Yongin, Gyeonggi 446–701, Korea Charleen T. Chu Department of Pathology, University of Pittsburgh School of Medicine, 200 Lothrop St., Pittsburgh, PA 15213, USA
[email protected] Megan M. Cleland Biochemistry Section, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), 35 Convent Drive, MSC 3704, Building 35/Rm, 2C917, Bethesda, MD 20892, USA Cécile Delettre Inserm U1051, Institut des Neurosciences de Montpellier, Universités de Montpellier I et II, Montpellier, France Andrew Ferree Department of Pharmacology, Boston University School of Medicine, Boston, MA, USA Christian Hamel Inserm U1051, Institut des Neurosciences de Montpellier, Universités de Montpellier I et II, Montpellier, France Caroline Jose Laboratoire “MRGM” EA4576 (Maladies Rares: Génétique et Métabolisme), Université de Bordeaux, Bordeaux, France Mariusz Karbowski Center for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, MD 21201, USA and Department of Molecular Biology and Biochemistry, University of Maryland School of Medicine, Baltimore, MD 21201, USA Guy Lenaers Inserm U1051, Institut des Neurosciences de Montpellier, Universités de Montpellier I et II, Montpellier, France
[email protected] Stuart A. Lipton Center for Neuroscience, Aging, and Stem Cell Research, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA
[email protected]
Contributors
G. Angus McQuibban Department of Biochemistry, University of Toronto, Toronto, ON, Canada
[email protected] Dan Miléa UMR CNRS 6214 - Inserm U771, Angers, France and Département d’Ophtalmologie, Centre Hospitalier Universitaire, Angers, France Mervyn J. Monteiro Center for Biomedical Engineering and Technology, University of Maryland School of Medicine, Baltimore, MD 21201, USA and Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
[email protected] Tomohiro Nakamura Center for Neuroscience, Aging, and Stem Cell Research, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA Vincent Procaccio UMR CNRS 6214 - Inserm U771, Angers, France and Département de Biochimie et Génétique, Centre Hospitalier Universitaire, Angers, France Pascal Reynier UMR CNRS 6214 - Inserm U771, Angers, France and Département de Biochimie et Génétique, Centre Hospitalier Universitaire, Angers, France Rodrigue Rossignol Laboratoire “MRGM” EA4576 (Maladies Rares: Génétique et Métabolisme), Université de Bordeaux, Bordeaux, France
[email protected] Jarungjit Rujiviphat Department of Biochemistry, University of Toronto, Toronto, ON, Canada Emmanuelle Sarzi Inserm U1051, Institut des Neurosciences de Montpellier, Universités de Montpellier I et II, Montpellier, France
xi
xii
Contributors
Zu-Hang Sheng Synaptic Function Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Building 35, Room 2B-215, 35 Convent Drive, Bethesda, MD 20892–3706, USA
[email protected]. Orian Shirihai Department of Medicine, Section of Molecular Medicine, Boston University School of Medicine, Boston, MA, USA
[email protected] Linsey Stiles Department of Medicine, Section of Molecular Medicine, Boston University School of Medicine, Boston, MA, USA and Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA, USA Christophe Verny UMR CNRS 6214 - Inserm U771, Angers, France and Département de Neurologie, Centre Hospitalier Universitaire, Angers, France Hongmin Wang Division of Basic Biomedical Sciences, University of South Dakota, Vermillion, SD 57069, USA Richard J. Youle Biochemistry Section, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), 35 Convent Drive, MSC 3704, Building 35/Rm, 2C917, Bethesda, MD 20892, USA
[email protected]
Chapter 1
The Genetics of Mitochondrial Fusion and Fission Eliana Y.L. Chan, Jarungjit Rujiviphat, and G. Angus McQuibban*
Abstract Mitochondrial research has undergone a true renaissance in the last few years. One can hardly pick up one of the top basic research or clinical research journals without seeing a new discovery about mitochondrial function in cellular/human health and disease. This book describes the most important aspects of mitochondrial function in neurodegeneration. This chapter serves as an introduction to the history of mitochondrial research, and also as an introduction to one of the fundamental cell biological nuances of mitochondrial activity, the gymnastics of double membrane fusion and fission. Here, we will discuss the genetic and biochemical characterization of the molecular machinery that orchestrates these complex processes. Further, we will introduce how these membrane dynamics contribute to both organelle and cellular function, and extend these findings to human disease. Keywords Mitochondrial fusion and fission • Mitochondrial morphology • Genetic screens • Dynamin-related proteins • Mechanoenzymes • Membrane scission and fusion • Proteolytic processing • Membranes and lipid homeostasis • Mitophagy • Neurodegeneration Abbreviations PA-GFP Fzo EM Mfn1/2 Dnm1 Drp1 Ugo1
photoactivatible green fluorescent protein fuzzy onions electron microscopy mitofusins 1 and 2 dynamin 1 dynamin-related protein 1 ugo is Japanese for fusion
* Eliana Y.L. Chan and Jarungjit Rujiviphat contributed equally to this chapter. E.Y.L. Chan, J. Rujiviphat, and G.A. McQuibban (*) Department of Biochemistry, University of Toronto, Toronto, ON, Canada e-mail:
[email protected] B. Lu (ed.), Mitochondrial Dynamics and Neurodegeneration, DOI 10.1007/978-94-007-1291-1_1, © Springer Science+Business Media B.V. 2011
1
2
Pcp1 Mgm Mdm10/30/33/36 TetO7 Phb1/2 RNAi dsRNA mtDNA siRNA OPA1 cDNA PARL GTPase GTP GED Vps1 OM IMS IM Fis1 NMR TPR co-IP Mdv1 Caf4 Num1 Gag3 Net2 NTE WD-40 Mff Letm1 CaMKIa GDAP1 CMT Mtp18 MTGM BDLP GDP MTS MPP ATP ADOA TEM
E.Y.L. Chan et al.
processing of cytochrome c peroxidase 1 mitochondrial genome maintenance 1 mitochondrial distribution and morphology 10/30/33/36 tetracycline-regulatable promoter with 7 regulatory units prohibitins 1 and 2 ribonucleic acid interference double-stranded ribonucleic acid mitochondrial deoxyribonucleic acid small interfering ribonucleic acid optic atrophy 1 complementary deoxyribonucleic acid presenilin-associated rhomboid-like guanosine triphosphate hydrolase guanosine triphosphate guanosine triphosphate effector domain vacuolar protein sorting 1 outer membrane intermembrane space inner membrane mitochondrial fission 1 nuclear magnetic resonance tetratricopeptide repeat Co-immunoprecipitation mitochondrial division 1 CCR4 Associated Factor nuclear migration 1 glycerol-adapted growth 3 named after the complex mitochondrial network of the yeast mutant N-terminal extension Beta-transducin repeats mitochondrial fission factor eucine zipper-EF-hand containing transmembrane protein 1 Ca2+/calmodulin-dependent protein kinase Ia Ganglioside-induced differentiation protein 1 Charcot-Marie-Tooth Mitochondrial protein 18 kDa mitochondrial targeting GxxxG motif bacterial dynamin-like protein guanosine diphosphate mitochondrial targeting sequence matrix processing peptidase adenosine triphosphate Autosomal Dominant Optic Atrophy transmission electron microscopy
1 The Genetics of Mitochondrial Fusion and Fission
GTPgS SCF TIM23 PAM MitoPLD CL PA Ups1/2 Gep1 MMM1 CRD1 PSD1 MAPL SUMO1 Bax Bak SENP5 MARCH-V MITOL RING DUBs Cdk1 PKA PP2A ROS ETC BCL2 PINK1 PD
3
guanosine 5¢-O-[gamma-thio]triphosphate Skp Cullin, F-box containing complex translocase of the inner mitochondrial membrane 23 Presequence translocase-associated motor mitochondrial phospholipidase D cardiolipin phosphatidic acid unprocessed 1/2 genetic interactor of prohibitin 1 maintenance of mitochondrial morphology cardiolipin synthase 1 phosphatidylserine decarboxylase 1 mitochondrial-anchored protein ligase small ubiquitin-like modifier 1 Bcl-2-associated X protein Bcl-2-associated K protein ? sentrin/SUMO-specific protease 5 membrane-associated RING-CH-V mitochondrial ubiquitin ligase Really interesting new gene deubiquitinase cyclin-dependent kinase 1 protein kinase A phosphatase 2A reactive oxygen species electron transport chain B-cell leukemia/lymphoma 2 PTEN induced putative kinase 1 Parkinson’s disease
1.1 Mitochondrial Dynamics: 100 years in the Making Since the 1850s, cytologists had observed granular structures in the cytoplasm of living cells. It was in 1857 that Swiss anatomist Rudolph Albert von Kölliker described these granular structures in the sarcoplasm of insect muscle cells. He showed in 1888 that these granules swelled in water and possessed a membrane. Although these structures were named “sarcosomes” in 1890, Carl Benda would introduce the term “mitochondrion” in 1898, derived from the Greek words mitos meaning threaded, and chondron meaning grain. Although the term “mitochondrion” became the most widely accepted name for this organelle, the term “sarcosome” is still used in present day to describe mitochondria in muscle cells. See Fig. 1.1 for a summary and overview of the past 100 years of mitochondrial research and discoveries.
2000
1950
1900
1850
Term “mitochondrion” was introduced First mitochondrial stains were introduced.
First successful mitochondrial purification
High-resolution electron micrographs. Mitochondria were revealed to consist of double membrane and that the inner membrane consisted of transversely oriented ridges.
1898
1948
1952
Present
to
2002
1997 2000 2001
1988
1964
1960
Mitochondria are recognized as dynamic organelles. Revealing players in mitochondrial fusion and fission. Understanding the mechanisms and regulations.
Proper mitochondrial fusion and fission were first shown to be crucial for the transmission of parental mitochondria to zygotes.
Term "Cristae" was introduced.
Named “sarcosomes”
1890
1913
First observed and described as granular structures in sarcoplasm of insect muscle cells
1857
Roles in cell cycle and cellular development. Functions in signalling including apoptotic pathway. Importance of mitophagy and its link to apoptosis.
Mitochondria were first shown to play a role in apoptosis.
Purified mitochondria were shown to contain enzymes for TCA cycle, fatty acid oxidation, and the respiratory assembly. The respiratory system was shown to be present in mitochondria from all cell types. Role in maintain ion gradient was first shown.
1948-1951
First discovery that respiration was associated with the granular structure.
More mitochondria-related genes identified in neurodegenerative diseases. Pathophysiological in-
Mutations in genes required for mitochondrial fusion and fission were identified in patients with neurodegenerative diseases.
Diseases associated with mutations in mitochondrial DNA were first identified.
The presence of mitochondrial DNA was confirmed.
Noticed fibers within the mitochondria were sensitive to nucleic acid stains.
4 E.Y.L. Chan et al.
Fig. 1.1 The past 100 years of mitochondria: Mitochondrial studies began over 100 years ago. The discoveries are categorized as findings in mitochondrial structure (beige), mitochondrial function (green) and mitochondrial DNA and related diseases (blue). It has been more than 100 years in attempting and refining the visualization of mitochondria. Advances in the successful purification of mitochondria greatly accelerated the discoveries of mitochondrial functions. Around the same time, the presence of mitochondrial DNA was revealed. Subsequently, many studies uncovered mitochondria-related diseases. In the past decade (grey background), tremendous progress has been made in recognizing mitochondria as dynamic organelles, studying its roles in several diverse cellular processes and discovering mitochondria-related genes that are linked to neurodegenerative diseases
1 The Genetics of Mitochondrial Fusion and Fission 5
6
E.Y.L. Chan et al.
Identification of mitochondria in the early days were challenging since there were many granular structures in the cell. The first mitochondrial stains were introduced in 1898 by Benda and Michaelis. Benda introduced crystal violet, and Michaelis introduced Janus green, an oxidation-reduction dye. In 1908, based on their response to different stains, Regaud concluded that mitochondria contain phospholipid and protein, easing the identification of mitochondria in cell types other than muscle. Since the early 1930s, researchers had attempted on many occasions to isolate intact mitochondria. Hogeboom, Schneider and Palade reported the first successful mitochondrial purification in 1948. They used 0.88 M sucrose to disperse rat liver cells, and were able to easily separate nuclei, mitochondria and microsomes by differential centrifugation. More importantly, the isolated mitochondria had a filamentous structure characteristic of those in rat liver cells, indicating that they had purified intact mitochondria (Hogeboom et al. 1947, 1948). Coincidentally, work from other groups had indicated that the oxidation of fatty acids was dependent on certain elements in liver homogenates. In particular, it was imperative that the structure be maintained in this easily damaged element (Munoz and Leloir 1943; Lehninger 1945). The report that intact mitochondria could be purified using 0.88 M sucrose prompted Lehninger and Kennedy to test the ability of isolated mitochondria to oxidize fatty acids. They reported that purified mitochondria could oxidize fatty acids and intermediates of the Krebs cycle at a rate similar to that of intact liver cells. In addition, they also observed that oxidative phosphorylation was concomitant with these oxidations (Kennedy and Lehninger 1948). Over time, work by others confirmed that this respiratory system is present in mitochondria from all cell types examined, regardless of plant or animal origin (Schneider 1948; Lehninger 1949; Kennedy and Lehninger 1949; Potter et al. 1951). Although Warburg had discovered in 1913 that respiration was associated with granular insoluble structures in the cell, it was not until these breakthroughs approximately 40 years later that confirmed mitochondria were the sites of respiration and oxidative phosphorylation. Soon after the discovery that mitochondria catalyzed oxidative phosphorylation, several groups found that mitochondria also maintained ion gradients. These ions included Na+, K+ and Ca2+ (Macfarlane and Spencer 1953; Bartley and Davies 1954). In order to maintain a gradient, it was clear that mitochondria needed to be membrane-bound. High-resolution electron micrographs provided by Palade and Sjöstrand in 1952 and 1953 confirmed the structure of mitochondria (Palade 1952; Sjostrand 1953). They found that mitochondria had a double membrane, and that the inner membrane consisted of transversely oriented ridges. Palade introduced the term “cristae” to describe the ridges seen in the mitochondrial inner membrane. He noticed that the cristae varied in number and spacing depending on the cell type from which the mitochondria were isolated (Palade 1952). It would later be known that these cristae folds increased the surface area of the mitochondrial inner membrane, enabling more efficient oxidative phosphorylation.
1 The Genetics of Mitochondrial Fusion and Fission
7
The next important mitochondrial discovery was the identification that mitochondria contained DNA. Non-mendelian cytoplasmic inheritance had been discovered in plants by Carl Correns since the early 1900s. This discovery in yeast by Boris Ephrussi in 1950 indicated that factors other than chloroplasts could be inherited by non-mendelian genetics. The Ephrussi laboratory used DNA mutagens and found that these mutations were cytoplasmically inherited although there had been no evidence of cytoplasmic DNA at the time (Roman 1980). Visualizing chick embryo mitochondria by electron microscopy in 1963, Margrit and Sylvan Nass noticed fibres within the mitochondria that were sensitive to nucleic acid stains. They showed in two back-to-back publications that these nucleic acid-containing fibres were DNA. The fibres were not removed when fixed with potassium permanganate indicating they were not RNA, and they were sensitive to DNAse (Nass and Nass 1963a, b). The presence of mitochondrial DNA (mtDNA) was further confirmed by Haslbrunner, Tuppy and Schatz. Using purified yeast mitochondria, biochemical analyses indicated that small, but significant amounts of DNA co-purified with mitochondria (Schatz et al. 1964). The discovery of mtDNA sparked new interest in mitochondrial research and supported speculations that eukaryotic mitochondria evolved from endosymbiotic bacteria. Due to its bioenergetic capability and the early observations of shape and size of mitochondria, it is believed that mitochondria evolved from symbiotic living of bacteria inside primitive cells. Later, evidence such as the existence of a unique mitochondrial genome, ribosomes, and compositions of the inner and outer membranes further support this theory. With the discovery of mtDNA came the identification of diseases associated with its mutations. Wallace and Holt were the first to identify diseases associated with mutations in mtDNA (Wallace et al. 1988; Holt et al. 1988). Since then, many mitochondrial diseases have been identified and are caused not only by mutations in mtDNA, but also by mutations in nuclear genes encoding mitochondrial proteins. Research conducted in yeast to understand the process of mitochondrial inheritance determined that proper mitochondrial fusion and fission were crucial for the transmission of parental mitochondria to zygotes (Nunnari et al. 1997). Mitochondrial dynamics are now known to be crucial mediators of apoptosis and neurodegeneration. In the last decade much of the research work conducted on mitochondrial diseases has focused on the role of fusion and fission in disease pathogenesis. In 2001, Frank and colleagues discovered that mitochondrial fission was a process that preceded apoptosis. Inhibition of a mitochondrial fission factor prevented cell death (Frank et al. 2001). Furthermore, inhibition of mitochondrial fusion with unopposed fission promoted apoptosis (Sugioka et al. 2004). At approximately the same time that mitochondrial dynamics were discovered to be important in cell death, mutations in genes required for mitochondrial fusion and fission were identified in patients with neurodegenerative diseases (Alexander et al. 2000; Kijima et al. 2004; Waterham et al. 2007). These discoveries are at the heart of the mitochondrial disease field at the moment. Nonetheless, none of these recent advances would have been possible without the 100 years of preceding research and remarkable discoveries made by our predecessors. The basic functions of mitochondria are summarized in Fig. 1.2.
8
E.Y.L. Chan et al.
Fig. 1.2 Mitochondrial structures and functions. (a) Static visualization of mitochondria. Thinsectioned transmission electron micrographs provide static views of mitochondria (arrow heads) as individual bean-shaped organelles. (Figure modified from McQuibban et al. 2003) (b) Dynamic observation of mitochondria. Fluorescence microscopy reveals the network and dynamic nature of mitochondria. These are a series of time-resolved images of yeast expressing mitochondrialtargeted GFP in 3-min intervals. Scale bar: 2 mm. (Figure modified from Shaw and Nunnari 2002). (c) Mitochondrial membrane architecture. Mitochondria are double-membrane-bound organelles consisting of four subcompartments: outer membrane, intermembrane space, matrix and inner membrane that folds into cristae. (d) Mitochondrial functions. Mitochondria are sites for several cellular processes, from left to right: metabolism, cellular respiration via the electron transport chain (ETC), calcium buffering and the apoptotic pathway. Metabolic pathways in mitochondria include the
1 The Genetics of Mitochondrial Fusion and Fission
9
1.1.1 First Description of Mitochondrial Dynamics One of the first in-depth descriptions of mitochondria in cells was achieved by Lewis and Lewis in 1915. Using cultured chick cells, they were able to observe live and fixed mitochondria, and could describe mitochondrial movement, quantity and dynamics. What they referred to as mitochondrial fusion and branching/separation (fission) are now known to be distinct, regulated processes required for proper mitochondrial function and inheritance (Nunnari et al. 1997; Twig et al. 2008; Chen 2005; Dimmer 2002). Figure 1.3 shows more recent fluorescent microscope images of mitochondria rapidly undergoing fusion and fission events. Changes in shapes, dislocation, fusion and fission were also noted and sketched out (Fig. 1.3). Despite the evidence of mitochondrial dynamics in 1915, mitochondria were often visualized and recorded by transmission electron microscopy as bean-shaped double-membrane organelles with four subcompartments: outer membrane, intermembrane space, inner membrane and matrix (Palade 1952; Sjostrand 1953) (Fig. 1.2). There were several observations that mitochondria have different morphologies according to cell types and stages in life cycle (Bereiter-Hahn 1990; Yaffe 1999). There were speculations that these different morphologies could be due to the dynamics of the organelle. However, it was not until the 1990s with the development of light microscopy and fluorescent probes that the dynamics of mitochondria in living cells were recorded and widely-accepted (Bereiter-Hahn and Voth 1994). Electron tomographs of three-dimensional mitochondrial structures serve as evidence for mitochondrial plasticity (Perkins et al. 2009). With the development of photoactivatible green fluorescent protein (PA-GFP), tracking the dynamics of a single mitochondrion has now become possible (Patterson and Lippincott-Schwartz 2002; Liu et al. 2009). Figures 1.3 and 1.4 summarize examples of mitochondrial visualization in different model organisms with a variety of microscopic approaches. Figure 1.4 also demonstrates the variety of mitochondrial morphologies that exist in different tissues; yet another example that this is a very dynamic and plastic compartment.
Fig. 1.2 (continued) oxidation of fatty acids and the conversion of pyruvate to acetyl CoA by pyruvate dehydrogenase (PDH) to enter the tricarboxylic acid (TCA) cycle. Transferring electrons and oxygen respiration by the ETC results in ATP production. Reactive oxygen species (ROS) are byproducts of cellular respiration. ROS are inactivated by mitochondrial superoxide dismutase (MnSOD/SOD2). The mitochondrial genome encodes subunits of the respiratory chain complexes. The adenine nucleotide translocator (ANT) and the voltage-dependent anion channel (VDAC) mediate shuttling of ATP and ADP. Mitochondria are essential for maintaining calcium ion homeostasis by the function of VDAC in the outer membrane and the Ca2+/H+ anti-porter in the inner membrane. ANT and VDAC also function with proteins in the Bcl-2 family shown in red in the apoptotic pathway. Pro-apoptotic members, Bak and Bax, facilitate the release of apoptosis inducing factor (AIF) and cytochrome c (CytC), respectively, activating caspases to trigger apoptosis. On the other hand, anti-apoptotic members, Bcl-2 and Bcl-X, inhibit the release of CytC and AIF
Fig. 1.3 Visualization of mitochondrial dynamics. (a) The first observation of the presence and the dynamic behavior of mitochondria in living cells by bright field microscopy. These sketches were derived from the observations of chick fibroblast cultures. The changes were described to be (a) bending, (b) shortening and elongating, (c) fusion of granules, (d) changing in shape and fusion to form a network, (e) changing in shape and fusion, and (f) changing in shape and fusion to form a single mitochondrion. The number below each sketch indicates the time observed. Figure taken from Lewis and Lewis, 1914. (b) Visualizing mitochondria in living cells by time-lapse fluorescence microscopy. Mitochondria were labeled with YFP. The blue color highlights mitochondria that were being monitored. Fusion was observed in the first three frames and fission was observed in the latter three frames. (Figure taken from Chan 2006) (c) Monitoring mitochondrial fusion by photoactivatable fluorescence microscopy. Mitochondria were labeled with mtRFP and photoactivatable mtGFP (mtPAGFP). A subset of mitochondria that were photoactivated are seen as yellow mitochondria. These mitochondria can then be monitored for a complete fusion process. Time zero indicates the start point of the fusion process. (Figure modified from Liu et al. 2009)
1 The Genetics of Mitochondrial Fusion and Fission
11
Fig. 1.4 Mitochondrial morphology (I) Normal and aberrant mitochondrial morphologies in model organisms. (A) Knocking-out fusion and fission genes in Saccharomyces cerevisiae results in abnormal mitochondrial morphologies. A tubulated mitochondrial network was observed in wild-type cells (Aa) while net formation and fragmentation were observed in Ddnm1 (Ab) and Dfzo1 (Ac) cells, respectively. (Figure modified from Shaw and Nunnari 2002). (B) Mutation in fzo causes a ‘fuzzy onion’ morphology of mitochondria in Drosophila melanogaster spermatids. (Ba) Wild-type mitochondria form into a giant onion in the onion stage of sperm development. (Bb) Instead of one giant mitochondrial derivative, individual mitochondria in fzo appear to wrap around each other and have failed to undergo proper fusion to form the nebenkern. (Figure modified from Hales and Fuller 1997). (C) Mutation in Drp-1 disrupts mitochondrial morphology in Caenorhabditis elegans muscle cells. Mitochondria in wild-type cells (Ca) have normal tubulated morphology whereas mitochondria in cells containing mutant Drp-1 (Cb) are observed as large blebs. (Figure modified from Labrousse et al. 1999) (D) Mitochondrial network is aberrant in OPA1 mutated mouse embryonic fibroblast cells. Similar to fragmentation of mitochondria in Fzo1 mutated yeast, the mitochondrial network in mutant OPA1 cells (Db) is fragmented, unlike tubulated mitochondria in wild-type cells (Da).(II) Diverse mitochondrial morphologies and distributions in various tissues. Mitochondrial morphology, distribution and mass vary in different cell types. From (A) to (D), electron microscopy images show mitochondrial morphologies observed in lung, kidney, cardiac muscle and neuron
12
E.Y.L. Chan et al.
Since the identification of mitochondrial dynamics, technological advances together with genetic, structural and biochemical approaches have enabled the field to dissect the molecular mechanisms of mitochondrial fusion and fission. This chapter will describe the discoveries in model organisms that have helped this field progress, and outline the mechanisms of mitochondrial fusion and fission. The functional significance of mitochondrial dynamics will also be discussed. The chapter will conclude with what we feel are the most important recent advances in the last couple of years, and discuss genetic and biochemical approaches to more clearly understand the complex cell-biological activity of this important organelle.
1.1.2 The First Identified Components in Fusion/Fission by Genetic Approaches Although mitochondrial fusion and fission had been observed in many cell types and organisms, it was not until 1997 that Hales and colleagues identified and characterized the first gene involved in mitochondrial dynamics. The Drosophila gene fuzzy onions (Fzo) is required for mitochondrial fusion in Drosophila spermatids. Mutations in Fzo result in abnormal sperm development and consequently male sterility (Hales and Fuller 1997). During the onion stage of spermatogenesis, mitochondria aggregate and fuse, forming two mitochondrial derivatives that wrap around each other, creating a spherical structure known as the Nebenkern. Electron microscope (EM) images of the cross section of WT Nebenkerns resemble onion slices whereas fzo Nebenkerns appear fuzzy and misshapen (see Fig. 1.4). Homologs of Drosophila fzo with similar functions in mitochondrial fusion have since been identified in many organisms including the nematode worm C. elegans (Fzo-1), the budding yeast S. cerevisiae (Fzo1) and in mammals (Mitofusins 1 and 2 [Mfn1 and Mfn2]; (Kanazawa et al. 2008; Hermann et al. 1998; Eura 2003; Chen 2003)). Mutational analyses in S. cerevisiae and C. elegans identified the second component of mitochondrial dynamics. The identification of yeast Dnm1 and its worm homolog Drp-1 were identified almost simultaneously to be factors required for mitochondrial fission (Bleazard et al. 1999; Labrousse et al. 1999). Previous studies in yeast (Dnm1) and mammals (Drp1) had indicated that Dnm1 and Drp1 are required in the maintenance of mitochondrial morphology and distribution (Otsuga et al. 1998; Smirnova et al. 2001). Two separate groups formally showed that Dnm1/Drp1 regulated mitochondrial morphology and distribution by participating in mitochondrial fission. Knocking-out Dnm1 in yeast resulted in a net-like mitochondrial morphology, a phenotype due to insufficient fission and unopposed fusion. Immunogold labeling indicated that Dnm1 was localized to mitochondrial constriction sites about to undergo fission and on tips of mitochondria that had just completed division. Furthermore, the Ddnm1 mutation rescued the fzo1-1 conditional mutant, implicating it as a fission factor (Bleazard et al. 1999). Consistent
1 The Genetics of Mitochondrial Fusion and Fission
13
with the observations in yeast, over-expression of Drp-1 in worms resulted in fragmented mitochondria instead of the long tubular mitochondrial network seen in WT worms. On the contrary, worms expressing mutant forms of Drp-1 had aggregated mitochondria due to lack of mitochondrial fission (Labrousse et al. 1999). Surprisingly, the aggregated mitochondria were connected by thin tubules. Further analysis by labeling the matrix and outer membrane (OM) with CFP and YFP respectively determined that those thin connecting tubules were tubules of the OM (see Fig. 1.4). This suggested that although mutant Drp-1 did not allow OM scission, IM scission still occurred (Labrousse et al. 1999). Since the identification of the founding fusion and fission genes Fzo and Dnm1/ Drp1, many other genes have been shown to be involved in maintaining proper mitochondrial morphology. Of particular note are genetic screens conducted in yeast and worms that have helped identify many of these new components.
1.1.3 Yeast Screens Ugo1 and Pcp1 (also known as Rbd1) were identified in a yeast screen as genes that suppressed the Dnm1 fission defect, implicating them as fusion factors. Since fission mutants lose their mtDNA, and the malfunction of either fusion or fission is sufficient for mtDNA loss, the authors screened mutants that retained mtDNA in the double mutant (indicating restored balance of fusion and fission), but lose their mtDNA in the presence of functional Dnm1 (indicating functional fission but lack of fusion). Dugo1 and Dpcp1 mutants had fragmented mitochondria reminiscent of Dfzo1 fusion mutants and rescued the Ddnm1 fission defect, strongly implying that they are required for proper mitochondrial fusion (Sesaki and Jensen 2001). Subsequent analysis of Pcp1 revealed that it is a serine protease required for the cleavage of Mgm1 (Sesaki 2003). Mgm1 had originally been identified as a gene required for mitochondrial genome maintenance (Jones and Fangman 1992). Further studies showed that deletion of Mgm1 not only resulted in the loss of mtDNA, but also compromised respiration and mitochondrial fusion (Jones and Fangman 1992; Wong et al. 2000). Identification of Pcp1-dependent Mgm1 cleavage revealed the regulation of mitochondrial dynamics by proteolytic processing (Sesaki 2003; McQuibban et al. 2003). A systematic genetic screen performed on 4,794 knock-out yeast mutants identified components required for the maintenance of mitochondrial morphology and respiratory growth. Mutants were screened for their inability to grow on glycerol (indicating respiratory incompetence) and aberrant mitochondrial morphology. The genes required to maintain normal mitochondrial distribution and morphology (MDM) were divided into three classes (Dimmer 2002; McConnell et al. 1990). Class I genes were essential for normal mitochondrial morphology; WT mitochondrial morphology was never observed in Class I mutants. Class II and III mutants had either fragmented or aggregated mitochondria but class II mutants were respiratory competent whereas class III mutants were petites (respiratory incompetent).
14
E.Y.L. Chan et al.
This systematic approach enabled genome-wide screening of yeast mutants, and identified 15 novel genes required for the maintenance of mitochondrial morphology (Dimmer 2002). Further characterization of Mdm30, a gene identified in the screen with previously unknown functions led to the discovery that ubiquitination might regulate the stability of Fzo1, a protein directly involved in mitochondrial fusion. Although previous studies had implicated ubiquitin and the proteasome in maintaining normal mitochondrial morphology, this study likely provided the first evidence of mitochondrial protein-targeted ubiquitination (Fritz 2003). The screens performed previously were unable to identify essential genes involved in mitochondrial dynamics (Dimmer 2002; Sesaki and Jensen 2001; McConnell et al. 1990; Burgess et al. 1994). Cells with any one of its essential genes knocked out were simply not viable. To examine whether essential genes were required for mitochondrial morphology, Altmann and colleagues used a collection of yeast strains with essential genes expressed under a regulatable TetO7 promoter. Gene repression was achieved by the addition of doxycycline to repress the TetO7 promoter (Gari et al. 1997; Mnaimneh et al. 2004). Of the 728 yeast genes that were screened, 119 of them were required for normal mitochondrial morphology. Expectedly, some of the highly enriched genes included those of the mitochondrial import machinery. Surprisingly, however, many genes involved in other processes were also highly enriched. These included genes involved in ergosterol biosynthesis, vesicular transport and the ubiquitin/26S proteasome-dependent degradation machinery. The results from this screen indicate that, albeit indirectly, many pathways affect mitochondrial morphology (Altmann 2005), and more research has to be conducted to determine the roles that these pathways play in mitochondrial dynamics (see later sections of chapter). Moreover, yeast multi-copy suppressor screens have been widely conducted to elucidate genes participating in the mitochondrial dynamics pathway. Num1 was found as a hit in the multi-copy suppressor screen of the DNM1-109 mutant (Cerveny et al. 2007). A high-copy suppressor of Mdm12 identified Phb2 belonging to the highly conserved family of prohibitins that function in maintaining IM architecture and processing of the mammalian Mgm1 homolog, OPA1. In addition, the synthetic genetic array (SGA) approach is a recent development to screen for genome-wide genetic interactions in a systematic format. For instance, the genetic interactome of prohibitins provided more insight into the function of prohibitins in the inner membrane and uncovered its role in phospholipid homeostasis. This activity may be linked to the regulation of Mgm1 processing and its role in the maintenance of mitochondrial morphology.
1.1.4 Worm Screen An RNAi screen was conducted in C. elegans to determine which of the known mitochondrial proteins were required for the maintenance of normal morphology. Worms expressing RFP-tagged TOM20 were fed E. coli cells expressing dsRNA
1 The Genetics of Mitochondrial Fusion and Fission
15
specific to the target genes. Mitochondria in the body wall muscles of these worms were examined for their morphology. Of the 719 genes predicted to be mitochondrial, more than 80% were required to maintain normal mitochondrial morphology. RNAi knock-down of 574 (79.8%) genes resulted in mitochondria that were fragmented while knock-down of the remaining 25 (3.5%) genes resulted in elongated mitochondria. Classification of the genes whose knock-down resulted in fragmentation yielded an unexpectedly high number of genes required for basic mitochondrial functions such as metabolism and oxidative phosphorylation. The results from this screen highlight the intricate relationship between proper mitochondrial function and dynamics (Ichishita et al. 2007).
1.1.5 Mammalian Studies The functions of several human orthologs of the fusion and fission molecules (as described above and below) have recently been studied in well-characterized cultured cell lines. For instance, over-expression of Drp1 was shown to alter mitochondrial morphology (Smirnova et al. 1998; Misaka et al. 2002). Furthermore, Drp1 and mitochondrial fission were shown to be essential for mitochondrial distribution in neurons (Chen and Chan 2009). In addition to simple over-expression systems in cultured cells, the siRNA knockdown approach has also provided great advances to the study of mitochondrial dynamics. For instance, knockdown of OPA1 leads to fragmentation of mitochondria (Olichon et al. 2003). Beyond experiments in tissue culture cells, genetic and biochemical approaches in mice have been powerful approaches in studying the role of mitochondrial dynamics in both cellular development and the pathophysiology of related diseases. The phenotypes and characterization of various mouse models have lead to a better understanding of the pathophysiology of many neurodegenerative diseases and uncovered the functional roles of the players in mitochondrial dynamics. Specifically, Mitofusins 1 and 2 (Mfn1/2) were identified as the mammalian orthologs of fly and yeast Fzo1 from a mouse cDNA library (Chen et al. 2003). Both Mfn1 and Mfn2 knock-outs show embryonic lethality of homozygous mutants. In addition, Mfn-deficient mouse embryonic fibroblast cells have altered mitochondrial morphology and dynamics. Similarly, homozygous Opa1 null mice also show early embryonic lethality. Heterozygous Opa1 mice are viable but their inter-crosses give no live progeny of Opa1−/− (Davies et al. 2007). Heterozygous Opa1 mice displayed fragmented mitochondria, abnormal optic nerve myelination and structure as well as impaired visual functions (Davies et al. 2007). PARL is the mammalian homologue of yeast Pcp1/Rbd1, and when its function is disrupted in the mouse, the animal dies at 6 weeks of age. At a molecular level, PARL knock-out mice reiterate the importance of PARL-dependent OPA1 processing, and reveal the pivotal role of OPA1 in apoptosis by regulating cytochrome c storage and release.
16
E.Y.L. Chan et al.
1.2 Mechanistic Models for the Molecular Machines of Mitochondrial Dynamics The pioneering discoveries of the molecular machineries of mitochondrial fusion and fission were largely derived from genetic studies in yeast, flies and worms as described above. Due to the simplicity of a single cell system and powerful genetic approaches, more is known about the molecular mechanisms of yeast mitochondrial dynamics. The key players have been characterized as mechanoenzymes. These mechanoproteins are the dynamin-related proteins (DRPs) (Hoppins et al. 2007). DRPs are large GTPases that are involved in several membrane remodeling events (Praefcke and McMahon 2004). They are distinguished from other GTPases by their ability to bind to lipids, self-assemble, and to self-stimulate its GTP hydrolysis activity (Praefcke and McMahon 2004). All DRPs contain three conserved domains; the catalytic GTPase domain serves as the site for GTP binding and hydrolysis; the middle domain and GTP effector domain (GED) are essential for oligomerization and self-assembly. The region between the middle domain and the GED serves as the site for lipid interactions (Praefcke and McMahon 2004). The four well-characterized dynamin-related proteins in yeast are Vps1, Dnm1, Mgm1 and Fzo1. Vps1 mediates Golgi vesicle formation while the other three DRPs function in mitochondrial dynamics. Dnm1 directly mediates the fission of mitochondria while Mgm1 and Fzo1 are the key players for mitochondrial fusion (Hoppins et al. 2007). These DRPs are highly conserved proteins and their higher eukaryotic counterparts (summarized in Table 1.1) are also fission and fusion molecules. Beyond the DRPs, there are several other classes of proteins that orchestrate mitochondrial dynamics. The complexity of these processes can be attributed to the fact that unlike other organelles, mitochondria have a double membrane. Hence, proper mitochondrial fusion and fission requires the maintenance of four distinct compartments: the outer membrane (OM), the intermembrane space (IMS), the inner membrane (IM) and the matrix. The following section will focus on the mechanisms of mitochondrial fusion and fission, summarizing the findings in model organisms and key biochemical techniques that helped elucidate these complex mechanisms. Please see Fig. 1.5 for a pictorial summary of these membrane gymnastics.
1.2.1 Mitochondrial Fission 1.2.1.1 The Components of Mitochondrial Fission Dnm1/Drp1 Although the regulation of mitochondrial fission differs slightly from one organism to another, the core components required remain highly conserved. In general, mitochondrial membrane fission requires Fis1 and a dynamin-related protein
–
–
–
–
–
Num1
Mdm36
Mdm33
–
–
NUM1
MDM36
MDM33
MTP18
SH3GLB1
SUMO1
–
–
Caf4
CAF4
–
–
Mdv1
MDV1
MARCHV
Fis-1/2
Fis1
Drp-1
FIS1
Genes implicated in fission DNM1 Dnm1
–
–
–
–
–
–
–
–
Fis1
Drp1
SUMO1
MARCHV
Endophilin B1
MTP18
–
–
–
–
–
hFis1
DRP1
Dynamin-related GTPase acting as a mechanoenzyme that self-assembles to form ring and constricts mitochondria TRP repeats functioning in targeting of Dnm1 WD40 repeats serving as an adaptor for Fis1 and Dnm1 WD40 repeats serving as an adaptor for Fis1 and Dnm1 Cell-cortex anchored protein functioning in targeting of Dnm1 Fission molecule facilitating Dnm1 and Num1 complex Protein in intermembrane space involved in fission of yeast inner mitochondrial membrane Protein in intermembrane space involving in fission of mammalian inner mitochondrial membrane BAR domain containing protein involving in fission of mammalian outer mitochondrial membrane Ubiquitin ligase in mammalian mitochondrial outer membrane adding ubiquitins onto Drp1 and MFN2 Ubiquitin-like modifying enzyme modifying and regulating Drp1
Table 1.1 List of genes characterized to have implicated roles in mitochondrial dynamics Gene name S.ceverisiae C.elegans Drosophila Mammals Known function
(continued)
Related diseases
1 The Genetics of Mitochondrial Fusion and Fission 17
–
–
–
–
–
Pcp1/Rbd1
Mdm30
Ups1
PCP1
MDM30
UPS1
–
–
Rhomboid-7
–
Opa1-like
Eat-3
Ugo1
Fzo
–
Drosophila
Fzo-1
–
C.elegans
UGO
Genes implicated in fusion Fuzzy Fzo1 onions MGM1 Mgm1
GDAP1
Table 1.1 (continued) Gene name S.ceverisiae
PRELI
–
PARL
–
OPA1
MFN1, MFN2
GDAP1
Mammals
Dynamin-related GTPase possessing heptad repeats for tethering of mitochondria Dynamin-related GTPase mediating fusion and maintaining cristae structure Carrier protein coordinating outer and inner mitochondrial membrane fusion. Rhomboid serine protease involving in Mgm1 processing F-Box E3 ligase involving in maintaining Fzo1 level Protein in intermembrane space involving in regulating Mgm1 processing
Ganglioside-induce differentiationassociated protein involving in fission
Known function
ADOA
CMT2A
CMT4A
Related diseases
18 E.Y.L. Chan et al.
1 The Genetics of Mitochondrial Fusion and Fission
19
Dnm1/Drp1 (Bleazard et al. 1999; Mozdy et al. 2000; Tieu and Nunnari 2000). Dnm1/Drp1 are the DRPs involved in mitochondrial membrane fission. Yeast Dnm1 exists as punctate structures in the cytosol and on the mitochondrial OM (Otsuga et al. 1998; Naylor 2005), while mammalian Drp1 is mostly diffuse cytoplasmic, with some punctae on mitochondria (Smirnova et al. 2001). Despite their differences in localization, Dnm1/Drp1 in yeast, worms and mammals were found to localize to the OM at sites of mitochondrial fission (Sesaki and Jensen 1999; Legesse-Miller 2003) consistent with their roles as proteins that divide mitochondria. Although homologs have been identified in many organisms, it is the detailed biochemical and structural analyses on yeast Dnm1 and mammalian Drp1 that have helped shed light on the mechanism of DRP-mediated mitochondrial fission. Like dynamins, Dnm1/Drp1 assemble into dimers/tetramers (Fukushima et al. 2001; Shin et al. 1999). In addition, they organize into ring-like structures (Smirnova et al. 2001; Ingerman 2005; Yoon et al. 2001). The spirals formed by Dnm1 were able to constrict liposomes, reducing their diameter to that of mitochondrial constriction sites (Ingerman 2005). Independent studies using truncated forms of yeast Dnm1 and mammalian Drp1 identified the GED as an important region for the formation of higher ordered structures (Fukushima et al. 2001; Zhu 2004). The GED of mammalian Drp1 forms intermolecular interactions with itself and intramolecular interactions with the GTPase domain. K679 in the GED was found to be required for intra- not intermolecular interactions since the K679A mutation resulted in reduced intramolecular interactions but did not affect its intermolecular interactions (Zhu 2004). Other than a function in coordinating intra- and intermolecular interactions, the GED was also shown to be sufficient for mitochondrial targeting of Drp1 (Pitts 2004). One of the characteristic features of dynamins and DRPs is oligomerizationstimulated GTP hydrolysis. The first evidence that the mitochondrial fission DRPs also had this feature came from the analysis of yeast Dnm1. Ingerman, et al (Ingerman 2005) characterized the kinetics of GTP hydrolysis by Dnm1 and observed a lag in attaining the maximum rate of GTP hydrolysis. This lag was not observed in a Dnm1 middle domain mutant (Dnm1G385D) defective in self-assembly. Although this mutant could dimerize, it failed to form higher order structures that facilitated GTP hydrolysis (Ingerman 2005). A lethal mutation identified in the Drp1 middle domain (Drp1A395D) also compromised its organization into higher order oligomers. While Drp1 monomers still formed dimers/tetramers, they failed to organize into higher order structures (Chang et al. 2010). Localization of the Dnm1G385D middle domain mutant to mitochondria indicates that the oligomeri zation occurred after recruitment of the dimer to the membrane (Bhar 2006). These data strongly suggest that Dnm1/Drp1 self-assemble into higher order oligomers upon recruitment to the mitochondria, and that this self-assembly is the ratelimiting step in GTP hydrolysis (Ingerman 2005; Bhar 2006). The lethality of the reported Drp1A395D mutation points to the importance of this domain and its role in oligomerization and proper Dnm1/Drp1 function.
20
E.Y.L. Chan et al.
Fig. 1.5 Mechanistic models of yeast mitochondrial fusion and fission. The diagram illustrates proposed models of mitochondrial dynamics and mechanisms of actions by the key players. Blue boxes, (a–c), show sequential steps of mitochondrial fusion whereas red boxes, (d–f), present the proposed mitochondrial fission event. Grey boxes, (g–i), show the currently known regulatory pathways in mitochondrial fusion and fission. Proposed model of mitochondrial fusion: (a) The mitochondrial fusion machinery complex consists of Fzo1 and Ugo1, anchored to the outer membrane, l-Mgm1, anchored to the inner membrane, and s-Mgm1, peripherally associated with the inner membrane. Fzo1 tethers mitochondria by forming a complex in trans via its coiled-coil region. Following the tethering step, it is yet unclear how Fzo1 causes fusion of the outer membrane bilayers. Ugo1 is suggested to be crucial for the lipid-mixing step. (b) Both l-Mgm1 and s-Mgm1 are the key players in the inner membrane fusion reaction. l-Mgm1 is proposed to serve as a docking site for s-Mgm1 recruitment. Homo- and hetero-oligomerization of the two isoforms in both cis and trans are important for tethering of the opposing inner membranes. As observed in OPA1, membrane tubulation is a possible action that drives membrane fusion (blue question mark). Tubulation increases the curvature of the membrane, creating high-energy stress that can be relieved upon fusion. (c) The mechanism following the tethering of inner membranes is largely unknown. Besides functioning in mitochondrial fusion, Mgm1 also plays a crucial role in the maintenance of cristae structures (asterisk). Proposed model of mitochondrial fission: (d) Dnm1 acts as a mechanoenzyme to mediate membrane scission. Dnm1 is targeted to, oligomerizes, and assembles onto the cytosolic side of the outer membrane. Inner membrane fission may be mediated separately from outer membrane fission by the protein Mdm33. (e) Dnm1 self-assembles into a high-order helical structure in a GTP-dependent manner. This structure results in mitochondria wrapped by Dnm1 and membrane constriction by Dnm1 self-assembly. (f) Upon GTP hydrolysis, the fission event is completed and Dnm1 is released from the outer membrane. Regulation of mitochondrial dynamics: (g) Proteolytic processing of Mgm1 serves as a mode of regulation since equal molarity of s- and l-Mgm1 is critical for proper fusion. Alternative topogenesis is the
1 The Genetics of Mitochondrial Fusion and Fission
21
Fis1 Fis1 is an integral membrane protein on the mitochondrial OM that recruits Dnm1/ Drp1 to mitochondria (Mozdy et al. 2000; Yoon et al. 2001). In the absence of Fis1, Dnm1/Drp1 localization to mitochondria is severely compromised (Mozdy et al. 2000; Yoon et al. 2001). The N-terminus of Fis1 faces the cytosol and its C-terminus faces the IMS (Fig. 1.5; (Mozdy et al. 2000; James 2003)). Most of the protein resides in the cytosol, and is anchored to the OM by its C-terminal TM segment (Stojanovski 2004). Disruption of its short C-terminal tail with or without its TM segment disrupts yeast (Fis1) and human Fis1 (hFis1) localization to mitochondria (Mozdy et al. 2000; Stojanovski 2004; Yoon et al. 2003). Unlike Dnm1/Drp1 that appear as discrete punctae, Fis1 is uniformly distributed throughout the membrane (Mozdy et al. 2000). Solution NMR spectroscopy revealed that the cytosolic portion of yeast Fis1 (Fis1) and human Fis1 (hFis1) organizes into six a-helices (a1–a6) that resemble tetratricopeptide repeat (TPR) folds (Suzuki et al. 2003; Suzuki 2005). TPR motifs mediate protein-protein interactions and are usually a part of multiprotein complexes (reviewed in Blatch and Lassle, 1999 (Blatch and Lassle 1999)). Subsequent crystal structure analysis indicates that a2–a3 and a4–a5 of Fis1/hFis1 form two TPR motifs (TPR1/2) resulting in a concave hydrophobic binding pocket (Suzuki 2005; Dohm et al. 2004). The folding and structure of the six helices are very similar in Fis1 and hFis1. However, the N-terminus of hFis1 is largely unstructured (Suzuki et al. 2003) whereas that of Fis1 is longer and forms an a-helix strikingly similar to that of a1 in hFis1 (Suzuki 2005). Since TPR motifs mediate protein-protein interactions, it would seem intuitive that the TPRs in Fis1/hFis1 serve to recruit Dnm1/Drp1 to mitochondria during fission. Co-immunoprecipitation (co-IP) experiments performed after chemical cross-linking showed that hFis1 and Drp1 physically interact (Yoon et al. 2003). Subsequently, using truncated forms of Fis1/hFis1, it was determined that Fis1/hFis1 and Dnm1/Drp1 interacted in a TPR-dependent manner. However, contrary to the
Fig. 1.5 (continued) proposed mechanism for the balanced formation of s- and l-Mgm1. In this model, precursor Mgm1 translocates through the inner membrane and stops at the first hydrophobic segment. The N-terminal MTS is cleaved off resulting in l-Mgm1 anchored to the inner membrane. Alternatively, high mitochondrial ATP levels allow precursor Mgm1 to be pulled further into the matrix until the second hydrophobic segment that contains a sequence recognized by Rbd1. Rbd1 cleaves precursor Mgm1 into, s-Mgm1. Other proteins such as Ups1, Phb2 and Gep1 that have implicated roles in phospholipid homeostasis (represented by the purple sphere) may play a role in Mgm1 processing. (h) Fzo1 levels are regulated by ubiquitination and 26S proteasome degradation. Alpha-factor pheromone treatment causes Fzo1 proteasome-dependent degradation. Fzo1 was also shown to be ubiquitinated by Mdm30. However, it is uncertain whether ubiquitinated Fzo1 is targeted to 26S proteasome for degradation. (i) Targeting Dnm1 to outer membrane. Fis1/Mdv1 targeting of Dnm1 to mitochondria is essential for the fission event. The other two pathways, Fis1/Caf4 and Num1, are non-essential but important for Dnm1 targeting to the cell cortex. Mdm36 is involved in Num1 function. See main text for additional details
22
E.Y.L. Chan et al.
co-IPs performed after cross-linking, little to no binding between Dnm1/Drp1 and full-length Fis1/hFis1 was observed (Yu 2005; Wells et al. 2007). These data suggest that adaptor proteins may be required to bridge the interaction between Dnm1/ Drp1 and Fis1/hFis1. Although no adaptor proteins have been identified in mammals, in yeast, Mdv1, Caf4, Num1 and Mdm36 serve as adaptors to recruit Dnm1 to mitochondria (Cerveny et al. 2007; Tieu and Nunnari 2000; Griffin 2005; Cerveny 2003; Hammermeister et al. 2010). Mdv1/Caf4 Mdv1 and Caf4 are the yeast adaptor proteins required for the recruitment of Dnm1 to the mitochondrial surface. Mdv1 (also known as Gag3 and Net2) is a peripheral protein of the mitochondrial OM. It has an N-terminal extension (NTE), a centre coiled-coil domain and six or seven WD-40 repeats in its C-terminus (Tieu and Nunnari 2000; Fekkes et al. 2000; Cerveny et al. 2001). Mdv1 interacts with Fis1 and Dnm1 through its NTE and WD-40 repeats respectively (Tieu and Nunnari 2000; Naylor 2005). While data convincingly shows that Dnm1 binds efficiently to the Mdv1 WD-40 repeat only in its GTPbound state (Naylor 2005), the Mdv1 binding site on Fis1 is still controversial (Wells et al. 2007; Zhang and Chan 2007). Co-IPs performed using a dimeric form of Dnm1 (Dnm1G385D) showed that Mdv1-dependent recruitment of Dnm1 to mitochondria occurs before Dnm1 higher order assembly (Bhar 2006). Interestingly, Dnm1 localization to mitochondria is maintained in Dmdv1 mutants and mitochondrial fission is only partially compromised (Cerveny et al. 2001; Griffin 2006). These phenotypes are due to the redundant activity of Caf4. Caf4 is a protein that also contains WD-40 repeats and interacts with Fis1 and Mdv1 through its N-terminus. It also interacts with Dnm1 through its C-terminal WD-40 domain (Griffin 2005). Although the deletion of Mdv1 or Caf4 alone had little effect on Dnm1 localization, deleting both genes severely compromised its localization, to an extent similar to that of the Dfis1 mutant (Griffin 2005). This indicates that Mdv1 and Caf4 function as adaptor proteins, albeit with slight redundancy, to recruit Dnm1 to the mitochondrial membrane. Dnm1/Drp1 and Fis1/hFis1 are the core components in the mitochondrial fission machinery. Although adaptor proteins appear to be required for the recruitment of Dnm1/Drp1 to mitochondria, they have only been identified in yeast. Nevertheless, the mechanism of mitochondrial fission mediated by Dnm1/Drp1 and Fis1/hFis1 remains highly conserved. The OM protein Fis1/hFis1 recruits dimeric/tetrameric Dnm1/Drp1 to mitochondria in a TRP-dependent fashion mediated by adaptor proteins. Upon recruitment, the Dnm1/Drp1 dimers/tetramers bind GTP and assemble into ring-like higher order oligomers, constricting the mitochondrial membrane. Oligomerization-stimulated GTP hydrolysis provides the energy required to sever the membrane and subsequent dissociation of the Dnm1/Drp1 oligomer (see Fig. 1.5).
1 The Genetics of Mitochondrial Fusion and Fission
23
1.2.1.2 Additional Fission Proteins Mdm36/Num1 Complex Num1 is a protein that was isolated as a multi-copy supressor of a dominant-negative form of Dnm1 (Cerveny et al. 2007). Num1 had been previously characterized to be responsible for nuclear migration (Farkasovsky and Kuntzel 1995). Here, the authors demonstrated cortical localization of Num1 and frequent co-localization with Dnm1, and an activity of Num1 in mitochondrial division and inheritance. A recent study has further demonstrated the Num1/Dnm1 complex by characterizing the fission promoting protein Mdm36 (Hammermeister et al. 2010). This study showed that Mdm36 is responsible for maintaining protein complexes at the cell cortex to promote mechanical forces on mitochondrial membranes that can lead to membrane fission. Mff The Drosophila homolog of human Mff (mitochondrial fission factor) was identified in an RNAi screen for disruption in mitochondrial morphology using Drosophila S2R + cells. Immunofluorescence and protease protection experiments determined that Mff is a TM protein of the mitochondria OM. siRNA knock-down of Mff resulted in elongated mitochondrial tubules similar to those of Drp1 knockdown, but more severe than Fis1 knock-down mitochondria. Consistent with a function in mitochondrial fission, knock-down of Mff suppressed Mfn fusion defects and inhibited fragmentation-induced apoptosis. However, over-expression of Mff did not cause mitochondrial fragmentation, a phenotype identical to that of Drp1 over-expression. This suggests that although Mff, like Drp1, is a pro-fission protein, is not responsible for the rate-limiting step in mitochondrial fission (Gandre-Babbe and van der Bliek 2008). Letm1 LETM1 is a gene whose deletion has been associated with seizures in Wolf-Hirschhorn syndrome (Zollino et al. 2003). Characterization of the protein indicates Letm1 is an integral membrane protein of the mitochondrial IM, with the bulk of the protein facing the matrix (Schlickum et al. 2004; Dimmer et al. 2007). Like its yeast homolog Mdm38, Letm1 is required for the maintenance of proper mitochondrial morphology (Dimmer 2002; Dimmer et al. 2007). Overexpression or knock-down of Letm1 by RNAi resulted in fragmented ring-shaped mitochondria but did not affect mitochondrial function. Interestingly, fragmentation occurred in a Drp1-independent manner, but was rescued by nigericin, a pharmacological agent that restores the K+/H+ antiport. This implied that the fusion/fission balance was not disrupted, but rather reflected mitochondrial
24
E.Y.L. Chan et al.
plasticity. Mitochondria adapted to ion imbalance by changing its morphology in order to maintain function (Dimmer et al. 2007). Coincidentally, an independent study that identified Drp1 phosphorylation by the Ca2+/calmodulin-dependent protein kinase Ia (CaMKIa) observed similar ring-like mitochondria upon treatment with high levels of K+ (see regulating mitochondrial fission; (Han et al. 2008)). Recently we have characterized Letm1 in the fly (McQuibban et al. 2010) and demonstrated its potential role in neuronal activity and mitophagy, the autophagic clearance of damaged mitochondria (discussed in more detail later). Together, these data further support the notion that mitochondrial morphology is closely related to cellular ion levels, and can regulate the health of the organism in several ways. GDAP1 Ganglioside-induced differentiation protein 1 (GDAP1) is a protein implicated in Charcot-Marie-Tooth (CMT) disease. Mutations in GDAP1 were reported in patients with CMT, although the function of this protein has not been characterized (Baxter et al. 2002; Cuesta et al. 2002; Di Maria et al. 2004). Cell culture and protease protection analyses determined that GDAP1 is an integral membrane protein of the mitochondrial OM. Over-expression of GDAP1 resulted in highly fragmented mitochondria, while RNAi knock-down caused mitochondrial elongation. Although the mechanism by which GDAP1 promotes mitochondrial fission remains to be determined, these data demonstrate that GDAP1 is a newly identified member of the mitochondrial fission machinery (Niemann 2005). 1.2.1.3 Inner Membrane Fission Despite Dnm1/Drp1 and Fis1/hFis1 being the best characterized mitochondrial fission proteins, studies in yeast and worms indicate that they may only be responsible for OM fission. Mitochondria of C. elegans expressing mutant forms of Drp-1 were still connected by thin tubules of the OM while IM fission still occurred (Labrousse et al. 1999). Similarly, yeast Ddnm1 mutants did not achieve complete mitochondrial fission, but had matrix separation (Jakobs 2003). These data suggest that Dnm1/Drp1 and Fis1 are not required for IM fission, and that other components mediate this process. Yeast Mdm33, mammalian Mtp18 and MTGM were later identified and proposed to be factors mediating mitochondrial IM fission (Messerschmitt 2003; Tondera 2004, 2005; Zhao et al. 2009). Mdm33 has no known mammalian homologs while Mtp18 has known homologs only in metazoans (Messerschmitt 2003; Tondera 2004, 2005). MTGM, on the other hand, has homologs in eukaryotes from yeast to human. Remarkably, all mammalian orthologs of MTGM have 100% amino acid sequence identity (Zhao et al. 2009). Reduction of Mdm33,
1 The Genetics of Mitochondrial Fusion and Fission
25
Mtp18 and MTGM protein levels resulted in elongated mitochondria whereas over-expression led to fragmentation. These phenotypes are reminiscent of fission mutants, implicating them in the mitochondrial fission process. Although the topology of Mtp18 remains unclear, it is proposed to reside in the IMS (Tondera 2005). Mdm33 is an integral protein of the inner membrane with its C-terminus in the IMS and predicted N-terminal coiled-coil domains in the matrix. Analysis of its oligomeric state showed that Mdm33 has homotypic interactions, likely mediated by its coiled-coil domains. Over-expression of Mdm33 caused IM fragmentation and loss of cristae, suggesting IM fission defects. Based on these observations, Mdm33 on apposing IMs are proposed to form homotypic interactions through their coiled-coil domains in the matrix, mediating IM fission (Messerschmitt 2003). MTGM was identified as a human nuclear gene whose product is highly enriched in brain tumor cell lines and tumor tissues. Like Mdm33, MTGM is an integral membrane protein of the mitochondrial IM. Rather than coiled-coil domains, MTGM has a highly conserved tetrad of GxxxG motif that also mediates protein-protein interactions. MTGM-induced mitochondrial fragmentation is Drp1-dependent, indicating that it could be a regulator of Drp1. However, its mitochondrial IM localization suggests that MTGM might mediate IM fission (Zhao et al. 2009). Additional experiments have to be conducted to determine if MTGM is directly involved in IM fission or whether it is simply a regulator of Drp1.
1.2.2 Mitochondrial Fusion Mitochondrial fusion is distinct from other intracellular membrane fusion events because it requires the fusion of two separate membranes coordinately even though these two fusion processes are rather separable events (Hoppins et al. 2007). In yeast, while Fzo1 mediates outer and Mgm1 mediates inner membrane fusions, Ugo1 may be the key to coordinating these two events and has been recently shown to be involved in the lipid-mixing step. Importantly, these three key players are known to form a stable complex (Hoppins et al. 2007). While the mechanism of how the DRPs and other factors function in membrane fission/scission is largely known (as detailed above), the mechanism of the opposite reaction, membrane fusion, is still unclear due to lack of detailed structural information. There are an increasing number of studies that suggest DRPs can mediate fusion in a similar mechanism as fission by membrane tubulation. This tubulation of the mitochondrial membrane would increase curvature stress and drive the fusion reaction. The crystal structure of bacterial dynamin-like protein BDLP and its liposome tubulation structure have shed some light on our understanding of the potential DRP-mediated fusion reaction mechanism (Low and Lowe 2006; Low et al. 2009). We will now detail what is presently known about mitochondrial membrane fusion (see also Fig. 1.5)
26
E.Y.L. Chan et al.
1.2.2.1 Outer Membrane Fusion Fzo1 Fzo1 is anchored to the outer mitochondrial membrane with both its N- and C-termini facing the cytoplasm. Similar to Dnm1, self-assembly and GTPase activity are crucial for Fzo1 function. Fzo1 possesses predicted coiled-coil regions of the heptad repeat domains for stable cis and trans Fzo1-Fzo1 interactions. Cis interactions of Fzo1 in the same membrane may lead to self-assembly of Fzo1, and trans interactions of Fzo1 is essential for tethering the fusing mitochondria (Hoppins et al. 2007). MFN1 and MFN2 are mammalian orthologs of Fzo1. Even though the two mitofusins share 80% similarity, evidence suggests that they have functional differences. The trans interactions for tethering mitochondria are observed in MFN1 but to a lesser extent in MFN2 (Benard and Karbowski 2009). Apoptosis-related proteins Bax and Bak specifically associate with MFN2 but not MFN1. In addition, mutations in MFN2 but not MFN1 are linked to Charcot-Marie-Tooth disease type 2A. Mechanistic Model of Outer Membrane Fusion As mentioned above, the trans Fzo1 complex formation through anti-parallel interactions of coiled-coil regions is likely the key step in outer membrane fusion. However, it is as yet unknown what the subsequent mechanistic steps are. In fact, few details are known due to a lack of in vitro structural studies on Fzo1. Since BDLP is closely related to Fzo1, the mechanistic function of Fzo1 may be similar to that of BDLP. We know that BDLP binds to, tubulates, and may also induce a compressed bilayer by distorting the lipid tails (Low and Lowe 2006; Low et al. 2009). GDP-bound BDLP has less affinity for the lipid bilayer and may possess a dimeric structure that differs from that of the GTP-bound form. Hence, a model is proposed that GTP binding induces the assembly and tubulation of membranes, and GTP hydrolysis leads to its depolymerization, leaving a highly curved outer leaflet in a high-energy state which will be stabilized upon fusion (Low et al. 2009). 1.2.2.2 Inner Membrane Fusion Mechanistic Model of Inner Membrane Fusion Mgm1/OPA1 Mgm1 was first identified in a screen for genes involved in mitochondrial genome maintenance. Mutations in MGM1 caused temperature-sensitive loss of mtDNA (Jones and Fangman 1992). Mgm1 was later shown to play a role in mitochondrial
1 The Genetics of Mitochondrial Fusion and Fission
27
fusion and subsequently shown to be a key mediator of inner membrane fusion. Deletion and mutations in MGM1 were shown to result in fragmented mitochondria and impaired mitochondrial fusion during mating that could be rescued by a DNM1 deletion (Wong et al. 2000, 2003). By an in vitro mitochondrial fusion assay, Mgm1 was shown to directly mediate inner membrane fusion. Temperature sensitive mutants of Mgm1 are defective in inner but not outer membrane fusion (Meeusen et al. 2004). Mgm1 is a nuclear-encoded protein containing an N-terminal mitochondrial targeting sequence (MTS) that is followed by two hydrophobic segments. It is targeted to the mitochondrial IM via its MTS and is proteolytically processed into two isoforms, l-Mgm1 and s-Mgm1, by the matrix processing peptidase (MPP) and the rhomboid serine protease Rbd1/Pcp1, respectively (McQuibban et al. 2003; Herlan et al. 2003). Maintaining approximately equal molar concentrations of l-Mgm1 and s-Mgm1 is crucial, and the formation of s-Mgm1 was shown to be ATP dependent (Herlan et al. 2004). Both isoforms are necessary for Mgm1 function, and they may serve different roles in the fusion process since l-Mgm1 does not require a functional GTPase domain and localizes more to the IM cristae (Zick et al. 2009). Like the other DRPs, Mgm1 consists of three core dynamin domains: the GTPase domain, a Middle domain and the GED. In addition, our studies suggest that Mgm1 may contain a lipid-binding domain located between middle and GED domain (De Vay et al. 2009; Rujiviphat et al. 2009). Consistent with other DRPs, Mgm1 function also relies on a functional GTPase domain and GED. Mitochondria of yeast strains containing mutations in the GTPase domain and the GED fail to fuse in the in vitro fusion assay (Meeusen et al. 2006). Both cis and trans Mgm1 self-interactions have been observed by immunoprecipitation and immuno-gold labeling thinsectioned EM (Zick et al. 2009; Meeusen et al. 2006). GTP hydrolysis, selfoligomerization and lipid interactions have been shown to be essential characteristics of Mgm1 since mutants lacking these activity in vitro have phenotypes similar to that of MGM1 deleted strain (Zick et al. 2009; Rujiviphat et al. 2009; Meeusen et al. 2006; Meglei and McQuibban 2009). The mammalian ortholog of Mgm1 is OPA1 whose mutations cause Autosomal Dominant Optic Atrophy (ADOA) (Delettre et al. 2000). There are eight splice variants of OPA1 and each one undergoes at least one proteolytic processing event resulting in several long- and short-isoforms of OPA1 (Delettre et al. 2001). In addition to the cleavage of OPA1 by PARL, the ortholog of Rbd1/Pcp1, the precursor of OPA1 is also cleaved by the intermembrane space and matrix AAA-proteases (McQuibban et al. 2006; Ishihara et al. 2006; Duvezin-Caubet et al. 2007). The exact functions of each isoform and specific OPA1 processing pathways remain to be elucidated. OPA1 has also been shown to hydrolyze GTP and was recently shown to have the ability to tubulate liposomes. In addition, purified bacterially-expressed OPA1 showed GTPase activity (Griparic and van der Bliek 2005). Like s-Mgm1, purified s-OPA1 also binds to phospholipids and possesses lipid-dependent stimulated GTPase activity (Ban et al. 2010). Most importantly, these lipid-binding activities seem to be crucial for OPA1 function because several OPA1 disease alleles lack these characteristics (Ban et al. 2010).
28
E.Y.L. Chan et al.
How Does the Inner Membrane Really Fuse? Based on previous evidence from the in vitro fusion assay, Mgm1 might mediate mitochondrial inner membrane fusion via a two-step mechanism: tethering and lipid mixing (Meeusen et al. 2006). The tethering step relies on the self-oligomerization of Mgm1 via the GED since a tight interface of the inner membranes following outer membrane fusion was not observed in Mgm1 with mutations in the GED by thinsectioned TEM images (Meeusen et al. 2006). This tethering step ensures the tight interface of the inner membranes to facilitate fusion. Similar to Fzo1, membrane tubulation may also facilitate the lipid-mixing step by increasing membrane curvature where membrane stress could be relieved upon fusion. Interestingly, liposome tubulation by OPA1 has been recently reported (Ban et al. 2010). Even though it is known that a functional GTPase domain is required for the lipid-mixing step, it is still unclear how the GTPase cycle comes into play in the fusion mechanism. Understanding how nucleotide hydrolysis is required for lipid fusion will be the next big advance in our understanding of how this class of mechanoenzymes works. Of note, GTPgS binding abolishes OPA1 liposome tubulation. Nevertheless, studies show that Mgm1/OPA1 can self-assemble into a crystalline array in the absence of GTP, indicating that GTP is not essential for binding or self-assembly onto the membrane (Rujiviphat et al. 2009; Ban et al. 2010). Moreover, tethering can still be observed in temperature-sensitive Mgm1 with a mutation in the GTPase domain (Meeusen et al. 2006). Hence, GTPase activity may cause changes in Mgm1/OPA1 structure and membrane topology during the lipid-mixing step. Further studies are required to understand this important aspect of Mgm1/OPA1 function and will be discussed at the end of this chapter. A possible model for how Mgm1/OPA1 works to fuse membranes is shown in Fig. 1.6. 1.2.2.3 Coordinating Outer and Inner Membrane Fusion Given the fact that mitochondria have four distinct biochemical compartments, and that disruption of this organization can lead to cell death by apoptosis, the coordination and regulation of membrane fusion is critically important. In yeast, there exists a relatively well-characterized protein that could serve a bridging function during this complex process. Ugo1 is a multi-spanning membrane protein that contains a carrier domain. Ugo1 is believed to serve as the bridge to physically tether Mgm1 and Fzo1. Ugo1 binds to both Fzo1 and Mgm1 independently and at different sites. In addition, the Fzo1-Mgm1 interaction is abolished in absence of Ugo1 (Sesaki and Jensen 2004). However, despite the identification of this fusion machinery protein complex, it is still unclear what the exact role of Ugo1 is. It is proposed that Ugo1 may have a structural role and that its interactions in the complex promote structural changes on Fzo1 to mediate fusion (Hoppins and Nunnari 2009). On the other hand, Ugo1 is also proposed to act in the lipid-mixing step (Hoppins and Nunnari 2009). Ugo1 was recently shown to be essential for both outer and inner membrane fusion but required after the tethering step (Hoppins et al. 2009). To
1 The Genetics of Mitochondrial Fusion and Fission
29
Fig. 1.6 Mechanistic model of Mgm1-mediated membrane fusion: From the top left to the bottom right corner shows an averaged image of s-Mgm1 oligomeric rings to a proposed model of Mgm1mediated mitochondrial fusion. The background pattern shows s-Mgm1 assembled onto liposomes as oligomeric rings. An averaged image of the s-Mgm1 oligomer consists of six monomer densities (a). These six monomers can be interpreted as two stacks of trimers shown in red and yellow (b). These cstacking trimers could be how s-Mgm1 tethers two opposing membranes to mediate membrane fusion (c and d)
date, no human homolog of Ugo1 has been identified. Due to the critical role that Ugo1 plays in fusion, it is proposed that a protein with a similar function to Ugo1 is required for bridging OPA1 and MFN1/2 activities and plays a role in mammalian mitochondrial fusion. The identity and characterization of this key biochemical activity is needed to fully dissect mammalian mitochondrial fusion and represents a key missing piece of the puzzle.
1.2.3 Regulatory Pathways of Membrane Fusion 1.2.3.1 Ubiquitination It is well-known that proper mitochondrial morphology requires the correct maintenance of Fzo1 protein levels and that this is regulated by 26S proteasome degradation (Hoppins and Nunnari 2009). It is also known that treatment with the
30
E.Y.L. Chan et al.
alpha-factor pheromone triggers Fzo1 proteasome-dependent degradation (Hoppins and Nunnari 2009). Further, Fzo1 is known to be ubiquitinated and degraded in an Mdm30-dependent manner (Hoppins and Nunnari 2009). Mdm30 is an F-box containing protein and is a component of the SCF E3 ubiquitin ligase complex that ubiquitinates Fzo1 and targets it for degradation by the 26S proteasome. However, there is conflicting evidence that ubiquitinated Fzo1 degradation is independent of the SCF complex and the 26S proteasome. In addition to its role in Drp1 stability, the E3 ubiquitin ligase MARCH-V has been shown to interact with the pro-fusion protein MFN2 (Nakamura et al. 2006), and MFN1 was recently shown to be its main ubiquitination substrate (Park et al. 2010). Further, a ubiquitinated form of OPA1 has also been observed, but the pathway or significance of this is not yet known. These recent demonstrations are summarized in Fig. 1.7. These data that demonstrate the key role of adding ubiquitins to these fusion molecules begs the question: what is the de-ubiquitylation factor and how must it contribute to this aspect of mitochondrial regulation and dynamics? 1.2.3.2 Proteolytic Processing Alternative topogenesis is the widely-accepted model of Mgm1 processing (Herlan et al. 2004). In this model, the processing of Mgm1 is regulated by ATP levels and the mitochondrial membrane potential (Herlan et al. 2004). Likewise, it has been demonstrated that mitochondrial ATP levels and membrane potential are important factors for OPA1 processing (Guillery et al. 2008; Baricault et al. 2007). In an attempt to identify proteins involved in Mgm1 processing, Ups1 was identified. Knocking-out Ups1 led to the abolishment of s-Mgm1 formation due to a defect in Mgm1 sorting (Sesaki et al. 2006). Instead of having a regulatory role on Rbd1/ Pcp1 activity, Ups1 appears to play a role in cardiolipin homeostasis. This key mitochondrial lipid is required for stabilizing the TIM23-PAM complex that is a key molecular component of the mitochondrial inner membrane import system (Tamura et al. 2009). Yet another family of proteins, the prohibitins are known to impact processing of Mgm1/OPA1. In this case, knocking-out Phb2 in mice leads to a reduction in the OPA1 long isoform (Merkwirth et al. 2008). Interestingly, recent studies show that Phb2 forms a multimeric complex with Phb1 and together they act as a scaffold in the inner membrane. Taken together, these data underscore the complexity and diversity of regulating the processing of the key machineries of mitochondrial membrane fusion. 1.2.3.3 Lipid Metabolism There has been increasing evidence demonstrating the cross talk between lipid metabolism and mitochondrial membrane dynamics (Furt and Moreau 2009). Knocking-down MitoPLD, the enzyme that converts cardiolipin (CL) to phosphatidic acid (PA), leads to less fusion, and its over-expression leads to aggregation of mitochondria (Choi et al. 2006). Interestingly, these mitochondria are separated by
1 The Genetics of Mitochondrial Fusion and Fission
31
Fig. 1.7 Regulation of the mammalian mitochondrial fusion and fission machinery: The diagrams illustrate elucidated proteins with implicated regulatory roles in mammalian mitochondrial fusion and fission. Arrowhead bold lines represent well-established positive regulations. Arrowhead dash lines represent possible positive regulations. Blunt end bold lines represent negative regulations. (a) The regulation of mitochondrial fusion. MARCH-V interacts and ubiquitinates MFN1, and the degradation of MFN1 is proteasome-dependent. MitoPLD is required for fusion and promotes the tethering of mitochondria in an MFN-dependent manner. PSID was shown to be essential for mitochondrial fusion but the exact function is still unknown. Since PSID converts PS to PE, providing negative membrane curvature, it may play a role in fusion by altering the lipid composition. Proteins in the Bcl-2 family have implicated roles in fusion. Members like Bax and Bak are profusion proteins under normal conditions but pro-fission in apoptotic cells. The Bcl-2 protein may modulate MFN and OPA1 functions in mitochondrial fusion. The function of Bcl-2 proteins is also linked to cytochrome c release that could be due to outer membrane permeabilization or cristae junction disruption. (b) The regulations on mitochondrial fission. hFis1 functions in the localization of DRP1, but the recruitment of Drp1 is not entirely dependent on hFis1. DRP1 and hFis1 are ubiquitinated and degraded in a proteasome-dependent manner. E3 ligases found to mediate this ubiquitination are MARCH-V and Parkin. Since GDAP1 has an implicated role in hFis1 activity and lipid homeostasis, GDAP1 may play a role in fission by modulating hFis1 function or lipid composition. Drp1 is regulated by sumoylation. Sumoylation with SUMO1 by MAPL stabilizes Drp1 and promotes fission. SENP5 is required for DRP1 desumoylation. Phosphorylation is another known regulator of DRP1. DRP1 is phosphorylated by several kinases. MTP18 affects DRP1-dependent fission but its exact function is unknown. There are speculations that MTP18 might mediate inner membrane fission or is involved in fission complex formation. Bcl-2 proteins also have implicated roles in modulating DRP1 function and mitochondrial fission
a distance equivalent to half that of heptad repeat-mediated tethered mitochondria. Therefore, these aggregated mitochondria may be due to an excess of tethering but a complete lack of the lipid mixing suggesting that MitoPLD may function in the lipid-mixing step of outer membrane fusion. Recently, there have been several findings that connect the functional relationship between phospholipid metabolism with Mgm1 processing and mitochondrial
32
E.Y.L. Chan et al.
morphology. Ups1, which has an implicated role in Mgm1 sorting/processing, was shown to act antagonistically with Ups2/Gep1 in regulating cardiolipin levels (Tamura et al. 2009). Phb1 that forms into a multimeric complex with Phb2 was shown to genetically interact with several genes involved in mitochondrial morphology maintenance such as MDM10 and MMM1. PHB1 also has genetic interactions with UPS1, GEP1 as well as genes directly involved in lipid metabolism, CRD1 and PSD1. Altered l- and s-Mgm1 ratios were observed in GEP1, PSD1 and CRD1 knock-out strains (Osman et al. 2009). It is clear that there is still much to discover with respect to the control, orchestration and regulation of mitochondrial membrane fusion. With respect to mitochondrial membrane fission events, the core machinery as described above suggests that cytoplasmic regulators exist for this complex process. In particular, fission factors are almost all cytoplasmic facing, making them very accessible to many post-translational modifying enzymes of the cell. Now, we will discuss the best-characterized activities in regulating the division of mitochondria.
1.2.4 Regulatory Pathways of Membrane Fission 1.2.4.1 Sumoylation Drp1 is covalently conjugated to a small ubiquitin-like modifier SUMO1. Sumoylation of Drp1 by MAPL protects it from degradation, increasing mitochondrial fragmentation (Harder et al. 2004; Braschi et al. 2009). Although Drp1 is transiently sumoylated at steady state, induction of apoptosis leads to increased Drp1 sumoylation in a Bax/Bak-dependent fashion. This increase in Drp1 stability on mitochondria also coincides with Bax localization to the mitochondrial membrane (Wasiak et al. 2007). Interestingly, endophilin B1, a fatty acyl transferase, has been shown to regulate Bax localization to mitochondria (Takahashi et al. 2005). Knock-down of endophilin B1 by RNAi caused mitochondrial elongation, implying that it is a pro-fission factor (Karbowski 2004). Together, these data suggest that endophilin B1 might regulate Bax-dependent sumoylation of Drp1, increasing its stability to promote mitochondrial fission. SENP5 is a SUMO protease that catalyzes the removal of Sumo1 from mitochondrial proteins including Drp1. Over-expression of SENP5 led to increased removal of Sumo1 from Drp1 and destabilization of the protein, promoting its degradation. As a result, mitochondria became elongated. In contrast, knockingdown SENP5 by shRNA resulted in increased Drp1 sumoylation and consequent mitochondrial fragmentation (Zunino et al. 2007). Besides steady state desumoylation of Drp1, SENP5 also desumoylates Drp1 during the G2/M transition of the cell cycle. As previously demonstrated, regulating mitochondrial fission during the cell cycle is intimately linked to the regulation of Drp1 (Taguchi et al. 2007). Drp1 is phosphorylated during the G1/S transition to ensure mitochondrial fragmentation in early mitosis and proper mitochondrial inheritance to daughter
1 The Genetics of Mitochondrial Fusion and Fission
33
cells (Taguchi et al. 2007; Boldogh et al. 2001). SENP5 desumoylation of Drp1 during mitosis increases Drp1 oligomerization, facilitating mitochondrial fission (Zunino et al. 2009). Although desumoylation during the G2/M transition increases fission, steady state desumoylation of Drp1 promoted mitochondrial elongation (Zunino et al. 2007, 2009). These data underscore the importance of this post-translational modification, and it is likely that several other factors undergo sumoylation to regulate mitochondrial division in the different contexts during the life of the cell. 1.2.4.2 Ubiquitination It is becoming increasingly clear that ubiquitination is a key regulator of mitochondrial function. Later in the chapter, we will discuss an emerging theme in mitochondrial research – quality control that is intimately regulated by ubiquitination. With respect to fusion and fission, MARCH-V (also known as MARCH5 and MITOL) is a mitochondrial OM-localized E3 ubiquitin ligase with an N-terminal RING finger motif (Nakamura et al. 2006; Yonashiro et al. 2006). It binds to and ubiquitinates hFis1 and Drp1, promoting their degradation (Nakamura et al. 2006; Yonashiro et al. 2006). hFis1 is ubiquinated in cells expressing WT MARCH-V, but not a catalytically inactive form of the protein. Similarly, Drp1 was also ubiquitinated by WT MARCH-V, albeit to a lesser degree than hFis1, possibly owing to its primarily cytosolic localization (Yonashiro et al. 2006). It has also been well established that the pro-fusion proteins Fzo1/MFN are subject to ubiquitination (Hoppins and Nunnari 2009). As more studies are published, the list of ubiquitin-tagged mitochondrial proteins will grow. Interestingly, there have been very few reports that characterize the enzymes that remove ubiquitin (the so-called DUBs) from their substrates. 1.2.4.3 Phosphorylation During mitosis, mitochondria undergo morphological changes to ensure proper inheritance to daughter cells (Boldogh et al. 2001). In HeLa cells, the tubular mitochondrial network becomes fragmented in early mitosis and reforms into an interconnected network after telophase and cytokinesis. This early mitotic fragmentation is Drp1-dependent. Biochemical analyses indicated that Drp1 is phosphorylated by Cdk1/cyclin B during the G1/S transition on S616 within the Drp1 GED. Mutating S616 to an alanine (Drp1S616A) abolished phosphorylation and resulted in a less fragmented mitochondrial network in early mitosis. This demonstrates that Cdk1/ cyclin B phosphorylation of Drp1 during early mitosis promotes mitochondrial fission (Taguchi et al. 2007). Drp1 is also phosphorylated by the cAMP-dependent kinase (PKA) and the Ca2+/ calmodulin-dependent protein kinase Ia (CaMKIa) at S637 (Han et al. 2008; Chang and Blackstone 2007; Cribbs and Strack 2007). PKA phosphorylation negatively regulates Drp1 intramolecular interactions and GTPase activity. Consequently,
34
E.Y.L. Chan et al.
over-expression of phosphomimetic mutants prevented mitochondrial fission, resulting in the accumulation of highly interconnected mitochondria (Chang and Blackstone 2007; Cribbs and Strack 2007). S637 is also the phosphorylation site for CaMKIa. CaMKIa phosphorylation can be selectively stimulated by treatment with high K+. However, unlike phosphorylation by PKA that reduced fission, phosphorylation by CaMKIa resulted in increased recruitment of Drp1 to mitochondria and a consequent increase in mitochondrial fission (Han et al. 2008; Cribbs and Strack 2007). Due to the importance in maintaining proper mitochondrial dynamics, this discrepancy might reflect the fine-tuned regulation of Drp1-dependent mitochondrial fission. Since the Drp1 sequence around S637 is highly conserved, phosphorylation on S637 might serve as a universal regulatory mechanism for Dnm1/Drp1 across species (Han et al. 2008; Chang and Blackstone 2007; Cribbs and Strack 2007). Unexpectedly, the phosphomimetic mutant of S616 (S616D) did not show any change in intra- or intermolecular interactions, GTPase activity or mitochondrial morphology (Chang and Blackstone 2007). However, since phosphorylation on S616 is a cell cycle-dependent event, the S616D mutation might not have physiological significance in this study and hence resulted in no phenotype abnormalities. Phosphorylation on S637 is a reversible event mediated by the Ca2+-dependent phosphatase calcineurin (Cribbs and Strack 2007; Cereghetti et al. 2008). Mitochondrial depolarization results in fragmentation and concomitant calcineurin dephosphorylation of Drp1 on S637. Inhibition of calcineurin prevents mitochondrial fragmentation, indicating that dephosphorylation of Drp1 promotes mitochondrial fission (Cereghetti et al. 2008). These results are consistent with the anti-fission effect of Drp1 phosphorylation by PKA (Chang and Blackstone 2007; Cribbs and Strack 2007). Accordingly, the Drp1S637D phosphomimetic mutant was almost exclusively cytosolic while the Drp1S637A dephosphomimetic mutant localized to mitochondria. This demonstrates that dephosphorylation of Drp1 results in its recruitment to mitochondria promoting fission (Cereghetti et al. 2008). Although it is unclear whether calcineurin dephosphorylation has kinase specificity, these data suggest that calcineurin might selectively dephosphorylate PKA-dependent phospho-Drp1. Recently, protein phosphatase 2A (PP2A) and its regulatory subunit Bb2 were identified as regulators of mitochondrial fission. Upon induction of apoptosis, Bb2 recruited PP2A to the mitochondrial surface and promoted mitochondrial fission in a Drp1- and Fis1-dependent manner (Dagda et al. 2008). Although the mechanism of PP2A/Bb2 in the regulation of mitochondrial fission was not examined, a possibility might be the dephosphorylation of Drp1 by PP2A. This would be consistent with calcineurin dephosphorylation of Drp1 promoting mitochondrial fission (Cereghetti et al. 2008). 1.2.4.4 S-Nitrosylation Another post-translational modification of Drp1 is S-nitrosylation. This is not surprising since dynamins have been shown to be S-nitrosylated (Kang-Decker et al. 2007; Wang et al. 2006). Nitric oxide produced in response to the Ab peptide implicated in Alzheimer’s disease resulted in S-nitrosylation of Drp1. A C644A
1 The Genetics of Mitochondrial Fusion and Fission
35
mutation that abrogated Drp1 S-nitrosylation prevented Ab-induced neurotoxicity. S-nitrosylation of Drp1 induces mitochondrial fission by promoting Drp1 dimerization and increased GTPase activity (Cho et al. 2009). It is clear that mitochondrial fusion and fission is a highly complex, and highly regulated process. While researchers can all agree that the mitochondrion is a very dynamic compartment, there is less consensus regarding the role for mitochondrial dynamics, in either a single cell like yeast, or in the context of a metazoan such as ourselves.
1.3 Possible Roles of Mitochondrial Dynamics The remaining chapters in this book will discuss in detail the various contexts that the cell utilizes mitochondrial dynamics, and the resulting pathologies that incur when these dynamics are perturbed. However, we will discuss very briefly some of the more well-characterized cell biological roles for mitochondrial dynamics in every cell.
1.3.1 Roles in Cell Cycle and Development In yeast, mitochondrial fission and fusion is important during budding and mating. In the same way, mitochondrial dynamics are crucial for cell development in higher eukaryotes and embryogenesis in mammals. Mitochondrial dynamics are also important for several cellular processes. Mitochondrial dynamics supports intracellular mitochondrial motility. These dynamics are required for the distribution of mitochondria to supply diverse bioenergetic requirements especially in specialized cells. For instance, mitochondrial fusion and fission are required for distributing mitochondria to neuron dendrites and axon terminals for synaptic activity (Kann and Kovacs 2007). Mitochondrial dynamics have a direct role in the apoptosis pathway (see Fig. 1.2). Specifically, cytochrome c that is normally stored in cristae is released to the cytosol and activates caspases that in turn switch on the apoptosis pathways. Up-regulated mitochondrial fission leads to more cytochrome c release and cell death, and up-regulated mitochondrial fusion can suppress the induction of apoptosis (Kann and Kovacs 2007).
1.3.2 Roles in Mitochondrial Genome Maintenance Due to the nature of the mitochondrial nucleiod, ROS production from the electron transport chain (ETC) and mtDNA replication/repair systems, the mitochondrial genome is prone to DNA damages. Mitochondrial dynamics may have evolved to diminish these damages and maintain the integrity of the mitochondrial genome. Since the mitochondrial genome encodes subunits of the complexes of the ETC,
36
E.Y.L. Chan et al.
mtDNA mutations can lead to impaired ETC and ATP production. Possibly as a means of cross-complimentation, fusion of a mitochondrion containing undamaged mitochondrial DNA could functionally replace the damaged component to result in the rapid recovery of ATP production. In addition, mixing of mitochondrial genomes allows transcomplementation of mtDNA and the dilution and tolerance of mtDNA mutations (Schon and Gilkerson 2010; Chen et al. 2010). On the other hand, fission may lead to selecting out malfunctioning mitochondria (see Fig. 1.1). In support of this idea, studies show that only transient but not complete mitochondrial fusion was observed in OPA1 knock-down or over-expressing cells (Liu et al. 2009), and mitochondria with abnormal shape have a reduced ability to fuse to normal ones (Navratil et al. 2008).
1.3.3 Roles in Quality Control Systems Mitophagy and apoptosis are quality control mechanisms at organellar and cellular levels, respectively. Mitophagy is a mechanism by which severely damaged mitochondria are degraded to prevent them from fusing and sharing toxic material with other mitochondria in the network (discussed in more detail below). Impaired mitophagy can have a deleterious effect on cellular processes and result in the activation of apoptosis. Apoptosis prevents the spreading and accumulation of these defective cells and can rescue the organism from the pathology of necrosis. In this way, the cell has a means to either rescue a cell, or commit it to death if the damage is too great (see Fig. 1.8). It is becoming more and more realized that there is a tight relationship between maintaining mitochondrial dynamics, functions and various quality control systems. Specifically, impaired mitochondrial dynamics causes mitochondrial dysfunction. At the same time, mitochondrial dysfunction can affect OPA1 processing leading to fragmentation and sequestering of damaged mitochondria by mitophagy (Tatsuta and Langer 2008). In apoptotic cells, BCL2-like proteins positively affect DRP1 activity but negatively affect MFN2 and OPA1 activity causing mitochondrial fragmentation. This fragmentation facilitates mitophagy and the release of cytochrome c to activate apoptosis (Fig. 1.8) (Tatsuta and Langer 2008). In general, the cell has evolved subtle, refined and elegant ways to preserve function.
1.4 Disruption of Mitochondrial Dynamics Causes Neurodegeneration For many years it was not clear why mitochondrial disruption led to an impairment of neuronal function. However, several key aspects of the neuronal system make it vulnerable to even minor deficiencies in mitochondrial dynamics and activity that
1 The Genetics of Mitochondrial Fusion and Fission
37
Fig. 1.8 Roles of mitochondrial dynamics in genome maintenance and organellar and cellular quality controls: Mitochondria are prone to cellular stresses, DNA damages and reactive oxygen species (ROS) that can cause mutations in mitochondrial DNA (mtDNA). The mitochondrial genome (double-helix circles) encodes for subunits of complexes in the electron transport chain, therefore damage of the mitochondrial genome (colored in black) also leads to impaired oxidative phosphorylation (OXPHOS). These deficiencies can be rescued by mitochondrial fusion (blue arrows) and fission (red arrows) events. On the left side, mitochondrial fusion results in a rapid energy supply and replenishment of impaired OXPHOS by providing intact essential proteins. After several rounds of mtDNA replication and mitochondrial fusion, mtDNA complementation and dilution of mutated mtDNA occur (colored in grey) to maintain the integrity of the mitochondrial genome. On the right side, mitochondrial fission also has a protective role. Mitochondrial fission may selectively (or by chance) segregate out mitochondria that contain damaged genomes. These mitochondria can undergo several rounds of fusion to complement their defects as mentioned above. Alternatively, severely damaged mitochondria are subject to mitophagy where fission/fragmentation facilitates engulfment by the autophagosome. If the damage is too excessive, fission also leads to the release of cytochrome c that activates caspases and subjects the cell to apoptosis, and the game is over
include: (1) the requirement for the distribution of mitochondria to distant axon terminal and the dendrite; (2) the requirement of mitochondrial ATP production and Ca2+ buffering for proper neuronal activity; (3) accumulated mtDNA mutational load is common in most neurodegenerative diseases, likely due to (2); and (4) the
38
E.Y.L. Chan et al.
Fig. 1.9 Disruption in mitochondrial dynamics causes neurodegeneration. (a) Fusion and fission are required for distributing mitochondria to axon terminals and dendrites. In normal cells, mitochondria, shown as white elongated shapes, are distributed throughout the neuron and enriched around terminal buttons to supply ATP for synaptic activity. In fusion and fission defective neurons, mitochondria do not get distributed but get concentrated in the cell body. Fragmentation and elongation due to lack of fusion and fission, respectively, also cause mitochondria to accumulate damages and to malfunction, colored in black. (b) Abnormality in mitochondrial dynamics causes neurodegeneration. As described in (a), mitochondrial dynamics are essential for mitochondrial distribution to synaptic sites. Poor mitochondrial distribution causes insufficient ATP production and Ca2+ buffering that are crucial for synapses. Hence, synaptic dysfunction results in the aftermath of disrupted mitochondrial dynamics, leading to neurodegeneration. In addition, abnormal mitochondrial dynamics, especially fragmentation, causes unregulated apoptosis that leads to neuronal cell death, and once again, it’s game over
quality control system given that unregulated apoptosis induced by disrupted mitochondrial dynamics and excessive mitophagy leads to neuronal cell death with no regeneration system in place. All of these aspects can lead to synaptic degeneration and neuronal cell death (see Fig. 1.9). Several chapters in this book will describe these events in detail, and in the context of specific human diseases.
1.5 Future of the Field and Compelling Questions 1.5.1 Compelling Questions in Mitochondrial Fusion and Fission Events This past decade has seen a true resurgence in mitochondrial research that has elaborated on many aspects of mitochondrial dynamics. Genetic studies have identified key players and their regulators while biochemical studies have provided
1 The Genetics of Mitochondrial Fusion and Fission
39
insight into their functions and mechanisms. However, several questions remain to be answered with respect to both regulatory pathways and detailed molecular mechanisms of fusion and fission. Even though we know quite a bit about both the molecular players of mitochondrial fission and how it works at a biophysical level, many genes implicated in the fission event still have unknown functions. For instance, besides its role in lipid metabolism, the exact role of GDAP1 in mitochondrial fission is still unknown. Mutations in GDAP1 cause CMT4A implying that GDAP1 plays a significant role in dynamics. Thus, studies on GDAP1 may provide insight into regulation of the fission event and pathophysiology underlining neurodegenerative diseases. Further studies on the phosphorylation regulation of Drp1 will shed light on the synchronization of mitochondrial dynamics with the cell cycle and with signaling by kinases. In addition, PINK1, which is linked to familial Parkinson’s disease (PD), is one of the kinases that can modulate mitochondrial fission in a Drp1-dependent manner. It is still unclear whether this is due to direct phosphorylation by PINK1 on fission molecules or an indirect involvement of a kinase cascade. More understanding of PINK1 will provide a clearer picture on fission regulation and the functional role of PINK1 in PD. Loss-of-function approaches by a double knock-down of PINK1 with other candidates in the kinase cascade or fusion/fission genes may provide more insight into its pathway in relation to mitochondrial dynamics. With respect to studies on mitochondrial fusion, many questions remain unanswered. It is still unclear how outer and inner membrane fusions occur as separate events but yet coordinated. Specific studies that reveal how Fzo1/MFN and all the isoforms of Mgm1/ OPA1 mediate fusion will clarify the overall picture of mitochondrial fusion and provide more insight into the role of these previously identified genes. For instance, to determine whether the role of Ugo1 in fusion is indeed in the lipid-mixing step of Fzo1 and Mgm1, we need to first understand how Fzo1- and Mgm1-mediated fusion works. In addition, Ugo1 at present appears to be fungal only. Do we have a Ugo1 ortholog, or have we evolved a different mechanism of fusion? Perhaps OPA1 is the answer. Indeed, why are there only two isoforms of Mgm1 as compared to eight for OPA1 with the complicating factor that several proteases have been identified to process OPA1? Synthetic genetic array or multi-copy suppressor screens could be ways to reveal additional genetic interactors that may be important in mitochondrial fusion in yeast. With respect to the challenge of OPA1, it is difficult to truly understand how and why the OPA1 isoforms have come about. One approach could be to determine the expression pattern of all the isoforms and correlate that with all of the putative OPA1 proteases. This could be done in different cell types and stress conditions to determine whether there is a regulation at post-transcriptional or post-translational level. These types of studies are required to truly understand this most complex process. Recent studies have also indicated that lipid metabolism may be another main regulatory pathway in mitochondrial dynamics. Several genes implicated in mitochondrial fusion and fission such as Endophilin B1, GDAP1, mitoPLD, PSD1 and PHB1/2, also have a role in lipid metabolism. Besides the speculation that some phospholipids can create more membrane curvature than others, the exact functional relationship is unclear. Future studies on lipid homeostasis are necessary
40
E.Y.L. Chan et al.
since an important aspect of mitochondrial function is lipid metabolism and the functions of fusion/fission molecules are modulated by their interactions with lipids and overall lipid compositions of the mitochondrial membranes. Identifying genetic and physical interactors will provide greater insight into the pathways interconnecting lipid homeostasis with mitochondrial dynamics.
1.6 The Most Recent and Important Discoveries in Mitochondrial Dynamics While the last 100 years of mitochondrial research has revealed several key discoveries, just in the last couple of years or so mitochondrial research has undergone a true resurgence with respect to understanding both the homeostasis and the pathology of mitochondrial activity within the cell. It appears that since the endosymbiotic event, the host cell has evolved an elegant mechanism to make sure its mitochondrial content remains as healthy as possible. We have already mentioned this quality control mechanism of autophagic removal of damaged mitochondria, now termed mitophagy (Tatsuta and Langer 2008). It is our belief that this discovery will truly revolutionalize and direct mitochondrial research for the next decade (even in the context of what we feel our three key outstanding questions discussed below). It is the simplicity of design in the quality control mechanism that is most appealing. Mitochondria are very harsh environments where proteins, lipids, and nucleic acids are constantly damaged. The cell must maintain a healthy mitochondrial network to thrive. In order to isolate and remove damaged compartments from the network, selective fission occurs. These newly formed mitochondria, due to their damage, can no longer provide energy nor maintain a potential across its inner membrane. This results in the deficient organelle being isolated as it can no longer undergo fusion with the rest of the network. The cell recognizes this damaged entity and flags it with ubiquitin moieties. This serves to recruit the autophagosomal machinery, with the end result of lysosomal destruction and recycling of basic building blocks back into the cytoplasm. Of course it all makes sense, but there are several key and obvious gaps in our understanding of the molecular mechanisms at play. This will be discussed in greater detail in Chap. 3.
1.7 Future Discoveries that will Advance the Field of Mitochondrial Dynamics 1.7.1 How Does Mitochondrial Fusion Work? While we, as authors of this chapter, may be biased towards this question as it is one of our main research pursuits, we feel it is still of fundamental importance to understand the biophysical details of membrane fusion. As more and more components
1 The Genetics of Mitochondrial Fusion and Fission
41
of the molecular machinery are identified, we should be able to formulate testable hypotheses as to how these complexes orchestrate the regulated mixing of membranes. Beyond understanding how a protein like Mgm1 and its two isoforms function to fuse the membranes in terms of torsional forces, figuring out its regulation is key. A mitochondrion is filled with folded invaginations of inner membrane cristae that remain distinct and do not undergo spontaneous fusion. However, when two mitochondria fuse their outer membranes, the respective inner membranes now undergo rapid and efficient fusion. What signal is sent or received to up-regulate the activity of Mgm1-mediated inner membrane fusion? As more detailed studies are conducted on additional components and the regulatory GTP cycle, we should be able to elucidate this basic activity.
1.7.2 How Is the Mitochondrial Genome Compartmentalized and Maintained? As stated in the introduction to this chapter, researchers have known for quite some time that mitochondria house their own genome. Over time the majority of the mitochondrial genome has been incorporated into the host’s nuclear genome. Most species have retained only a handful of genes on their mitochondrial genome, and all are components of the energy production system. Beyond understanding which genes have been retained (which in and of itself is an interesting and important question), figuring out how the genome is compartmentalized (the so-called mitochondrial nucleoid) is extremely important to elucidate mechanisms of inheritance and DNA quality control. It has long been known that as an organism ages it accumulates mutations in its mitochondrial genome largely due to the harsh chemical environment within the organelle. In 2004, a groundbreaking study directly demonstrated that accumulation of mutations in the mitochondrial genome directly resulted in aging in the mouse (Trifunovic et al. 2004; Chan 2006). Together, these data support the notion that maintaining the fidelity of the nucleotide sequence, as well as ensuring faithful transmission during cellular division is of the utmost importance for the well-being of the cell and organism. These functions must occur in a regulated manner, both spatially in the context of the nucleiod, and temporally with respect to the cell cycle. Our knowledge of these processes is currently in its infancy so we predict many more groundbreaking studies with respect to the mitochondrial genome.
1.7.3 How Is the Mitochondrion Integrated into the Rest of the Cellular Networks? We have come a long way from considering the mitochondrion to be an autonomous organelle that drifts amidst the cytoplasm generating the bulk of energy for its host. Perhaps the most convincing notion of mitochondrial integration into the life
42
E.Y.L. Chan et al.
of the cell is its pivotal role in directing apoptosis. While this was a key discovery, most cells are not undergoing apoptosis, as this represents extreme modes of developmental biology and cellular response to stress. One can imagine several homeostatic mechanisms that would rely on active signalling between the mitochondria and the cytoplasm, the cell surface, the nucleus, peroxisomes, etc. As genetic networks are characterized and protein complexes are understood, we should be able to unravel the vast array of mitochondrial directed activities in a normal healthy cell. It is our prediction that the next 100 years of mitochondrial research will be as exciting and informative as the last 100 years. Acknowledgments Research in the McQuibban lab is supported by grants from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Parkinson Society of Canada.
References Alexander, C., Votruba, M., Pesch, U. E., Thiselton, D. L., Mayer, S., Moore, A., Rodriguez, M., Kellner, U., Leo-Kottler, B., Auburger, G., Bhattacharya, S. S., and Wissinger, B. (2000) Nat Genet 26, 211–215 Altmann, K. (2005) Molecular Biology of the Cell 16, 5410–5417 Ban, T., Heymann, J. A., Song, Z., Hinshaw, J. E., and Chan, D. C. (2010) Hum Mol Genet 19, 2113–2122 Baricault, L., Segui, B., Guegand, L., Olichon, A., Valette, A., Larminat, F., and Lenaers, G. (2007) Exp Cell Res 313, 3800–3808 Bartley, W., and Davies, R. E. (1954) Biochem J 57, 37–49 Baxter, R. V., Ben Othmane, K., Rochelle, J. M., Stajich, J. E., Hulette, C., Dew-Knight, S., Hentati, F., Ben Hamida, M., Bel, S., Stenger, J. E., Gilbert, J. R., Pericak-Vance, M. A., and Vance, J. M. (2002) Nat Genet 30, 21–22 Benard, G., and Karbowski, M. (2009) Semin Cell Dev Biol 20, 365–374 Bereiter-Hahn, J. (1990) Int Rev Cytol 122, 1–63 Bereiter-Hahn, J., and Voth, M. (1994) Microsc Res Tech 27, 198–219 Bhar, D. (2006) J Biol Chem 281, 17312–17320 Blatch, G. L., and Lassle, M. (1999) Bioessays 21, 932–939 Bleazard, W., McCaffery, J. M., King, E. J., Bale, S., Mozdy, A., Tieu, Q., Nunnari, J., and Shaw, J. M. (1999) Nat Cell Biol 1, 298–304 Boldogh, I. R., Yang, H. C., and Pon, L. A. (2001) Traffic 2, 368–374 Braschi, E., Zunino, R., and McBride, H. M. (2009) EMBO reports 10, 748–754 Burgess, S. M., Delannoy, M., and Jensen, R. E. (1994) J Cell Biol 126, 1375–1391 Cereghetti, G. M., Stangherlin, A., de Brito, O. M., Chang, C. R., Blackstone, C., Bernardi, P., and Scorrano, L. (2008) Proceedings of the National Academy of Sciences 105, 15803–15808 Cerveny, K. L. (2003) Molecular Biology of the Cell 14, 4126–4139 Cerveny, K. L., McCaffery, J. M., and Jensen, R. E. (2001) Mol Biol Cell 12, 309–321 Cerveny, K. L., Studer, S. L., Jensen, R. E., and Sesaki, H. (2007) Dev Cell 12, 363–375 Chan, D. C. (2006) Cell 125, 1241–1252 Chang, C. R., and Blackstone, C. (2007) J Biol Chem 282, 21583–21587 Chang, C. R., Manlandro, C. M., Arnoult, D., Stadler, J., Posey, A. E., Hill, R. B., and Blackstone, C. (2010) J Biol Chem 285, 32494–32503
1 The Genetics of Mitochondrial Fusion and Fission
43
Chen, H. (2003) J Cell Biol 160, 189–200 Chen, H. (2005) J Biol Chem 280, 26185–26192 Chen, H., and Chan, D. C. (2009) Hum Mol Genet 18, R169-176 Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., and Chan, D. C. (2003) J Cell Biol 160, 189–200 Chen, H., Vermulst, M., Wang, Y. E., Chomyn, A., Prolla, T. A., McCaffery, J. M., and Chan, D. C. (2010) Cell 141, 280–289 Cho, D. H., Nakamura, T., Fang, J., Cieplak, P., Godzik, A., Gu, Z., and Lipton, S. A. (2009) Science 324, 102–105 Choi, S. Y., Huang, P., Jenkins, G. M., Chan, D. C., Schiller, J., and Frohman, M. A. (2006) Nat Cell Biol 8, 1255–1262 Cribbs, J. T., and Strack, S. (2007) EMBO reports 8, 939–944 Cuesta, A., Pedrola, L., Sevilla, T., Garcia-Planells, J., Chumillas, M. J., Mayordomo, F., LeGuern, E., Marin, I., Vilchez, J. J., and Palau, F. (2002) Nat Genet 30, 22–25 Dagda, R. K., Merrill, R. A., Cribbs, J. T., Chen, Y., Hell, J. W., Usachev, Y. M., and Strack, S. (2008) Journal of Biological Chemistry 283, 36241–36248 Davies, V. J., Hollins, A. J., Piechota, M. J., Yip, W., Davies, J. R., White, K. E., Nicols, P. P., Boulton, M. E., and Votruba, M. (2007) Hum Mol Genet 16, 1307–1318 Delettre, C., Lenaers, G., Griffoin, J. M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., Astarie-Dequeker, C., Lasquellec, L., Arnaud, B., Ducommun, B., Kaplan, J., and Hamel, C. P. (2000) Nat Genet 26, 207–210 Delettre, C., Griffoin, J. M., Kaplan, J., Dollfus, H., Lorenz, B., Faivre, L., Lenaers, G., Belenguer, P., and Hamel, C. P. (2001) Hum Genet 109, 584–591 DeVay, R. M., Dominguez-Ramirez, L., Lackner, L. L., Hoppins, S., Stahlberg, H., and Nunnari, J. (2009) J Cell Biol 186, 793–803 Di Maria, E., Gulli, R., Balestra, P., Cassandrini, D., Pigullo, S., Doria-Lamba, L., Bado, M., Schenone, A., Ajmar, F., Mandich, P., and Bellone, E. (2004) J Neurol Neurosurg Psychiatry 75, 1495–1498 Dimmer, K. S. (2002) Molecular Biology of the Cell 13, 847–853 Dimmer, K. S., Navoni, F., Casarin, A., Trevisson, E., Endele, S., Winterpacht, A., Salviati, L., and Scorrano, L. (2007) Human Molecular Genetics 17, 201–214 Dohm, J. A., Lee, S. J., Hardwick, J. M., Hill, R. B., and Gittis, A. G. (2004) Proteins 54, 153–156 Duvezin-Caubet, S., Koppen, M., Wagener, J., Zick, M., Israel, L., Bernacchia, A., Jagasia, R., Rugarli, E. I., Imhof, A., Neupert, W., Langer, T., and Reichert, A. S. (2007) Mol Biol Cell 18, 3582–3590 Eura, Y. (2003) J Biochem 134, 333–344 Farkasovsky, M., and Kuntzel, H. (1995) J Cell Biol 131, 1003–1014 Fekkes, P., Shepard, K. A., and Yaffe, M. P. (2000) J Cell Biol 151, 333–340 Frank, S., Gaume, B., Bergmann-Leitner, E. S., Leitner, W. W., Robert, E. G., Catez, F., Smith, C. L., and Youle, R. J. (2001) Dev Cell 1, 515–525 Fritz, S. (2003) Molecular Biology of the Cell 14, 2303–2313 Fukushima, N. H., Brisch, E., Keegan, B. R., Bleazard, W., and Shaw, J. M. (2001) Mol Biol Cell 12, 2756–2766 Furt, F., and Moreau, P. (2009) Int J Biochem Cell Biol 41, 1828–1836 Gandre-Babbe, S., and van der Bliek, A. M. (2008) Molecular Biology of the Cell 19, 2402–2412 Gari, E., Piedrafita, L., Aldea, M., and Herrero, E. (1997) Yeast 13, 837–848 Griffin, E. E. (2005) The Journal of Cell Biology 170, 237–248 Griffin, E. E. (2006) Journal of Biological Chemistry 281, 16599–16606 Griparic, L., and van der Bliek, A. M. (2005) Methods Enzymol 404, 620–631 Guillery, O., Malka, F., Landes, T., Guillou, E., Blackstone, C., Lombes, A., Belenguer, P., Arnoult, D., and Rojo, M. (2008) Biol Cell 100, 315–325
44
E.Y.L. Chan et al.
Hales, K. G., and Fuller, M. T. (1997) Cell 90, 121–129 Hammermeister, M., Schodel, K., and Westermann, B. (2010) Mol Biol Cell 21, 2443–2452 Han, X. J., Lu, Y. F., Li, S. A., Kaitsuka, T., Sato, Y., Tomizawa, K., Nairn, A. C., Takei, K., Matsui, H., and Matsushita, M. (2008) The Journal of Cell Biology 182, 573–585 Harder, Z., Zunino, R., and McBride, H. (2004) Current Biology 14, 340–345 Herlan, M., Vogel, F., Bornhovd, C., Neupert, W., and Reichert, A. S. (2003) J Biol Chem 278, 27781–27788 Herlan, M., Bornhovd, C., Hell, K., Neupert, W., and Reichert, A. S. (2004) J Cell Biol 165, 167–173 Hermann, G. J., Thatcher, J. W., Mills, J. P., Hales, K. G., Fuller, M. T., Nunnari, J., and Shaw, J. M. (1998) J Cell Biol 143, 359–373 Hogeboom, G. H., Schneider, W. C., and Pallade, G. E. (1947) Proc Soc Exp Biol Med 65, 320 Hogeboom, G. H., Schneider, W. C., and Pallade, G. E. (1948) J Biol Chem 172, 619–635 Holt, I. J., Harding, A. E., and Morgan-Hughes, J. A. (1988) Nature 331, 717–719 Hoppins, S., and Nunnari, J. (2009) Biochim Biophys Acta 1793, 20–26 Hoppins, S., Lackner, L., and Nunnari, J. (2007) Annu Rev Biochem 76, 751–780 Hoppins, S., Horner, J., Song, C., McCaffery, J. M., and Nunnari, J. (2009) J Cell Biol 184, 569–581 Ichishita, R., Tanaka, K., Sugiura, Y., Sayano, T., Mihara, K., and Oka, T. (2007) J Biochem 143, 449–454 Ingerman, E. (2005) J Cell Biol 170, 1021–1027 Ishihara, N., Fujita, Y., Oka, T., and Mihara, K. (2006) EMBO J 25, 2966–2977 Jakobs, S. (2003) Journal of Cell Science 116, 2005–2014 James, D. I. (2003) J Biol Chem 278, 36373–36379 Jones, B. A., and Fangman, W. L. (1992) Genes Dev 6, 380–389 Kanazawa, T., Zappaterra, M. D., Hasegawa, A., Wright, A. P., Newman-Smith, E. D., Buttle, K. F., McDonald, K., Mannella, C. A., van der Bliek, A. M., and Lu, B. (2008) PLoS Genetics 4, e1000022 Kang-Decker, N., Cao, S., Chatterjee, S., Yao, J., Egan, L. J., Semela, D., Mukhopadhyay, D., and Shah, V. (2007) J Cell Sci 120, 492–501 Kann, O., and Kovacs, R. (2007) Am J Physiol Cell Physiol 292, C641-657 Karbowski, M. (2004) The Journal of Cell Biology 166, 1027–1039 Kennedy, E. P., and Lehninger, A. L. (1948) J Biol Chem 172, 847–848 Kennedy, E. P., and Lehninger, A. L. (1949) J Biol Chem 179, 957–972 Kijima, K., Numakura, C., Izumino, H., Umetsu, K., Nezu, A., Shiiki, T., Ogawa, M., Ishizaki, Y., Kitamura, T., Shozawa, Y., and Hayasaka, K. (2004) Human Genetics 116, 23–27 Labrousse, A. M., Zappaterra, M. D., Rube, D. A., and van der Bliek, A. M. (1999) Mol Cell 4, 815–826 Legesse-Miller, A. (2003) Molecular Biology of the Cell 14, 1953–1963 Lehninger, A. L. (1945) The Journal of Biological Chemistry 161, 437–451 Lehninger, A. L. (1949) J Biol Chem 178, 625–644 Lewis, M. R., and Lewis, W. H. (1915) Am J Anat 17, 339–401 Liu, X., Weaver, D., Shirihai, O., and Hajnoczky, G. (2009) EMBO J 28, 3074–3089 Low, H. H., and Lowe, J. (2006) Nature 444, 766–769 Low, H. H., Sachse, C., Amos, L. A., and Lowe, J. (2009) Cell 139, 1342–1352 Macfarlane, M. G., and Spencer, A. G. (1953) Biochem J 54, 569–575 McConnell, S. J., Stewart, L. C., Talin, A., and Yaffe, M. P. (1990) J Cell Biol 111, 967–976 McQuibban, G. A., Saurya, S., and Freeman, M. (2003) Nature 423, 537–541 McQuibban, G. A., Lee, J. R., Zheng, L., Juusola, M., and Freeman, M. (2006) Curr Biol 16, 982–989 McQuibban, A. G., Joza, N., Megighian, A., Scorzeto, M., Zanini, D., Reipert, S., Richter, C., Schweyen, R. J., and Nowikovsky, K. (2010) Hum Mol Genet 19, 987–1000 Meeusen, S., McCaffery, J. M., and Nunnari, J. (2004) Science 305, 1747–1752 Meeusen, S., DeVay, R., Block, J., Cassidy-Stone, A., Wayson, S., McCaffery, J. M., and Nunnari, J. (2006) Cell 127, 383–395
1 The Genetics of Mitochondrial Fusion and Fission
45
Meglei, G., and McQuibban, G. A. (2009) Biochemistry 48, 1774–1784 Merkwirth, C., Dargazanli, S., Tatsuta, T., Geimer, S., Lower, B., Wunderlich, F. T., von Kleist-Retzow, J. C., Waisman, A., Westermann, B., and Langer, T. (2008) Genes Dev 22, 476–488 Messerschmitt, M. (2003) The Journal of Cell Biology 160, 553–564 Misaka, T., Miyashita, T., and Kubo, Y. (2002) J Biol Chem 277, 15834–15842 Mnaimneh, S., Davierwala, A. P., Haynes, J., Moffat, J., Peng, W.-T., Zhang, W., Yang, X., Pootoolal, J., Chua, G., and Lopez, A. (2004) Cell 118, 31–44 Mozdy, A. D., McCaffery, J. M., and Shaw, J. M. (2000) J Cell Biol 151, 367–380 Munoz, J. M., and Leloir, L. F. (1943) The Journal of Biological Chemistry 147, 355–362 Nakamura, N., Kimura, Y., Tokuda, M., Honda, S., and Hirose, S. (2006) EMBO Rep 7, 1019–1022 Nass, M. M., and Nass, S. (1963) J Cell Biol 19, 593–611 Nass, S., and Nass, M. M. (1963) J Cell Biol 19, 613–629 Navratil, M., Terman, A., and Arriaga, E. A. (2008) Exp Cell Res 314, 164–172 Naylor, K. (2005) J Biol Chem 281, 2177–2183 Niemann, A. (2005) The Journal of Cell Biology 170, 1067–1078 Nunnari, J., Marshall, W. F., Straight, A., Murray, A., Sedat, J. W., and Walter, P. (1997) Mol Biol Cell 8, 1233–1242 Olichon, A., Baricault, L., Gas, N., Guillou, E., Valette, A., Belenguer, P., and Lenaers, G. (2003) J Biol Chem 278, 7743–7746 Osman, C., Haag, M., Potting, C., Rodenfels, J., Dip, P. V., Wieland, F. T., Brugger, B., Westermann, B., and Langer, T. (2009) J Cell Biol 184, 583–596 Otsuga, D., Keegan, B. R., Brisch, E., Thatcher, J. W., Hermann, G. J., Bleazard, W., and Shaw, J. M. (1998) J Cell Biol 143, 333–349 Palade, G. E. (1952) Anat Rec 114, 427–451 Park, Y. Y., Lee, S., Karbowski, M., Neutzner, A., Youle, R. J., and Cho, H. (2010) J Cell Sci 123, 619–626 Patterson, G. H., and Lippincott-Schwartz, J. (2002) Science 297, 1873–1877 Perkins, G. A., Sun, M. G., and Frey, T. G. (2009) Methods Enzymol 456, 29–52 Pitts, K. R. (2004) J Biol Chem 279, 50286–50294 Potter, V. R., Lyle, G. G., and Schneider, W. C. (1951) J Biol Chem 190, 293–301 Praefcke, G. J., and McMahon, H. T. (2004) Nat Rev Mol Cell Biol 5, 133–147 Roman, H. (1980) Annu Rev Genet 14, 447–450 Rujiviphat, J., Meglei, G., Rubinstein, J. L., and McQuibban, G. A. (2009) J Biol Chem 284, 28682–28686 Schatz, G., Haslbrunner, E., and Tuppy, H. (1964) Biochemical and Biophysical Research Communications 15, 127–132 Schlickum, S., Moghekar, A., Simpson, J. C., Steglich, C., O’Brien, R. J., Winterpacht, A., and Endele, S. U. (2004) Genomics 83, 254–261 Schneider, W. C. (1948) The Journal of Biological Chemistry 176, 259–266 Schon, E. A., and Gilkerson, R. W. (2010) Biochim Biophys Acta 1800, 245–249 Sesaki, H. (2003) Biochemical and Biophysical Research Communications 308, 276–283 Sesaki, H., and Jensen, R. E. (1999) J Cell Biol 147, 699–706 Sesaki, H., and Jensen, R. E. (2001) J Cell Biol 152, 1123–1134 Sesaki, H., and Jensen, R. E. (2004) J Biol Chem 279, 28298–28303 Sesaki, H., Dunn, C. D., Iijima, M., Shepard, K. A., Yaffe, M. P., Machamer, C. E., and Jensen, R. E. (2006) J Cell Biol 173, 651–658 Shaw, J. M., and Nunnari, J. (2002) Trends Cell Biol 12, 178–184 Shin, H. W., Takatsu, H., Mukai, H., Munekata, E., Murakami, K., and Nakayama, K. (1999) J Biol Chem 274, 2780–2785 Sjostrand, F. S. (1953) Nature 171, 30–31 Smirnova, E., Shurland, D. L., Ryazantsev, S. N., and van der Bliek, A. M. (1998) J Cell Biol 143, 351–358 Smirnova, E., Griparic, L., Shurland, D. L., and van der Bliek, A. M. (2001) Mol Biol Cell 12, 2245–2256
46
E.Y.L. Chan et al.
Stojanovski, D. (2004) J Cell Sci 117, 1201–1210 Sugioka, R., Shimizu, S., and Tsujimoto, Y. (2004) J Biol Chem 279, 52726–52734 Suzuki, M. (2005) J Biol Chem 280, 21444–21452 Suzuki, M., Jeong, S.-Y., Karbowski, M., Youle, R. J., and Tjandra, N. (2003) Journal of Molecular Biology 334, 445–458 Taguchi, N., Ishihara, N., Jofuku, A., Oka, T., and Mihara, K. (2007) Journal of Biological Chemistry 282, 11521–11529 Takahashi, Y., Karbowski, M., Yamaguchi, H., Kazi, A., Wu, J., Sebti, S. M., Youle, R. J., and Wang, H. G. (2005) Molecular and Cellular Biology 25, 9369–9382 Tamura, Y., Harada, Y., Shiota, T., Yamano, K., Watanabe, K., Yokota, M., Yamamoto, H., Sesaki, H., and Endo, T. (2009) J Cell Biol 184, 129–141 Tatsuta, T., and Langer, T. (2008) EMBO J 27, 306–314 Tieu, Q., and Nunnari, J. (2000) J Cell Biol 151, 353–366 Tondera, D. (2004) Journal of Biological Chemistry 279, 31544–31555 Tondera, D. (2005) Journal of Cell Science 118, 3049–3059 Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly, Y. M., Gidlof, S., Oldfors, A., Wibom, R., Tornell, J., Jacobs, H. T., and Larsson, N. G. (2004) Nature 429, 417–423 Twig, G., Elorza, A., Molina, A. J., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., Alroy, J., Wu, M., Py, B. F., Yuan, J., Deeney, J. T., Corkey, B. E., and Shirihai, O. S. (2008) EMBO J 27, 433–446 Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M., Elsas, L. J., 2nd, and Nikoskelainen, E. K. (1988) Science 242, 1427–1430 Wang, G., Moniri, N. H., Ozawa, K., Stamler, J. S., and Daaka, Y. (2006) Proc Natl Acad Sci U S A 103, 1295–1300 Wasiak, S., Zunino, R., and McBride, H. M. (2007) The Journal of Cell Biology 177, 439–450 Waterham, H. R., Koster, J., van Roermund, C. W., Mooyer, P. A., Wanders, R. J., and Leonard, J. V. (2007) N Engl J Med 356, 1736–1741 Wells, R. C., Picton, L. K., Williams, S. C. P., Tan, F. J., and Hill, R. B. (2007) J Biol Chem 282, 33769–33775 Wong, E. D., Wagner, J. A., Gorsich, S. W., McCaffery, J. M., Shaw, J. M., and Nunnari, J. (2000) J Cell Biol 151, 341–352 Wong, E. D., Wagner, J. A., Scott, S. V., Okreglak, V., Holewinske, T. J., Cassidy-Stone, A., and Nunnari, J. (2003) J Cell Biol 160, 303–311 Yaffe, M. P. (1999) Nat Cell Biol 1, E149-150 Yonashiro, R., Ishido, S., Kyo, S., Fukuda, T., Goto, E., Matsuki, Y., Ohmura-Hoshino, M., Sada, K., Hotta, H., Yamamura, H., Inatome, R., and Yanagi, S. (2006) EMBO J 25, 3618–3626 Yoon, Y., Pitts, K. R., and McNiven, M. A. (2001) Mol Biol Cell 12, 2894–2905 Yoon, Y., Krueger, E. W., Oswald, B. J., and McNiven, M. A. (2003) Molecular and Cellular Biology 23, 5409–5420 Yu, T. (2005) Journal of Cell Science 118, 4141–4151 Zhang, Y., and Chan, D. C. (2007) Proceedings of the National Academy of Sciences 104, 18526–18530 Zhao, J., Liu, T., Jin, S. B., Tomilin, N., Castro, J., Shupliakov, O., Lendahl, U., and Nister, M. (2009) Journal of Cell Science 122, 2252–2262 Zhu, P. P. (2004) J Biol Chem 279, 35967–35974 Zick, M., Duvezin-Caubet, S., Schafer, A., Vogel, F., Neupert, W., and Reichert, A. S. (2009) FEBS Lett 583, 2237–2243 Zollino, M., Lecce, R., Fischetto, R., Murdolo, M., Faravelli, F., Selicorni, A., Butte, C., Memo, L., Capovilla, G., and Neri, G. (2003) Am J Hum Genet 72, 590–597 Zunino, R., Schauss, A., Rippstein, P., Andrade-Navarro, M., and McBride, H. M. (2007) Journal of Cell Science 120, 1178–1188 Zunino, R., Braschi, E., Xu, L., and McBride, H. M. (2009) Journal of Biological Chemistry 284, 17783–17795
Chapter 2
Relationships Between Mitochondrial Dynamics and Bioenergetics Giovanni Benard, Nadège Bellance, Caroline Jose, and Rodrigue Rossignol
Abstract In this chapter we describe the fundamental mechanisms by which mammalian cells regulate energy production, and we put emphasis on the importance of mitochondrial dynamics for the regulation of bioenergetics. We discuss both the impact of shape changes of the mitochondrion on organellar energy production, and the existence of reverse mechanisms of regulation of mitochondrial fusion and fission by the cellular energy state. Hence, in complement to pioneering concepts of metabolic control which only considered the key controlling steps of energy fluxes at the level of the respiratory chain, the recent study of mitochondrial dynamics highlights new possibilities for OXPHOS control. The implications of such a regulatory loop between mitochondrial dynamics and bioenergetics impacts several fields of human biology, as diverse as embryonic development, energy storage, cell motility, lipid and membrane biogenesis, intracellular trafficking and cell death. In addition, most neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and Hereditary Spastic Paraplegia are associated with defects in mitochondrial dynamics and bioenergetics. Therefore, to unravel the fundamental mechanisms by which mitochondrial form interacts with mitochondrial function could permit to increase our basic knowledge on the regulation of energy metabolism and to decipher the pathophysiology of a group of rare neuronal diseases. Keywords Mitochondria • Bioenergetics • Oxidative Phosphorylation • Dynamics • Neurodegenerative diseases Abbreviations ADP adenosine diphosphate ANT adenine nucleotide translocator ATP adenosine triphosphate G. Benard, N. Bellance, C. Jose, and R. Rossignol () Laboratoire “MRGM” EA4576 (Maladies Rares: Génétique et Métabolisme), Université de Bordeaux, Bordeaux, France e-mail:
[email protected] B. Lu (ed.), Mitochondrial Dynamics and Neurodegeneration, DOI 10.1007/978-94-007-1291-1_2, © Springer Science+Business Media B.V. 2011
47
48
CCCP COX CM CoQ Cyt c DAPI Dy DNP DRP1 EGFP EM ETC FADH2 FCCP FISH FMN 4Pi MICROSCOPE FRET GFP GTP H2O2 IBM ICS IM IMS JO2 MCA mPTP mt-NETWORK NADH OM OPA1 OXPHOS PDH PLD RCR RFP ROS SDH STED MICROSCOPY TMRM
G. Benard et al.
carbonyl cyanide m-chlorophenylhydrazone cytochrome c oxidase cristae membrane coenzyme Q cytochrome c diamidino-4¢,6-phénylindol-2 dichlorhydrate mitochondrial membrane electric potential 2,4-Dinitrophenol dynamin-related protein 1 enhanced GFP electron microscopy electron transfer chain flavin adenine dinucleotide reduced form carbonylcyanide-p-trifluoromethoxyphenylhydrazone fluorescent in situ hybridization flavin mononucleotide confocal microscope with two opposing lenses used for high resolution imaging of fluorescence fluorescence resonance energy transfer green fluorescent protein guanidin triphosphate hydrogen peroxyde inner boundary membrane intra cristae space inner membrane inter-membrane space respiratory rate metabolic control analysis mitochondrial permeability transition pore mitochondrial network nicotinamide adenine dinucleotide reduced form outer membrane gene encoding a dynamin-related mitochondrial protein causing autosomal dominant optic atrophy oxidative phosphorylation pyruvate dehydrogenase complex phospholipase D respiratory control ratio red fluorescent protein reactive oxygen species succinate dehydrogenase stimulated emission depletion microscopy tetramethyl rhodamine methyl ester
2 Relationships Between Mitochondrial Dynamics and Bioenergetics
49
2.1 Introduction Rapid progress in mitochondrial research recently demonstrated a critical role for mitochondrial fusion and fission in the modulation of mitochondrial functions as diverse as apoptosis, energetics, calcium signaling, and ROS generation (Rossignol and Karbowski 2009). Alternative observations also reported changes in mitochondrial form upon activation of apoptosis, cell division, or adaptation to low energy states. Hence, the link between mitochondrial dynamics and energy production can be investigated in two directions. In this chapter we present first the observations in favor of a regulation of mitochondrial dynamics by the mitochondrial energy state, and secondly we summarize the experimental results indicating a possible control of mitochondrial energy production by organellar, shape changes. Prior to develop these two hypotheses we describe briefly the mechanisms of cellular and mitochondrial energy production, as well as their regulation, and we give a basic introduction on mitochondrial dynamics. At the end of this chapter we highlight the importance of the link between mitochondrial dynamics and energetics in human pathology.
2.2 The Biochemistry of Energy Production In most human tissues, mitochondria provide the energy necessary for cell growth, and biological activities. It has been estimated that about 90% of mammalian oxygen consumption is mitochondrial, which primarily serves to synthesize ATP, although in variable levels according to the tissue considered and the organism’s activity status (Benard et al. 2006). Mitochondria intervene in the ultimate phase of cellular catabolism, following the enzymatic reactions of intermediate metabolism that degrade carbohydrates, fats and proteins into smaller molecules such as pyruvate, fatty acids and amino acids, respectively (Fig. 2.1). Mitochondria further transform these energetic elements into NADH and/or FADH2, through ß-oxidation and the Krebs cycle. Those reduced equivalents are then degraded by the mito chondrial respiratory chain in a global energy converting process called oxidative phosphorylation (OXPHOS) where the electrons liberated by the oxidation of NADH and FADH2 are passed along a series of carriers regrouped under the name of “respiratory chain” or “electron transport chain” (ETC), and ultimately transferred to molecular oxygen (Fig. 2.2). ETC is located in mitochondrial inner membrane, with an enrichment in the cristae. ETC consists of four enzyme complexes (complexes I – IV), and two mobile electron carriers (coenzyme Q and cytochrome c). These complexes are composed of numerous subunits encoded by both nuclear genes and mitochondrial DNA at the exception of complex II (nuclear only). It was demonstrated that these complexes can assemble into supramolecular assemblies called “supercomplexes” or respirasomes.
50
G. Benard et al.
Fig. 2.1 Main pathways of cellular and mitochondrial energy metabolism. The two main metabolic pathways, i.e glycolysis and oxidative phosphorylation are linked by the enzyme complex pyruvate dehydrogenase. Briefly, glucose is transported inside the cell and oxidized to pyruvate. Under aerobic conditions, the complete oxidation of pyruvate occurs through the TCA cycle to produce NADH, H+ and/or FADH2. These reduced equivalents are oxidized further by the mitochondrial respiratory chain
In presence of energy substrate (NADH or FADH2), the transfer of electrons from complex I (and/or II) to complex IV mediates the extrusion of protons from the matrix to the inter-membrane space, thus generating an electrochemical gradient of protons (DmH+) which is finally used by the F1-Fo ATP synthase (i.e. complex V) to produce adenosine triphosphate (ATP) the energetic currency of the cell. This gradient has two components: an electric potential (DY) and a chemical potential (DmH+) that can also be expressed as a pH gradient (DpH). According to the chemiosmotic theory (Mitchell 1961), DmH+ = DY−ZDpH, with Z = −2.303 RT/F. Under physiological conditions, mitochondrial energy production can alternate between two energy steady-states: basically, at state 4, respiration is slow and ATP is not produced (DY is high), while during state 3, respiration is faster and ATP is largely produced (DY is lower). In particular conditions, such as mitochondrial inner membrane permeabilization or the use of a chemical uncoupler, DY can be totally dispersed. As a consequence, respiration is accelerated and ATP production annihilated. The inhibition of respiratory chain complexes also generally decreases DY. Under physiological conditions, it is considered that mitochondria produce ATP in an intermediate state lying between state 3 and state 4. ATP is the only form
2 Relationships Between Mitochondrial Dynamics and Bioenergetics
H+
H+
H+
51
Intermembrane space
Cyt C
Q
e-
NADH +H+
e-
1/202
NAD+
Complex l NADH dehydrogenase 47 Subunits 7 mtDNA/40 nDNA
Matrix
H2O
FAD H2
ADP Pi
FAD
Complex ll Succinate dehydrogenase 4 Subunits 0 mtDNA/4 nDNA
Complex lll Complex lV Ubiquinol cytochrome Cytochrome C oxidase C oxidoreductase 11 Subunits 1 mtDNA /10 nDNA
13 Subunits 3 mtDNA/10 nDNA
H+
ATP
Complex V ATP synthase
17 Subunits 2 mtDNA/15 nDNA
Fig. 2.2 Mitochondrial respiratory chain. For mammals, the respiratory chain consists of four enzyme complexes (complexes I – IV) and two intermediary substrates (coenzyme Q and cytochrome c). The NADH + H+ and FADH2 produced by the intermediate metabolism are oxidized further by the mitochondrial respiratory chain to establish an electrochemical gradient of protons, which is finally used by the F1F0-ATP synthase (complex V) to produce ATP, the only form of energy used by the cell. In this simple representation of the respiratory chain, the supramolecular organization (supercomplexes, dimers) is not shown
of energy used by the cell, and when produced in the mitochondrion it is exported to the cytosol by the adenine nucleotide translocator (ANT) in exchange for cytosolic ADP. Generally, the transport of energy metabolites, nucleotides and cofactors into and out of the mitochondrial matrix is performed by transporters located in the inner membrane (Palmieri et al. 1996). Mitochondria also contain “shuttle” systems that permit the transport of NADH.
2.3 The Regulation of Cellular and Mitochondrial Energy Production In mammalian cells, energy homeostasis requires a constant coordination between cell activity, nutrient availability and the regulation of energy transformation processes. This is obtained via a complex system of signaling linking energy sensing and nutrient sensing to cellular effectors that include kinases and transcription factors. The AMP-activated protein kinases are activated upon alterations in the cellular AMP/ATP ratio, which is dictated by the balance between energy supply (ATP production) and energy demand (ATP consumption). When activated by AMP,
52
G. Benard et al.
the AMPK initiate a cascade of phosphorylation to switch on the catabolic pathways that produce ATP (glycolysis, oxidative phosphorylation via the stimulation of mitochondrial biogenesis), and to switch-off the anabolic pathways that consume ATP (protein synthesis, fatty acid synthesis, cholesterol synthesis) (for review see (Hardie 2007)). More recently, it was discovered that AMPK further regulates energy metabolism through the activation of the sirtuin SIRT1 (Canto and Auwerx 2009; Canto et al. 2009) and the downstream modulation of SIRT1 targets that include the peroxisome proliferator-activated receptor-y coactivator l alpha (PGC1a), and the forkhead box O1 (FOXO1) and 03 (FOXO3a) transcription factors. In the present chapter, we will discuss how mitochondrial dynamics interacts with the regulatory pathway of energy metabolism governed by AMPK and sirtuins, and reciprocally. The regulation of mitochondrial energy production is concerted and multi-site (Benard et al. 2010). The different levels of OXPHOS regulation include (1) the direct modulation of respiratory chain kinetic parameters, (2) modulation of OXPHOS intrinsic efficiency by changes in the basal proton conductance or the induced proton conductance, (3) possible changes in the morphological state of the mitochondrial compartment (as discussed here), (4) modulation of mitochondrial biogenesis and degradation, and (5) in situ regulation of mitochondrial heterogeneity by the cellular and the mitochondrial microenvironment. Most of these regulatory mechanisms (Fig. 2.3) of mitochondrial energy production were discovered at the
Fig. 2.3 Multi-site regulation of mitochondrial oxidative phosphorylation. The modulation of OXPHOS capacity and activity occurs at different levels to adapt mitochondrial energy production to the cellular needs and environmental bioenergetic constraints
2 Relationships Between Mitochondrial Dynamics and Bioenergetics
53
level of the respiratory chain and its surrounding lipid environment. Below, we discuss whether and how changes in mitochondrial fusion and fission impact these conserved mechanisms of bioenergetic regulation.
2.4 Mitochondrial Structure and Dynamics In the past decade, the development of fluorescence microscopy has allowed the gathering of a three dimensional view of the mitochondrion in living human cells (Bereiter-Hahn and Voth 1994; Griparic and van der Bliek 2001; Yaffe 1999). In these studies, the mitochondria looked as an organelle that appeared more like a wide network of long tubules rather than a collection of small individual vesicles. In Fig. 2.4, we see the arborescence of the mitochondrial network in living human cells. Mitochondrial dynamics is performed by fusion proteins and fission proteins, which could reveal new possibilities for the control of mitochondrial energy produc tion and cell viability (Benard and Karbowski 2009). In mammals, the proteins involved in mitochondrial fusion include the mitofusins MFN1 and MFN2, and OPA1 (different isoforms of OPA1 are generated by alternative splicing). SLP2 (Stoml2), MarchV, Bax and Bak interact with MFN2 to regulate fusion. In addition, different ATP-dependent or ATP independent proteases regulate fusion via OPA1 processing (Ehses et al. 2009). Low mitochondrial ATP levels, or the dissipation of the mitochondrial electric membrane potential across the inner membrane induce OPA1 cleavage by PARL and the matrix AAA (m-AAA) protease (Duvezin-Caubet et al. 2006). OMA1 mediates OPA1 processing if m-AAA proteases are absent or mitochondrial activities are impaired (Ehses et al. 2009). PISD and mito-PLD are proteins involved in the metabolism of phospholipid and could regulate mitochondrial
Intracristae space
lntermembrane Inner boundary membrane (IBM) space (IMS) One cristae
junction pore
Cristae membrane (CM)
Matrix
IBM
Respiratory chain (6 fold enrichment in CM as compared to IBM)
260 nm
IMS OM Outer membrane (OM)
Fig. 2.4 Mitochondrial structure. (a) Overview of the mitochondrial network in living human HeLa cells. The mitochondrial network was imaged by fluorescence microscopy (bi-photonic), using a matrix-targeted GFP. (b) Internal organization of the mitochondrial network; section of a tubule. This scheme illustrates the “cristae junction model” of mitochondrial interior. In this view, the pores could serve to regulate the release of cytochrome c during apoptosis
54
G. Benard et al.
fusion via changes in membrane composition (Furt and Moreau 2009). The role of MIB is unclear, and might also participate to mitochondrial fusion via MFN2 binding. The proteins involved in mitochondrial fission include FIS1 and DRP1. Mitochondrial Fission Factor (MFF) also plays a role in mitochondrial fission. The regulators of fission include MARCHV, Mff, Bcl-w and different kinases required for the phosphorylation of DRP1. DRP1 can also be nitrosylated (see below). So far, the interaction between mitochondrial dynamics and mitochondrial energetics remain unclear. To investigate the link between mitochondrial energy production and organellar shape changes, appropriate methods are needed to quantify changes both in mitochondrial form and function. Firstly, one can observe the shape of the mitochondrial network by epifluorescence or confocal microscopy in living cells using various fluorescent probes targeted to the mitochondrial matrix (GFPs, mitotrackers, TMRM…). For instance, inhibited fusion leads to a fragmented mitochondrial network while inhibited fission generates long tubules with signs of hyperfusion. The morphometric analysis of the mitochondrial compartment can be performed on microscopy images by using an automated computerized method to assess the length and branching degree of the mitochondrial particles (Koopman et al. 2005b). This method gives a quantitative evaluation based on the measurement of a form factor (combined measure of length and degree of branching), an aspect ratio (measure of length), and the overall content of mitochondria in the cell. In situations of altered fusion and fission (as occurs in neurological diseases caused by mutations in OPA1 and Mfn2, or DRP1, respectively) the viscosity of the mitochondrial matrix can also change (Benard and Rossignol 2008a; Koopman et al. 2008). Likewise, a test of mitochondrial fusion is available on cells containing different fluorescent proteins targeted to the mitochondrial matrix (matrix red fluorescent protein; mtRFP) or matrix green fluorescent protein (mtGFP). These two types of cells are fused with polyethylene glycol (PEG) to allow cell membrane fusion and the resulting polykaryons are analysed by confocal microscopy on the basis of their level of mtRFP and mtGFP colocalization. The mixing of green and red mitochondrial matrix-targeted proteins due to mitochondrial fusion leads to cells containing “yellow mitochondria” (Legros et al. 2002). Yet, the polyethylene glycol used for cell membrane fusion might also interfere with mitochondrial membrane fusion and perturbate the assay. Another possibility to measure mitochondrial fusion is to use mitochondrially targeted photoconvertible GFP (mito-Dendra) which changes color from green to red once activated by a blue laser. The mixing of the activated GFP with mitochondrial tubules generates yellow regions which can be counted as function of time to evaluate fusion, fission and transport (Koutsopoulos et al. 2010). Similar assays were also developed to investigate automatically the activity of mitochondrial fusion and fission (Jourdain and Martinou 2010). To further assess the activity of mitochondrial fission, it is also possible to use the so-called “CCCPassay” which inhibits fusion and allows fission to proceed. The time required, or the CCCP amount needed to visualize fission gives a measure of its activity. This test is indirect and considers that OPA1 processivity is unchanged in the different conditions. This test was used in Ehses et al. (2009) and Ishihara et al. (2003, 2006).
2 Relationships Between Mitochondrial Dynamics and Bioenergetics
55
2.5 Control of Mitochondrial Dynamics by Energy Metabolism (Hypothesis 1) The possible control of mitochondrial fusion by energy state was first suggested by studies (Legros et al. 2002; Ishihara et al. 2003) showing that mitochondrial fusion is altered by the collapse of mitochondrial membrane potential (DY). This was later partly explained by a DY-dependent cleavage of OPA1 (Duvezin-Caubet et al. 2006) and the subsequent inhibition of mitochondrial fusion. Fission can also be controlled by energy dependent processes since the phosphorylation of DRP1 by a cAMP-dependent kinase activates fission and promotes cell division. Hypothesis 1 (Fig. 2.5) was also inspired by a wide range of studies showing the alteration of cellular energy productions by the perturbation of mitochondrial fusion and fission (notably in different pathologies), as we reviewed previously in (Benard and Rossignol 2008b) and (Benard et al. 2010). Yet, the signals that mediate changes in energy state to the fusion-fission machinery remain poorly understood, and different possibilities can be proposed. A conceivable hypothesis of a bioenergetic control of mitochondrial fusion and fission by the mitochondrial and/or the cellular energy states arise from the evidence that OPA1, MFN1, MFN2 and DRP1 require GTP to perform their mechanical activity. This idea was initially proposed by Petr Jezek in 2009 (Jezek and PlecitaHlavata 2009; Jezek et al. 2009). The GTP formation by the Krebs cycle followed by GTP extrusion by the ANT could directly modulate the extent of mitochondrial fusion (Jezek and Plecita-Hlavata 2009; Jezek et al. 2009). The conversion of
Exercise training Energy needs (AMPK) MARCHV
selective degradation Uncouplin
g inhibits
Low DY
Functional complementation
fusion
High DY
OPA1 long isoforms
Mfn2
Mitochondrial network and sub-networks
Metabolites diffusion Respirasome activity channeling
Fusion 3 Mitochondrial particles (fragmented network)
GTP DRP1 binding
NDP kinase
Apoptosis Cell division
ATP Fission GTP NDP kinase ATP
Oxidative Phosphorylation
Fig. 2.5 Mutual link between mitochondrial bioenergetics and dynamics (schematic representation of hypotheses 1 and 2 described in the text)
56
G. Benard et al.
ATP to GTP by nucleoside diphosphate kinases (NDP kinases) located either on the surface of the mitochondrion, or in the intermembrane space (Chen and Douglas 1987) might also play an important role in the bioenergetic control of these dynamins. The NDP kinase D (NM23-H4) was shown to be associated with the outer and inner mitochondrial membranes (Lacombe et al. 2000; Milon et al. 2000) and was not found in the soluble fractions. NDP kinase D and porin distribute similarly among the fractions, thus strongly suggesting that NDP kinase D is associated, like porin, with contact sites between the outer and the inner membrane. In addition to NDPkinase D, intra-mitochondrial NDP kinases were found in pigeon. The Nm23-H6 partially colocalizes with mitochondria (Tsuiki et al. 1999). Besides this possibility, the analysis of the different proteins involved in mitochondrial fusion or fission has evidenced post-translational modifications for DRP1, OPA1, and MFN2, which might also intervene in the modulation of mitochondrial dynamics and the subsequent control of OXPHOS capacity in response to cellular energy state and nutrients availability. First, DRP1 can be phosphorylated, ubiquitylated, nitrosylated and sumoylated. So far, the impact of these changes on mitochondrial energy production have not been investigated, and solely the effects on DRP1 recruitment to mitochondrial membrane, DRP1 turnover, fission activity or the sensitivity to apoptosis were analysed (Karbowski et al. 2007; Ishihara et al. 2003; Figueroa-Romero et al. 2009; Nakamura et al. 2006). The lowered expression of DRP1 by RNA interference induces the impairment of OXPHOS with a strong reduction of ATP synthesis capacity (Benard et al. 2007). Regarding OPA1, it is well documented that a loss of mitochondrial membrane potential (i.e. uncoupling by CCCP (Duvezin-Caubet et al. 2006)) triggers the cleavage of long isoforms of OPA1 to shorter forms, and reduces the ability for mitochondrial fusion (Legros et al. 2002). This cleavage can be performed by different m-AAA proteases which may or may not require ATP and can be controlled by prohibitins; the interaction of both the proteases and their regulators by the cellular energy states also remains to be clarified. How the energy state modifies their expression level and self-proteolytic state remains elusive. Likewise, 8 OPA1 isoforms result from alternate splicing of three exons (Ex4, Ex4b and Ex5b) and the impact of variable energy states on this pattern of OPA splicing is unknown. Alternative splicing is an important mechanism to create protein diversity and to regulate gene expression in a tissue- or developmental-specific manner. Interestingly, the activity of the spliceosome depends on the levels of ATP, since the PRP16 RNA-dependent ATPase is required for the second catalytic step of pre-mRNA splicing (Schwer and Guthrie 1992). The downregulation of OPA1 expression in human cells, or the occurence of pathogenic mutations in this protein are associated with an alteration of OXPHOS functioning (Chen et al. 2005; Chevrollier et al. 2008; Olichon et al. 2003). Similar results were obtained with Mfn2 downregulation in human cells or transgenic mice (Chen and Chan 2009). Again, it is still unknown how these changes in mitochondrial fusion and fission alter the mechanisms of energy production. Mfn2 can also be conjugated with MARCHV (Nakamura et al. 2006; Karbowski et al. 2007) to stimulate its fusion activity. Recent observations also describe a role for
2 Relationships Between Mitochondrial Dynamics and Bioenergetics
57
MFN2 in controlling ATP/ADP exchanges, possibly through protein-protein interactions, which might offer an additional mechanism by which mitochondrial fusion could control mitochondrial energy production (Guillet et al. 2009). Lastly, Mfn2 was recently identified at the interface between the endoplasmic reticulum and the mitochondrion, with a possible role in the regulation of mitochondrial Ca2+ uptake (de Brito and Scorrano 2008). Since matricial calcium can stimulate different mitochondrial dehydrogenases and transporters, which participate in energy production, Mfn2 might also be engaged in the regulation of mitochondrial energetics via calcium signalling. The hypothesis of a role for OPA1, DRP1 and MFN2 in the regulation of mitochondrial and cellular energy production is emphasized by the discovery of diseases caused by mutations in these proteins (see below). As discussed above, energy metabolism is regulated by different pathways involved in nutrient sensing, oxygen sensing or energy needs sensing. How these master regulators of energy metabolism interact with the mitochondrial fusion and fission proteins also remain to be investigated. The activation of Sirt1 by resveratrol stimulates AMPK activity and induces the upregulation of Mfn2 in neurons (Dasgupta and Milbrandt 2007). Likewise, in skeletal muscle, the expression of an active form of AMPK (transgenic mice Tg-AMPKg3225Q) triggers the upregulation of MFN-2 (mitofusin 2), OPA-1 (dynamin-like GTPase-optic atrophy 1) and DRP-1 (dynaminrelated protein 1) (Garcia-Roves et al. 2008).
2.6 Control of Mitochondrial Energetics by Organellar Dynamics (Hypothesis 2) Theoretical studies on the regulation of oxidative phosphorylation in skeletal muscle mitochondria suggest that only a direct activation by “some cytosolic factors” of all oxidative phosphorylation enzymes is able to account for the large increase in VO2 and ATP turnover accompanied by only a very moderate increase in ADP concentration during the rest to work transition (Korzeniewski 2000; Korzeniewski and Mazat 1996). Yet, recent findings in mitochondrial physiology might allow to propose a hypothetic role for mitochondrial dynamics in the rapid regulation of OXPHOS output. Indeed, a recent study by the group of JC. Martinou evidenced a rapid stress-induced mitochondrial hyperfusion (SIMH), which is accompanied by an increase in mitochondrial ATP production (Tondera et al. 2009). This process involved the mitochondrial inner membrane protein SLP-2 and was dependent on mitochondrial oxidative phosphorylation since it was blocked in RhoO cells that exhibited a normal mitochondrial membrane potential, but were unable to synthesize ATP. The SIMH was observed in situations of stress, as induced by actinomycin D, cycloheximide or UVs, which also induced a large increase in the cellular ATP content (220%, 160% and 120% of the untreated control, respectively). The increased ATP levels associated with SIMH could be attributed to a combined stimulation of OXPHOS and glycolysis, as well as a possible inhibition of the ATP consuming activities. Still, the mechanisms by which this
58
G. Benard et al.
(hyper)fusion event could initiate an increase in mitochondrial and glycolytic ATP synthesis remain unexplained. It may be postulated that mitochondrial fusion could increase the speed of diffusion of energy metabolites (ADP, NADH) within the mitochondrial tubules, or that such conformational changes impact the respirasome organization and activate signalling cascades which remain to be deciphered. Likewise, the overexpression of mitofusin 2 improves the mitochondrial capacity to produce ATP and stimulates glucose oxidation (Bach et al. 2005). This could be explained by a higher fusion of the mitochondrial network, but also a stimulation of mitochondrial biogenesis, as Mfn2 plays a role in both processes (Zorzano et al. 2009a, b). Furthermore, MFN2 interacts with the proto-oncogene Ras, and Ras activity was associated with the modulation of mitochondrial respiration through the regulation of complex I (Baracca et al. 2010). Hence, the interaction between Mfn2 and Ras could participate to the regulation of mitochondrial ATP production, but this point remains to be evaluated. Lastly, new insights into the critical relationships between mitochondrial dynamics and programmed cell death have demonstrated an interaction between Bax and Bak with Mfn2 (Karbowski et al. 2006) which might suggest that Bcl-2 family members may also regulate apoptosis through organelle morphogenesis machineries. Interestingly, Bcl2 can also regulate directly mitochondrial respiration, through the modulation of cytochrome c oxidase (COX) activity (Chen and Pervaiz 2009, 2007). A closer link between mitochondrial energetics and apoptosis could emerge in the coming years. In addition to Mfn2, the fusion protein OPA1 could also participate in the control of mitochondrial respiration since the removal of the m-AAA protease (which cleaves OPA1 in a Dy-dependent manner) limits the capacity of the oxidative phosphorylation system to supply ATP under conditions of high energy demand (Ehses et al. 2009). Hypothesis 2 (Fig. 2.5) also includes a control of mitochondrial dynamics by the cellular energy state via changes in mitochondrial membrane composition. Mitochondrial function relies fundamentally on organellar membranes properties, since chemiosmosis cannot exist without membrane impermeability to protons (Mitchell 1961), respiratory chain supercomplexes organization is conditioned by the lipid surrounding (Pfeiffer et al. 2003) and changes in mitochondrial membrane fluidity can alter bioenergetics (Benard et al. 2007; Benard and Rossignol 2008b, a; Aleardi et al. 2005). Thus, modifications of the phospholipid composition of mitochondrial membranes could participate to the control of energy production or apoptosis. For instance, it was shown that changes in organellar membranes fluidity alter both the functioning of OXPHOS and the overall dynamics of the mitochondrial network, in a mutual way (Benard et al. 2007). The control of the mitochondrial apoptotic pathway is also conditioned by changes in organellar membrane integrity (MOMP) and composition (Sandra et al. 2005; Newmeyer and FergusonMiller 2003; Wei et al. 2001; Kuwana et al. 2002). It remains to be shown whether changes in mitochondrial membrane composition induced by difference in energy state could contribute to the observed changes in mitochondrial network morphology. A study revealed that an ancestral member of the phospholipase D (PLD) superfamily of lipid-modifying enzymes is required for mitochondrial fusion by hydrolysing cardiolipin to generate phosphatidic acid (Choi et al. 2006). In this
2 Relationships Between Mitochondrial Dynamics and Bioenergetics
59
study, the silencing of MitoPLD significantly reduced mitochondrial membrane potential and presumably associated mitochondrial energy production. To conclude on hypothesis 2, only few observations are available regarding the stimulation of OXPHOS by an increase in mitochondrial fusion, while numerous reports indicate an impairment of mitochondrial respiration in situations of altered fusion or fission (Benard and Rossignol 2008b). Therefore, more evidences are needed to prove that mitochondrial fusion and fission proteins actively participate in the regulation of mitochondrial respiration.
2.7 Mitochondrial Fusion and Functional Complementation (Consequence of Hypothesis 2) When two mitochondrial particles fuse, they can exchange materials that could permit compensation for a defective mitochondrial energy production at the cellular level. The study of Nakada et al. (2001) was the first to show the existence of mitochondrial genetic and functional complementation in vivo by analyzing the skeletal muscle of different transgenic mice containing various degrees of heteroplasmy (percentage of mutant mitochondrial DNA per cell). These authors never observed the coexistence of respiratory chain complex IV active and inactive mitochondria by histochemical staining within single muscle fibers despite the presence of 89% heteroplasmy. This might indicate that genetic complementation was attained in the muscle fibers, possibly via the inter-mitochondrial particles fusion and mixing of their content. During aging, the different proteins located in the mitochondrial network (as well as mitochondrial DNA molecules) can be progressively damaged by the high local concentration of reactive oxygen species (ROS), thus creating a heterogeneous situation where active DNAs and protein complexes could coexist with damaged ones along the tubules (heteroplasmy). In this case, the fusion of mitochondrial particles could allow functional complementation (Benard and Rossignol 2008b). Depending on the morphological state of the mt-network, the internal complementation can be variable. In the fragmented state, no exchange can occur between the different particles, creating an heterogeneous situation inside the cells. Therefore, reactions of fusion and fission could modulate the network organization and impact the capacity for compensating OXPHOS defects. Furthermore, we showed that such compensation exists until a threshold is reached (Rossignol et al. 1999, 2000, 2003) (upon strong inhibition of mitochondrial respiratory chain), and we also showed that mitochondrial fragmentation occurs once this threshold is reached (Benard et al. 2007). Accordingly, forced fusion of the mitochondrial network might allow a higher resistance (higher threshold) to a pathogenic respiratory chain impairment induced by a specific inhibitor of complex I. The mitochondrial threshold effect shows that large defects in the activity of respiratory chain complexes (induced by aging or pathogenic mutations) can occur in muscle or brain without triggering a reduction of the mitochondrial ATP production. We postulate that mitochondrial fusion and the exchange of materials such as energy metabolites and mitochondrial subunits could permit functional complementation.
60
G. Benard et al.
The role of mitochondrial fusion in promoting intramitochondrial diffusion of metabolites could be important since studies indicate the existence of segmentation along the tubules that sequester the matrix into successive domains within the same tubule. This segmentation was observed in different analyses of mitochondrial interior physical continuity, using either JC1 or photoactivable GFP, as well as FRAP experiments (Collins et al. 2002; Partikian et al. 1998; Twig et al. 2006, 2008a). The use of rosGFP1, or GFPpH also reveals zones of variable intensity in the mtnetwork of a same cell. In this case, the lipid nature of the intratubular barriers remains to be clarified, as well as their protein composition. The existence of internal barriers inside the tubule has important repercussions for the modalities of energy production, as they could abrogate the diffusion of substrates and metabolites required for oxidative phosphorylation. Different pre-fragmented domains could exist next to each other along the tubules, with differences in energy states, determined by the composition of OXPHOS complexes, the local concentration of substrates and activators of the energetic machinery, the variable volume of the different compartments (ICS and IMS), and the surrounding cytoplasm ATP needs. Thus, the idea of mitochondrial tubules operating as long uninterrupted electric cables might need to be revisited. Furthermore, it is also possible that the internal heterogeneity of mitochondrial tubule, in regard to OXPHOS activity, could be dictated by the local needs for ATP and the demand for oxygen (Mironov 2007; Mironov and Symonchuk 2006), but more studies are needed to validate this view. Mitochondrial networking could also play a role in genetic inter-mitochondrial particles complementation (Nakada et al. 2001), but this requires complete fusion and physical continuity. An alternative could be the existence of partial and transient sub-networks that will define larger functional domain. Twig et al. validated this view by using a matrix targeted photoactivable GFP (Twig et al. 2006). They showed that different subnetworks are coexisting and can undergo internal fission or fusion, without loss of their global architecture. Each network is defined by luminal continuity, equipotentiality, and boundaries which cannot be predicted without consideration of these parameters. This idea of subnetwork was previously proposed by the group of Dimitri Zorov that described the existence of Clusters Formed by Chains of Mitochondria that were called Streptio mitochondriale (Bakeeva et al. 1978). Taken together, these different observations permit the definition of four hierarchical levels of organization of the mitochondrion: the segment, the tubule, the sub-network and the global network. Each of these structures could play different roles in the synthesis and delivery of the vital ATP to various cellular areas, as well as to coordinate the different functions of the mitochondrion.
2.8 Mitochondrial Dynamics, Cell Cycle, and Organogenesis The overall networked and ramified architecture of the mitochondrion could be conserved throughout species. In some eukaryotic microorganisms such as Trypanosoma the mitochondrion is typically observed as a single highly ramified organelle.
2 Relationships Between Mitochondrial Dynamics and Bioenergetics
61
Likewise, the protozoan Toxoplasma present only one ramified mitochondrion. Yet, the comparison of the mitochondrial network in different cell types (Kuznetsov et al. 2009) as well as the study of its internal organization in muscle, heart, liver, kidney and brain taken from rats shows a large diversity in mitochondrial shape and organization which could be partly explained by differences in energy supply and demand, as well as a tissue-specific regulation of fusion and fission. A link between the cell cycle and mitochondrial dynamics was evidenced in Hela cells, as the mitochondrial network becomes fragmented in early mitotic phase, and fused again in the daughter cells (Margineantu et al. 2002; Chang and Blackstone 2007). This process depends on Drp1 phosphorylation by Cdk1/cyclin. Mitochondrial dynamics might also play a determinant role during cell development as Campello S et al. showed that mitochondria specifically concentrate at the uropod during lymphocyte migration, by a process involving rearrangements of their shape (Campello et al. 2006). In this study, mitochondrial fission facilitated relocation of the organelles and promoted lymphocyte chemotaxis, whereas mitochondrial fusion inhibited both processes. In Drosophila, the polar granules are tightly associated with mitochondria in early embryos, suggesting that mitochondria could contribute to pole cell formation (Amikura et al. 2001a, b). It was even reported that mitochondrial large and small rRNAs are transported from mitochondria to polar granules prior to pole cell formation. Fujiwara S. and Satoh N. showed that during ooplasmic segregation, mitochondria are mainly distributed to the myoplasmic region in embryos of the ascidian HaloCynthia roretzi (Fujiwara et al. 1993). Recently, a transgenic mice model showed that brain-specific Drp1 ablation caused developmental defects of the cerebellum (Wakabayashi et al. 2009). Likewise, a primary culture of NS-Drp1(−/−) mouse forebrain showed a decreased number of neurites and defective synapse formation (Ishihara et al. 2009). Lastly, the removal of Mfn2 from the cerebellum in a transgenic mice model (Chen et al. 2007), triggered neurodegeneration caused by loss of mitochondrial fusion. In this model, during development and after maturity, Purkinje cells required Mfn2 (but not Mfn1) for dendritic outgrowth, spine formation, and cell survival.
2.9 Mitochondrial Dynamics, Energetics and Diseases The recent discoveries of pathogenic mutations in genes essentials for fusion and fission of the mitochondrial network have complicated the physiopathological mechanisms of these diseases (Detmer and Chan 2007), and led to questions about the similarities between enzymatic defects in respiratory chain complexes versus the perturbation of mt-network dynamics. Why do they lead to similar clinical consequences, how do they interact, and what are the molecular and signaling bases that connect each other? Recent hypotheses in the field of mitochondrial physiopathology even consider that defects of the mitochondrial network could be the final cause of the disease, consequently to mutations affecting primarily the respiratory chain complexes. For instance, the work of Duvezin et al. (2007) analyzed the
62
G. Benard et al.
fusion protein OPA1 in different cells models with a primary genetic defect in the respiratory chain complexes. These included cybrids created from a patient with myoclonus epilepsy and ragged-red fibers (MERRF) syndrome, mouse embryonic fibroblasts harboring an error-prone mitochondrial mtDNA polymerase gamma, heart tissue derived from heart-specific TFAM knock-out mice suffering from mitochondrial cardiomyopathy, and skeletal muscles from patients suffering from mitochondrial myopathies such as myopathy encephalopathy lactic acidosis and stroke-like episodes. They observed that dissipation of the mitochondrial membrane potential led to fast induction of proteolytic processing of OPA1 and concomitant fragmentation of mitochondria. Moreover, recovery of mitochondrial fusion depended on protein synthesis and was accompanied by resynthesis of large isoforms of OPA1. This could designate a novel mechanism by which the proteolytic processing of OPA1 could induce the fragmentation of energetically compromised mitochondrial segments. This could prevent the fusion of dysfunctional mitochondrial particle with the functional mitochondrial network. As discussed above, the relationships between mitochondrial energy production and mt-network organization are mutual (Benard et al. 2007). Hence, pathological mutations affecting either the respiratory chain, or the dynamic machinery, can both lead to OXPHOS deficiency and abnormal shaping of the mitochondrion. The observations of mt-network architecture in cells from patients with a genetic defect in respiratory chain show inconsistent abnormalities of the mt-network. The patterns of these changes can vary form one patient to another, as the clinical signs typically do. Most studies looking at these aspects concerned the complex I deficiencies, in human skin fibroblasts, since it is the most common cause of mitochondrial diseases. The group of Robinson B. analyzed the mitochondrial structure and motion dynamics in living cells with energy metabolism defects by real time microscope imaging (Pham et al. 2004). They concluded that skin fibroblasts from patients with mitochondrial complex I deficiency and normal fibroblasts treated with rotenone, or antimycin A, contained higher proportions of mitochondria in the swollen filamentous forms, nodal filaments, and ovoid forms rather than the slender filamentous forms found in normal cells. They also reported a decreased motility with more ovoid mitochondrial forms compared to the filamentous forms. Likewise, it was shown that when complex I activity was chronically reduced by 80% in human skin fibroblasts, using rotenone treatment, the percentage of moving mitochondria and their velocity decreased by 30% (Koopman et al. 2007). It was proposed that ROS generated by the ETC in pathological situations could be responsible for such observed changes in mt-network organization. To test this hypothesis, Werner Koopman and Sjoerd Verkaart developed a fine and reliable method for the simultaneous quantification of oxidant levels and cell spreading (Koopman et al. 2005a, b, 2006a, b), based the monitoring of CM-H2DCF conversion into DCF upon intracellular oxidation, by video-rate confocal microscopy. After an extensive validation of their protocol, these authors looked at the ROS steady-state levels in fibroblasts taken from patients with a complex I deficiency and demonstrated a 2.5-fold higher oxidative stress in these cells. In another study, the same group demonstrated that superoxide production is increased in complex I deficient cell lines, in proportion
2 Relationships Between Mitochondrial Dynamics and Bioenergetics
63
to the enzymatic activity decrease. Interestingly, the redox state of these cells remained unaffected, even though oxidative stress was higher (Koopman et al. 2005b). Lastly, they analyzed the consequence of complex I deficiency on the mitochondrial network organization and observed a higher branching and elongation of the tubules, qualified as “mitochondrial outgrowth” (Koopman et al. 2005a). The questions arise about the importance of mt-network adaptations for the diagnosis of mitochondrial diseases. This could allow a first check as an easy test on blood cells, with a rapid mitochondrial staining and direct visualization on a fluorescent microscope. All OXPHOS defects will not be identified this way (Guillery et al. 2008; Benard et al. 2007), but large deficiencies could be observed at the level of the mt-network, owing that the cell type under consideration expresses sufficiently the metabolic defect. It was reported that an heterozygous, dominant-negative mutation in the dynamin-like protein 1 gene (DLP1) could cause a pathological conditions associated with microcephaly, abnormal brain development, optic atrophy and hypoplasia, persistent lactic acidemia, and a mildly elevated plasma concentration of very-long-chain fatty acids. The DLP1 protein is involved in the fission of mt-network tubules, and we showed that its absence can impair the synthesis of ATP by the mitochondrion (Benard et al. 2007). Thus, the mitochondrial network organization is a new parameter that must be taken into account for physiopathological analyses of mitochondrial diseases. The possible interaction between mitochondrial dynamics and energy production could offer an opportunity for the discovery of drugs that target mitochondrial fusion or fission with a stimulatory effect on energy metabolism, to the benefit of patients suffering from obesity, diabetes and mitochondrial/neuromuscular diseases (Zorzano et al. 2009a, b). Defective fusion or fission are the cause of rare human neurological disorders such as Charcot-Marie Tooth type 2a, Autosomal Dominant Optic Atrophy, Lethal Defect of Mitochondrial and Peroxisomal Fission, Spastic Paraplegia or a dominant form of spino-cerebellar ataxia, SCA28 (defective proteins MFN2, OPA1/3, DRP1, Paraplegin or AFG3l2 respectively), the pathophysiological molecular mechanisms of which still remain unknown. Recent evidence also suggest that mitochondrial dynamics is impaired in Parkinson’s disease, and that Parkin could be involved in the selective degradation of altered mitochondrial particles (Narendra et al. 2008, 2009). Twig and colleagues proposed a life cycle of mitochondrial particles where regions of the mitochondrial network with low membrane potential could be selectively targeted and brought to degradation (Twig et al. 2008a, b), presumably through a Parkin-mediated mechanism. In Alzheimer’s disease, elevated levels of S-nitrosylated Drp1 were found in brain samples from AD patients and AD mouse models, along with extensive mitochondrial fragmentation (Cho et al. 2009). For all of the above listed diseases, the impairment of mitochondrial energy production as observed in fibroblasts taken from patients with OPA1 or MFN2 mutations still remain unexplained at the molecular level. Acknowledgments We thank the French National Institute for Scientific and Medical Research (INSERM), Université Victor Segalen Bordeaux 2, Région Aquitaine, Ammi, and Cancéropôle Grand Sud-Ouest for financial support. N. Bellance was supported by a Grant from INSERM/ Région Aquitaine and G. Benard by a grant from ANR.
64
G. Benard et al.
References Aleardi, A. M., Benard, G., Augereau, O., Malgat, M., Talbot, J. C., Mazat, J. P., Letellier, T., Dachary-Prigent, J., Solaini, G. C. & Rossignol, R. (2005) Gradual Alteration of Mitochondrial Structure and Function by beta-Amyloids: Importance of Membrane Viscosity Changes, Energy Deprivation, Reactive Oxygen Species Production, and Cytochrome c Release. J Bioenerg Biomembr, 37, 207–225. Amikura, R., Hanyu, K., Kashikawa, M. & Kobayashi, S. (2001a) Tudor protein is essential for the localization of mitochondrial RNAs in polar granules of Drosophila embryos. Mech Dev, 107, 97–104. Amikura, R., Kashikawa, M., Nakamura, A. & Kobayashi, S. (2001b) Presence of mitochondriatype ribosomes outside mitochondria in germ plasm of Drosophila embryos. Proc Natl Acad Sci U S A, 98, 9133–8. Bach, D., Naon, D., Pich, S., Soriano, F. X., Vega, N., Rieusset, J., Laville, M., Guillet, C., Boirie, Y., Wallberg-Henriksson, H., Manco, M., Calvani, M., Castagneto, M., Palacin, M., Mingrone, G., Zierath, J. R., Vidal, H. & Zorzano, A. (2005) Expression of Mfn2, the Charcot-MarieTooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes, 54, 2685–93. Bakeeva, L. E., Chentsov YU, S. & Skulachev, V. P. (1978) Mitochondrial framework (reticulum mitochondriale) in rat diaphragm muscle. Biochim Biophys Acta, 501, 349–69. Baracca, A., Chiaradonna, F., Sgarbi, G., Solaini, G., Alberghina, L. & Lenaz, G. (2010) Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells. Biochim Biophys Acta, 1797, 314–23. Benard, G. & Karbowski, M. (2009) Mitochondrial fusion and division: Regulation and role in cell viability. Semin Cell Dev Biol, 20, 365–74. Benard, G. & Rossignol, R. (2008a) Mitochondrial fluidity matters. Focus on “Inherited complex I deficiency is associated with faster protein diffusion in the matrix of moving mitochondria”. Am J Physiol Cell Physiol, 294, C1123. Benard, G. & Rossignol, R. (2008b) Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid Redox Signal, 10, 1313–42. Benard, G., Faustin, B., Passerieux, E., Galinier, A., Rocher, C., Bellance, N., Delage, J. P., Casteilla, L., Letellier, T. & Rossignol, R. (2006) Physiological diversity of mitochondrial oxidative phosphorylation. Am J Physiol Cell Physiol. Benard, G., Bellance, N., James, D., Parrone, P., Fernandez, H., Letellier, T. & Rossignol, R. (2007) Mitochondrial bioenergetics and structural network organization. J Cell Sci, 120, 838–48. Benard, G., Bellance, N., Jose, C., Melser, S., Nouette-Gaulain, K. & Rossignol, R. (2010) Multi-site control of cellular and mitochondrial energy production. BBA Bioenergetics Jun-Jul;1797(6–7):698–709. Bereiter-Hahn, J. & Voth, M. (1994) Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech, 27, 198–219. Campello, S., Lacalle, R. A., Bettella, M., Manes, S., Scorrano, L. & Viola, A. (2006) Orchestration of lymphocyte chemotaxis by mitochondrial dynamics. J Exp Med, 203, 2879–86. Canto, C. & Auwerx, J. (2009) PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol, 20, 98–105. Canto, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P. & Auwerx, J. (2009) AMPK regulates energy expenditure by modulating NAD(+) metabolism and SIRT1 activity. Nature. Chang, C. R. & Blackstone, C. (2007) Drp1 phosphorylation and mitochondrial regulation. EMBO Rep, 8, 1088–9; author reply 1089–90. Chen, H. & Chan, D. C. (2009) Mitochondrial dynamics – fusion, fission, movement, and mitophagy – in neurodegenerative diseases. Hum Mol Genet, 18, R169-76.
2 Relationships Between Mitochondrial Dynamics and Bioenergetics
65
Chen, W. J. & Douglas, M. G. (1987) Phosphodiester bond cleavage outside mitochondria is required for the completion of protein import into the mitochondrial matrix. Cell, 49, 651–8. Chen, Z. X. & Pervaiz, S. (2007) Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells. Cell Death Differ, 14, 1617–27. Chen, Z. X. & Pervaiz, S. (2009) Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. Cell Death Differ. Chen, H., Chomyn, A. & Chan, D. C. (2005) Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem, 280, 26185–92. Chen, H., Mccaffery, J. M. & Chan, D. C. (2007) Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell, 130, 548–62. Chevrollier, A., Guillet, V., Loiseau, D., Gueguen, N., De Crescenzo, M. A., Verny, C., Ferre, M., Dollfus, H., Odent, S., Milea, D., Goizet, C., Amati-Bonneau, P., Procaccio, V., Bonneau, D. & Reynier, P. (2008) Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann Neurol, 63, 794–8. Cho, D. H., Nakamura, T., Fang, J., Cieplak, P., Godzik, A., Gu, Z. & Lipton, S. A. (2009) S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science, 324, 102–5. Choi, S. Y., Huang, P., Jenkins, G. M., Chan, D. C., Schiller, J. & Frohman, M. A. (2006) A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. Nat Cell Biol. Collins, T. J., Berridge, M. J., Lipp, P. & Bootman, M. D. (2002) Mitochondria are morphologically and functionally heterogeneous within cells. Embo J, 21, 1616–27. Dasgupta, B. & Milbrandt, J. (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A, 104, 7217–22. De Brito, O. M. & Scorrano, L. (2008) Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature, 456, 605–10. Detmer, S. A. & Chan, D. C. (2007) Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol, 8, 870–9. Duvezin-Caubet, S., Jagasia, R., Wagener, J., Hofmann, S., Trifunovic, A., Hansson, A., Chomyn, A., Bauer, M. F., Attardi, G., Larsson, N. G., Neupert, W. & Reichert, A. S. (2006) Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem, 281, 37972–9. Duvezin-Caubet, S., Koppen, M., Wagener, J., Zick, M., Israel, L., Bernacchia, A., Jagasia, R., Rugarli, E. I., Imhof, A., Neupert, W., Langer, T. & Reichert, A. S. (2007) OPA1 processing reconstituted in yeast depends on the subunit composition of the m-AAA protease in mitochondria. Mol Biol Cell, 18, 3582–90. Ehses, S., Raschke, I., Mancuso, G., Bernacchia, A., Geimer, S., Tondera, D., Martinou, J. C., Westermann, B., Rugarli, E. I. & Langer, T. (2009) Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J Cell Biol, 187, 1023–36. Figueroa-Romero, C., Iniguez-Lluhi, J. A., Stadler, J., Chang, C. R., Arnoult, D., Keller, P. J., Hong, Y., Blackstone, C. & Feldman, E. L. (2009) SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. Faseb J, 23, 3917–27. Fujiwara, S., Kawahara, H., Makabe, K. W. & Satoh, N. (1993) A complementary DNA for an ascidian embryonic nuclear antigen Hgv2 encodes a protein closely related to the amphibian histone-binding protein N1. J Biochem, 113, 189–95. Furt, F. & Moreau, P. (2009) Importance of lipid metabolism for intracellular and mitochondrial membrane fusion/fission processes. Int J Biochem Cell Biol, 41, 1828–36. Garcia-Roves, P. M., Osler, M. E., Holmstrom, M. H. & Zierath, J. R. (2008) Gain-of-function R225Q mutation in AMP-activated protein kinase gamma3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J Biol Chem, 283, 35724–34. Griparic, L. & Van Der Bliek, A. M. (2001) The many shapes of mitochondrial membranes. Traffic, 2, 235–44.
66
G. Benard et al.
Guillery, O., Malka, F., Frachon, P., Milea, D., Rojo, M. & Lombes, A. (2008) Modulation of mitochondrial morphology by bioenergetics defects in primary human fibroblasts. Neuromuscul Disord, 18, 319–30. Guillet, V., Gueguen, N., Verny, C., Ferre, M., Homedan, C., Loiseau, D., Procaccio, V., AmatiBonneau, P., Bonneau, D., Reynier, P. & Chevrollier, A. (2009) Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A disease. Neurogenetics. Hardie, D. G. (2007) AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol, 8, 774–85. Ishihara, N., Jofuku, A., Eura, Y. & Mihara, K. (2003) Regulation of mitochondrial morphology by membrane potential, and DRP1-dependent division and FZO1-dependent fusion reaction in mammalian cells. Biochem Biophys Res Commun, 301, 891–8. Ishihara, N., Fujita, Y., Oka, T. & Mihara, K. (2006) Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. Embo J, 25, 2966–77. Ishihara, N., Nomura, M., Jofuku, A., Kato, H., Suzuki, S. O., Masuda, K., Otera, H., Nakanishi, Y., Nonaka, I., Goto, Y., Taguchi, N., Morinaga, H., Maeda, M., Takayanagi, R., Yokota, S. & Mihara, K. (2009) Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol, 11, 958–66. Jezek, P. & Plecita-Hlavata, L. (2009) Mitochondrial reticulum network dynamics in relation to oxidative stress, redox regulation, and hypoxia. Int J Biochem Cell Biol, 41, 1790–804. Jezek, P., Plecita-Hlavata, L., Smolkova, K. & Rossignol, R. (2009) Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development. Int J Biochem Cell Biol. Jourdain, A. & Martinou, J. C. (2010) Mitochondrial dynamics: quantifying mitochondrial fusion in vitro. BMC Biol, 8, 99. Karbowski, M., Norris, K., MM., C., Jeong, S. & Youle, R. J. (2006) Role of BAX and BAK in mitochondrial morphogenesis. Nature, Online publication doi:10.1038/nature05111. Karbowski, M., Neutzner, A. & Youle, R. J. (2007) The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J Cell Biol, 178, 71–84. Koopman, W. J., Verkaart, S., Visch, H. J., Van Der Westhuizen, F. H., Murphy, M. P., Van Den Heuvel, L. W., Smeitink, J. A. & Willems, P. H. (2005a) Inhibition of complex I of the electron transport chain causes O2-. -mediated mitochondrial outgrowth. Am J Physiol Cell Physiol, 288, C1440-50. Koopman, W. J., Visch, H. J., Verkaart, S., Van Den Heuvel, L. W., Smeitink, J. A. & Willems, P. H. (2005b) Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. Am J Physiol Cell Physiol, 289, C881-90. Koopman, W. J., Verkaart, S., Van Emst-De Vries, S. E., Grefte, S., Smeitink, J. A. & Willems, P. H. (2006a) Simultaneous quantification of oxidative stress and cell spreading using 5-(and-6)chloromethyl-2¢,7¢-dichlorofluorescein. Cytometry A, 69, 1184–92. Koopman, W. J., Visch, H. J., Smeitink, J. A. & Willems, P. H. (2006b) Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblasts. Cytometry A, 69, 1–12. Koopman, W. J., Hink, M. A., Verkaart, S., Visch, H. J., Smeitink, J. A. & Willems, P. H. (2007) Partial complex I inhibition decreases mitochondrial motility and increases matrix protein diffusion as revealed by fluorescence correlation spectroscopy. Biochim Biophys Acta, 1767, 940–7. Koopman, W. J., Distelmaier, F., Hink, M. A., Verkaart, S., Wijers, M., Fransen, J., Smeitink, J. A. & Willems, P. H. (2008) Inherited complex I deficiency is associated with faster protein diffusion in the matrix of moving mitochondria. Am J Physiol Cell Physiol, 294, C1124–32. Korzeniewski, B. (2000) Regulation of ATP supply in mammalian skeletal muscle during resting state – intensive work transition. Biophys Chem, 83, 19–34. Korzeniewski, B. & Mazat, J. (1996) Theoretical studies on control of oxidative phosphorylation in muscle mitochondria at different energy demands and oxygen concentrations. Acta Biotheoretica, 44, 263–269.
2 Relationships Between Mitochondrial Dynamics and Bioenergetics
67
Koutsopoulos, O. S., Laine, D., Osellame, L., Chudakov, D. M., Parton, R. G., Frazier, A. E. & Ryan, M. T. (2010) Human Miltons associate with mitochondria and induce microtubule-dependent remodeling of mitochondrial networks. Biochim Biophys Acta, 1803, 564–74. Kuwana, T., Mackey, M. R., Perkins, G., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R. & Newmeyer, D. D. (2002) Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell, 111, 331–42. Kuznetsov, A. V., Hermann, M., Saks, V., Hengster, P. & Margreiter, R. (2009) The cell-type specificity of mitochondrial dynamics. Int J Biochem Cell Biol, 41, 1928–39. Lacombe, M. L., Milon, L., Munier, A., Mehus, J. G. & Lambeth, D. O. (2000) The human Nm23/ nucleoside diphosphate kinases. J Bioenerg Biomembr, 32, 247–58. Legros, F., Lombes, A., Frachon, P. & Rojo, M. (2002) Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. Mol Biol Cell, 13, 4343–54. Margineantu, D., Cox, W., Sundell, L., Sherwood, S., Beechen, J. & Capaldi, R. (2002) Cell cycle dependent morphology changes and associated mitochondrial DNA redistribution in mitochondria of human cell lines. Mitochondrion, 1, 397–478. Milon, L., Meyer, P., Chiadmi, M., Munier, A., Johansson, M., Karlsson, A., Lascu, I., Capeau, J., Janin, J. & Lacombe, M. L. (2000) The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinase. J Biol Chem, 275, 14264–72. Mironov, S. L. (2007) ADP regulates movements of mitochondria in neurons. Biophys J, 92, 2944–52. Mironov, S. L. & Symonchuk, N. (2006) ER vesicles and mitochondria move and communicate at synapses. J Cell Sci, 119, 4926–34. Mitchell, P. (1961) Coupling of phosphorylation to electron and hydrogen transfer by a chemiosmotic type of mechanism. Nature, 191, 144–148. Nakada, K., Inoue, K., Ono, T., Isobe, K., Ogura, A., Goto, Y. I., Nonaka, I. & Hayashi, J. I. (2001) Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA. Nat Med, 7, 934–40. Nakamura, N., Kimura, Y., Tokuda, M., Honda, S. & Hirose, S. (2006) MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep, 7, 1019–22. Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol, 183, 795–803. Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. (2009) Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy, 5, 706–8. Newmeyer, D. D. & Ferguson-Miller, S. (2003) Mitochondria: releasing power for life and unleashing the machineries of death. Cell, 112, 481–90. Olichon, A., Baricault, L., Gas, N., Guillou, E., Valette, A., Belenguer, P. & Lenaers, G. (2003) Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem, 278, 7743–6. Palmieri, F., Bisaccia, F., Capobianco, L., Dolce, V., Fiermonte, G., Iacobazzi, V., Indiveri, C. & Palmieri, L. (1996) Mitochondrial metabolite transporters. Biochim Biophys Acta, 1275, 127–32. Partikian, A., Olveczky, B., Swaminathan, R., Li, Y. & Verkman, A. S. (1998) Rapid diffusion of green fluorescent protein in the mitochondrial matrix. J Cell Biol, 140, 821–9. Pfeiffer, K., Gohil, V., Stuart, R. A., Hunte, C., Brandt, U., Greenberg, M. L. & Schagger, H. (2003) Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem, 278, 52873–80. Pham, N. A., Richardson, T., Cameron, J., Chue, B. & Robinson, B. H. (2004) Altered mitochondrial structure and motion dynamics in living cells with energy metabolism defects revealed by real time microscope imaging. Microsc Microanal, 10, 247–60. Rossignol, R. & Karbowski, M. (2009) Editorial of the directed issue on mitochondrial dynamics in biology and medicine. Int J Biochem Cell Biol, 41, 1748–9. Rossignol, R., Malgat, M., Mazat, J.-P. & Letellier, T. (1999) Threshold Effect and Tissue Specificity. J of Biological Chemistry, 274, 33426–33432.
68
G. Benard et al.
Rossignol, R., Letellier, T., Malgat, M., Rocher, C. & Mazat, J. P. (2000) Tissular variation in the control of oxidative phosphorylations, implication for mitochondrial diseases. Biochemical Journal, 347, 45–53. Rossignol, R., Faustin, B., Rocher, C., Malgat, M., Mazat, J. P. & Letellier, T. (2003) Mitochondrial threshold effects. Biochem J, 370, 751–62. Sandra, F., Degli Esposti, M., Ndebele, K., Gona, P., Knight, D., Rosenquist, M. & Khosravi-Far, R. (2005) Tumor necrosis factor-related apoptosis-inducing ligand alters mitochondrial membrane lipids. Cancer Res, 65, 8286–97. Schwer, B. & Guthrie, C. (1992) A conformational rearrangement in the spliceosome is dependent on PRP16 and ATP hydrolysis. Embo J, 11, 5033–9. Tondera, D., Grandemange, S., Jourdain, A., Karbowski, M., Mattenberger, Y., Herzig, S., Da Cruz, S., Clerc, P., Raschke, I., Merkwirth, C., Ehses, S., Krause, F., Chan, D. C., Alexander, C., Bauer, C., Youle, R., Langer, T. & Martinou, J. C. (2009) SLP-2 is required for stress-induced mitochondrial hyperfusion. Embo J, 28, 1589–600. Tsuiki, H., Nitta, M., Furuya, A., Hanai, N., Fujiwara, T., Inagaki, M., Kochi, M., Ushio, Y., Saya, H. & Nakamura, H. (1999) A novel human nucleoside diphosphate (NDP) kinase, Nm23-H6, localizes in mitochondria and affects cytokinesis. J Cell Biochem, 76, 254–69. Twig, G., Graf, S. A., Wikstrom, J. D., Mohamed, H., Haigh, S. E., Elorza, A., Deutsch, M., Zurgil, N., Reynolds, N. & Shirihai, O. S. (2006) Tagging and tracking individual networks within a complex mitochondrial web with photoactivatable GFP. Am J Physiol Cell Physiol, 291, C176-84. Twig, G., Elorza, A., Molina, A. J., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., Alroy, J., Wu, M., Py, B. F., Yuan, J., Deeney, J. T., Corkey, B. E. & Shirihai, O. S. (2008a) Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. Embo J, 27, 433–46. Twig, G., Hyde, B. & Shirihai, O. S. (2008b) Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta, 1777, 1092–7. Wakabayashi, J., Zhang, Z., Wakabayashi, N., Tamura, Y., Fukaya, M., Kensler, T. W., Iijima, M. & Sesaki, H. (2009) The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice. J Cell Biol, 186, 805–16. Wei, M. C., Zong, W. X., Cheng, E. H., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., Macgregor, G. R., Thompson, C. B. & Korsmeyer, S. J. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 292, 727–30. Yaffe, M. P. (1999) Dynamic mitochondria. Nat Cell Biol, 1, E149-50. Zorzano, A., Liesa, M. & Palacin, M. (2009a) Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int J Biochem Cell Biol, 41, 1846–54. Zorzano, A., Sebastian, D., Segales, J. & Palacin, M. (2009b) The molecular machinery of mitochondrial fusion and fission: An opportunity for drug discovery? Curr Opin Drug Discov Devel, 12, 597–606.
Chapter 3
Mitochondrial Dynamics and Autophagy Linsey Stiles, Andrew Ferree, and Orian Shirihai
Abstract Efficient mitochondrial quality control is critical for maintenance of a healthy mitochondrial population. Both mitochondrial dynamics and selective mitochondrial autophagy, termed mitophagy, contribute to mitochondrial turnover and quality control. Mitochondrial fusion and fission allow for complementation of mitochondrial solutes, proteins, and DNA but also for generation of unequal daughter organelles. Selective fusion is utilized for incorporation of polarized mitochondria back into the network, while a depolarized mitochondrion will not fuse, but instead will be targeted for elimination by mitophagy. Mitophagy is dependent on mitochondrial dysfunction, such as depolarization, and a number of proteins are required for core autophagic machinery, signaling, and mitochondrial segregation and targeting. The relationship between mitochondrial dynamics and autophagy and how they may contribute to both mitochondrial and cellular quality control is beginning to be elucidated. Even with the questions that remain in regards to the regulation and interdependence of mitochondrial dynamics and mitophagy, it is clear that alterations in these processes lead to mitochondrial dysfunction and pathological states such as neurodegeneration. Keywords Mitochondrial dynamics • Mitochondrial quality control • Mitophagy • Aging • Neurodegeneration
L. Stiles Department of Medicine, Section of Molecular Medicine, Boston University School of Medicine, Boston, MA, USA and Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA, USA A. Ferree Department of Pharmacology, Boston University School of Medicine, Boston, MA, USA O. Shirihai () Department of Medicine, Section of Molecular Medicine, Boston University School of Medicine, Boston, MA, USA e-mail:
[email protected] B. Lu (ed.), Mitochondrial Dynamics and Neurodegeneration, DOI 10.1007/978-94-007-1291-1_3, © Springer Science+Business Media B.V. 2011
69
70
L. Stiles et al.
Abbreviations A9-DA AD ALS AMPK ATG CA CCCP CMA CMT2A Cvt DA DLB DN DNM1L Drp1 ER ERK1/2 ETC Fzo1p GAP HIF LAMP-2A LC3; (MAP)LC3 MAO mdivi-1 Mfn1/2 mPTP MPTP mtDNA mTOR mtPA-GFP NGF OPA1 PBMC PD PE PI PINK1 RGC Rheb ROS TMRE
A9-subtype dopaminergic neurons of the substantia nigra pars compacta Alzheimer’s disease amyotrophic lateral sclerosis 5¢adenosine-monophosphate activated protein kinase autophagy-related genes constitutively active carbonyl cyanide m-chlorophenylhydrazone chaperone-mediated autophagy Charcot-Marie-Tooth neuropathy type 2A cytoplasmic to vacuole targeting dopaminergic dementia with Lewy Bodies dominant negative dynamin 1-like dynamin related protein 1 endoplasmic reticulum extracellular signal-regulated protein kinase 1/2 electron transport chain fuzzy onion protein GTPase-activating protein hypoxia-inducing factor lysosomal-associated membrane protein 2A microtubule-associated protein light chain 3 monoamine oxidase mitochondrial division inhibitor mitofusin 1 and 2 mitochondrial permeability transition pore 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mitochondrial DNA mammalian target of Rapamycin mitochondrial photoactivatable green fluorescent protein nerve growth factor optic atrophy protein 1 peripheral blood mononuclear cells Parkinson’s disease phosphatidylethanolamine phosphatidylinositol PTEN-induced kinase 1 retinal ganglion cells Ras homolog enriched in brain reactive oxygen species tetramethylrhodamine ethyl ester
3 Mitochondrial Dynamics and Autophagy
TOR TORC1/2 Ulk1/2 VDAC1 Vps
71
target of Rapamycin TOR complex 1 and 2 Unc-51-like kinase 1 and 2 voltage-dependent anion channel 1 vacuolar protein-sorting.
3.1 A Brief Overview of Mitochondrial Dynamics Mitochondria function as heterogeneous networks that undergo frequent fusion and fission events, constituting mitochondrial dynamics, which regulate their morpho logy, number, and function (Bereiter-Hahn and Voth 1994; Chen and Chan 2005). Mitochondrial dynamics have been demonstrated to contribute to mitochondrial function in a number of systems including budding yeast, pancreatic b-cells, muscle, and neurons (Liesa et al. 2009). It has been established that mitochondrial dynamics can influence almost every aspect of the mitochondrion including biogenesis, bioenergetics, heterogeneity and elimination (Wikstrom et al. 2009; Hyde et al. 2010). Proteins that mediate mitochondrial fusion and fission have been identified. In mammals, fusion is regulated by at least three mitochondrial localized GTPases: mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), and optic atrophy protein 1 (OPA1) (Santel and Fuller 2001; Misaka et al. 2002). The yeast homologs of these proteins are Fzo1p (Mfn1/2) and Mgm1p (OPA1) (Merz et al. 2007). Mfn1 and Mfn2 are loca lized to the outer mitochondrial membrane, while OPA1 is an inner mitochondrial membrane protein. Mitochondrial fusion is a two step process where fusion of the inner and outer membranes occurs as separate events. Fission is mediated by the transmembrane protein Fis1 and cytosolic GTPase dynamin related protein 1 (Drp1/ DNM1L); with Fis1 as the rate limiting factor of fission in some models. The yeast homologs to the fission proteins are Dnm1p (Drp1) and Fis1p (James et al. 2003; Praefcke and McMahon 2004). Drp1 translocates from the cytosol to scission sites on the outer mitochondrial membrane to initiate fission events. It should be noted that many of these proteins have roles outside of mitochondrial fusion and fission. For instance, it has been shown that Mfn2 is located on endoplasmic reticulum (ER), where it can regulate ER morphology and ER to mitochondria tethering; a process required for efficient Ca2+ homeostasis (de Brito and Scorrano 2008). Fis1 and Drp1 are localized to peroxisomes and have been shown to mediate peroxisomal fission in a similar manner to that of mitochondrial fission (Koch et al. 2003, 2005). Mitochondrial dynamics are essential to maintain a metabolically efficient mitochondrial population and disruption of either fusion or fission alters mitochondrial morphology and functionality. Fusion contributes to maintenance of oxidative phosphorylation and mitochondrial membrane potential, with loss of fusion gene rally resulting in mitochondrial fragmentation, decreased mitochondrial membrane potential and oxygen consumption, and often increased reactive oxygen species (ROS) production and susceptibility to apoptosis (Chen and Chan 2010; Zorzano et al. 2010). Fusion allows for the generation of continuous membranes and matrix
72
L. Stiles et al.
lumen, which subsequently allows for complementation of solutes, metabolites, and proteins. Complementation is thought to be a key mechanism by which mitochondria can rescue a damaged unit within the network. Mitochondrial fission is also a modulator of mitochondrial function. Fission regulates inheritance of mitochondria by daughter cells within dividing cells, cellular differentiation (neuronal, cardiac, and muscle cells), and progression of apoptosis. Loss of fission results in increased mitochondrial connectivity, loss of mtDNA, bioenergetic deficiency and changes in apoptosis (Liesa et al. 2009; Karbowski 2010). Alterations to mitochondrial fusion and fission have been demonstrated in a number of conditions including neurodegeneration, obesity, and type II diabetes. Additionally, mutations in mitochondrial dynamics proteins have been identified in human pathologies. Mutations in OPA1 lead to autosomal dominant optic atrophy, which is the most common form of hereditary optic neuropathy (Alexander et al. 2000). Charcot-Marie-Tooth (CMT) disease is a group of genetically heterogeneous diseases of the peripheral nervous system, characterized by distal muscle atrophy. Mutations in Mfn2 have been identified that result in CMT Type 2A (Zuchner et al. 2004). These data place mitochondrial dynamics and function at the crossroads of human pathologies, in particular neurodegenerative diseases.
3.2 Autophagy Christian de Duve coined the term ‘autophagy’ meaning ‘self-eating’ in 1963 (Klionsky 2007). In 1967, he published work showing that mitochondria are located within lysosomes when rat liver was perfused with glucagon (Deter et al. 1967; Deter and De 1967). Recently, the field of autophagy has rapidly expanded with research demonstrating that autophagy contributes to survival in the face of starvation (nutrient-deprivation) and to turnover of damaged organelles and proteins with long half-lives. Autophagy is a key regulator of human health and aging, as it has been implicated in a number of diseases including type II diabetes, cardiomyopathies, and neurodegeneration (Essick and Sam 2010; Fujitani et al. 2010). There are three broad classifications of autophagy: chaperone-mediated autophagy, microautophagy, and macroautophagy. All three forms of autophagy promote proteolytic degradation of cytosolic components within the lysosome. In chaperonemediated autophagy (CMA), individual proteins with a consensus binding sequence (KFERQ) are recognized and delivered to the lysosome by a complex of chaperone proteins, such as heat shock cognate protein of 70 kDa (hsc70). The CMA targeted proteins then cross the lysosomal membrane via a translocation complex that includes lysosomal-associated membrane protein 2A, LAMP-2A (Orenstein and Cuervo 2010). During microautophagy, cytosolic components are directly taken up via invagination of the lysosomal membrane. In contrast, macroautophagy is the process by which macromolecular cytosolic components are degraded via sequestration in a double-membrane structure, which fuses with the lysosome to deliver the enclosed material for degradation (Glick et al. 2010; Yang and Klionsky 2010b;
3 Mitochondrial Dynamics and Autophagy
73
Goldman et al. 2010). Macroautophagy, herein referred to as autophagy, is the process by which mitochondria amongst other organelles (such as ER, ribosomes, and peroxisomes) are degraded for recycling and elimination.
3.2.1 Autophagic Machinery The process of autophagy (Fig. 3.1) begins with an isolation membrane derived from a lipid bilayer contributed by ER and/or trans-Golgi, endosomes, and possibly mitochondria (Hailey et al. 2010); although the exact origin of the isolation membrane, also known as the phagophore, is controversial (Eskelinen 2008). The membrane expands to engulf its cargo, which is then contained within a double-membraned structure known as the autophagosome. The autophagosome fuses with the lysosome to form an autolysosome, also called an autophagolysosome, which degrades its contents via lysosomal acidic hydrolases. The resulting breakdown products are delivered back to the cytosol by lysosomal permeases and transporters where they can be reused (Yang and Klionsky 2010a).
Phagophore initiation/ formation
Elongation
Closure
Maturation/ Fusion
Autophagosome
Bafilomycin chloroquine
3MA wortmannin
Lysosome Ulk1/2 complex
mAtg9
Atg16L complex
LC3-II
Class III PtdIns3K
Permease
Acid Hydrolase
Pepstatin A + E64D
Degradation
Fig. 3.1 Overview of the mammalian autophagic machinery. Autophagy is a multi-step process that is initiated by the formation of the phagophore. This step can be blocked by using the chemical PI3-kinase inhibitors 3-methyladenine (3MA), LY294002, or, wortmannin. Phagophore formation is followed by elongation, and closure of the phagophore to form the autophagosome. Maturation of the autophagosome occurs upon fusion with a lysosome, generating the autophagolysosome. The maturation step can be inhibited by bafilomycin, an inhibitor of vacuolar H + ATPase (V-ATPase), and the lysosomotropic agent, chloroquine. Acid hydrolases degrade the cargo within the autophagolysosome, which can be blocked by the lysosomal protease inhibitors, pepstatin A and E64D. Breakdown products can be transported out of the autophagolysosome through permeases for recycling. Adapted from (Yang and Klionsky 2010a)
74
L. Stiles et al.
3.2.2 Molecular Mechanism of Autophagy in Yeast Major advancements in understanding molecular mechanisms of autophagy came from the discovery of several autophagy-related genes (ATG) in Saccharomyces cerevisiae yeast. Many mammalian homologs exist and a subset of these Atg proteins are considered the core components required for autophagosome formation (Yang and Klionsky 2010b). In yeast, Atg1 exists in a complex, with Atg13 and Atg17, which is required for initial phagophore formation. Atg13 is phosphorylated in a Target of Rapamycin (TOR) kinase dependent manner, which prevents its binding to Atg1 and Atg17. Inactivation of TOR kinase complex 1 (TORC1) leads to dephosphorylation of Atg13, thereby promoting Atg1-Atg-13-Atg17 complex formation, generation of the phagophore, and autophagy. There are two complexes that incorporate Vps34, the only PI 3-kinase in yeast. Complex I consists of the proteins Vps34, Vps15, Atg6, and Atg14; this complex is necessary for the initiation of autophagy. Vps34 uses phosphatidylinositol (PI) as a substrate to generate phosphatidylinositol triphosphate, which is required for elongation of the phagophore as well as recruitment of other Atg proteins to the phagophore assembly site. The function of Vps34 is dependent on Vps15, a serine/ threonine kinase, that modulates membrane recruitment and stimulation of the PI 3-kinase activity of Vps34 (Stack et al. 1995). Complex II, consisting of Vps34, Vps15, Atg6, and Vps38, is involved in vacuolar sorting. Two ubiquitin-like systems are essential for autophagy in yeast: Atg5-Atg12 conjugation and Atg8 processing. These two conjugation systems are evolutionarily conserved from yeast to mammals and the nomenclature is essentially the same, except for Atg8. A number of mammalian homologs to Atg8 have been identified, the most prominent being microtubule associated protein light chain 3A (LC3). Additional Atg8 homologs include: GATE16, GABARAP, and Atg8L, all of which are processed in the same manner as Atg8 is in yeast (Tanida et al. 2006). See the mammalian molecular mechanisms of autophagy section below for more detailed information on the Atg5-Atg12 and LC3 conjugation systems.
3.2.3 Mammalian Homologs and Molecular Mechanism of Autophagy The Unc-51-like kinases,Ulk1 and Ulk2, are homologous to yeast Atg1 and participate in complex formation with mAtg13 and FIP200 (the mammalian homolog of yeast Atg17). Unlike the yeast complex, mAtg13 interacts with Ulk1, Ulk2, and FIP200 independently of its phosphorylation state. A great deal about how the phosphorylation requirements relate to autophagic activity is beginning to be elucidated. For example, it is currently known that mAtg13, Ulk1, Ulk2, FIP200, and mTOR are all phosphorylated/dephosphorylated within the complex and that
3 Mitochondrial Dynamics and Autophagy
75
this is regulated by nutritional state and modulates autophagic activity. Interestingly, one study demonstrated a role for Ulk1 in neurotrophic signaling (Zhou et al. 2007). Activation of TrkA receptors by nerve growth factor (NGF) leads to ubiquitination of Ulk1, subsequent association with p62, and binding to the NGF/TrkA complex. Through interactions with synaptic mediators of endocytosis, Ulk1 facilitated trafficking of the ligand-receptor complex into endosomes. This novel role of Ulk1 represents an important potential mechanism for axonal membrane homeostasis via autophagic and endosomal crosstalk (Komatsu et al. 2007). The role of the class III PI-3 kinase Vps34 and its binding partner Beclin-1 (homolog of yeast Atg6) has been studied extensively. The complex of Vps34, Beclin-1, and other regulatory proteins, such as p150 (homolog of Vps15), is required for the induction of autophagy. The role of Vps34 in complex I is conserved in yeast and mammals. UVRAG, BIF-1, Atg14L, Ambra, Rubicon, and Bcl-2 are additional regulatory proteins that complex with Vps34 and Beclin-1. UVRAG, BIF-1, Atg14L, and Ambra promote autophagy while Rubicon and Bcl-2 inhibit autophagy. The two ubiquitin-like conjugation systems that are essential for autophagy in mammals are Atg5-Atg12 conjugation and LC3 processing. In the Atg5-Atg12 system, Atg7 acts as an E1-like ubiquitin activating enzyme, which activates Atg12 by binding to its carboxyterminal glycine residue in an ATP-dependent manner. Atg12 is transferred to the E2-like carrier protein Atg10, which increases the efficiency of covalent binding of Atg12 to Atg5 (on lysine 130). The conjugated Atg5Atg12 interacts noncovalently with Atg16L, which oligomerizes to form the Atg16L complex: a large multimeric complex that associates with the extending phagophore. This association is thought to induce curvature in the expanding phagophore through recruitment of processed Atg8/LC3. The Atg16L complex dissociates from the phagophore membrane once the autophagosome is formed. Microtubule-associated protein light chain 3 (LC3) is encoded for by the mammalian homolog of yeast Atg8. LC3 is expressed as a full-length cytosolic protein, which is proteolytically cleaved to LC3-I by Atg4, a cysteine protease, upon induction of autophagy. This cleavage exposes a glycine, which is subsequently activated by Atg7, an E1-like enzyme, in an ATP-dependent manner. Activated LC3-I is transferred to Atg3, an E2-like carrier protein, before phosphatidylethanolamine (PE) is conjugated to the glycine to generate LC3-II. This lipidated form of LC3 is integrated into both internal and external faces of the phagophore membrane, where it is involved in fusion of membranes. LC3-II may also act as a ‘receptor’ on the phagophore surface that can interact with target material via adaptor molecules, such as ubiquitinated proteins and p62, to induce selective cargo uptake. The two conjugation systems (Atg5-Atg12 and LC3) are closely connected with Atg16L, which acts as an E3-like enzyme and determines the sites of LC3 recruitment and lipidation. In addition, it has been proposed that formation of the Atg16L complex may be dependent on Atg8/LC3 machinery given that mice lacking the ability to process LC3 (via knockout of Atg3) have reduced Atg5-Atg12 conjugation (Sou et al. 2008). Sou et al. have also demonstrated that autophagosomes from Atg3-deficient animals are smaller and ‘open-ended’, providing evidence that the
76
L. Stiles et al.
conjugation systems are involved in elongation and closure of the growing phagophore. This is further supported by experiments showing that autophagosomes are not closed in cells where LC3 lipidation is inhibited by overexpression of an inactive mutant of Atg4 (Fujita et al. 2008). The autophagosome is generated when the expanding ends of the phagophore fuse; although before the autophagosome is ready to fuse with the lysosome, it must first go through additional maturation steps by undergoing fusion events with early and late endosomes. It is thought that this connects endocytic and autophagic pathways to deliver both cargo and membrane fusion machinery to the autophagosome and to lower the pH of the vesicle. The lower pH of the autophagic vesicle makes it more suitable to house the lysosomal proteases that will breakdown the engulfed cargo. The source of lipid used for autophagosome formation and the process by which this lipid is moved to the site of assembly remains largely unknown. mAtg9 is a transmembrane protein that is required for mammalian autophagy and is hypothesized to act as a ‘membrane carrier’. Located in the trans-Golgi network and late endosomes, mAtg9 overlaps with LC3-positive autophagosomes upon starvation or rapamycin induction of autophagy. During starvation, the cycling of mAtg9 has been shown to require Ulk1 and hVps34 (Reggiori et al. 2004; Young et al. 2006). It has been proposed that mAtg9 may contribute to the formation of the autophagosome by delivering membrane components. This hypothesis is based on its function in yeast, yet this still remains to be demonstrated in mammalian cells. Nishida et al. have shown that there is the possibility of an alternative macroautophagy pathway (Nishida et al. 2009). They found that mouse cells lacking Atg5 or Atg7 can still form autophagosomes and autolysosomes and perform autophagymediated protein and mitochondrial degradation. Interestingly, lipidation of LC3 did not occur in the Atg5/Atg7-independent process of ‘macroautophagy’. The alternative autophagy pathway still utilized and was regulated by known autophagic proteins, such as Ulk1 and Beclin1. This implies that there may be more than one pathway in which mammalian macroautophagy can occur, including an Atg5/Atg7-dependent conventional pathway and an Atg5/Atg7-independent alternative pathway.
3.2.4 Signal Transduction Regulation of Autophagy Autophagy occurs both at a basal level to maintain cellular homeostasis and at a stimulated level when induced by cellular stressors, such as nutrient starvation, oxidative stress, and hypoxia. A number of signaling pathways upstream of the ‘Atg’ machinery, or the mammalian equivalents (Yang and Klionsky 2010a), modulate autophagy in response to intracellular and extracellular stresses as shown in Fig. 3.2. In yeast there are two functionally distinct protein complexes for the protein target of rapamycin (TOR): TOR complex 1 and 2 (TORC1 and TORC2). TORC1 has the primary role in regulating autophagy in response to nutrient availability.
3 Mitochondrial Dynamics and Autophagy
77
Fig. 3.2 Signal Regulation of Autophagy in Mammalian Cells. Autophagy is highly regulated by signaling networks, with mTOR as a common downstream target of many of the signal transduction regulators of autophagy. When mTOR is activated in conditions such as nutrient availability or Akt signaling, autophagy is inhibited. Activation of AMPK upon energy depletion causes inhibition of mTOR and stimulation of autophagy. ERK1/2 signaling and PI3K III/Beclin 1 complex formation induce autophagy. The anti-apoptotic protein Bcl-2 prevents the association of Beclin 1 and PI3K III
The mammalian homolog of TOR (mTOR) is a highly conserved serine/threonine protein kinase which acts as a key regulator of autophagy by sensing nutrient availability, growth factors, and cellular energy. mTOR activation inhibits autophagy under conditions where nutrients are readily available and is a downstream signal of PI 3-kinase, insulin signaling, growth factor receptor signaling, and the Akt pathways (Young et al. 2009). For instance, Akt signaling leads to phosphorylation and inhibition of the heterodimer Tsc1/Tsc2, which is a GTPase-activating protein (GAP) for the GTPase Ras homolog enriched in brain (Rheb). Rheb is required for mTOR activity, with the GDP-bound form inhibiting mTOR, while the GTP-bound form of Rheb stimulates mTOR. Akt inhibition of the Tsc1/Tsc2 complex activates mTOR signaling and thus has an inhibitory effect on autophagy. When mTOR is inhibited by stress conditions, such as hypoxia and starvation, autophagy is induced. Upstream signals of mTOR in this scenario include 5¢adenosine-monophosphate activated protein kinase (AMPK), which is activated by depleted ATP levels. Activation of AMPK promotes the activity of the Tsc1/Tsc2 complex, which favors the GDP-bound form of Rheb, leading to inhibition of mTOR and induction of autophagy. In response to hypoxia, autophagy is induced in part by mTOR inhibition and in part by hypoxia-inducing factor (HIF), which acts independently of mTOR.
78
L. Stiles et al.
HIF induces autophagy by targeting BNIP3 and BNIP3L, which are members of the Bcl-2 family of cell death regulators (Mazure and Pouyssegur 2009; Glick et al. 2010). In both the neonatal and adult brain, hypoxia induces a rapid and extensive autophagic induction (Adhami et al. 2006). It appears this response may not be entirely beneficial as mice lacking Atg7 are almost completely protected from ischemia-induced neurodegeneration. While much remains to be elucidated, this striking result suggests that modulation or temporary inhibition of neuronal autophagy may be a potential treatment strategy for ischemic stroke victims (Yue et al. 2009). One important effector of autophagy with connections to neurodegeneration is extracellular signal-regulated protein kinase 1/2 (ERK1/2). Brains from Parkinson’s disease (PD) patients exhibit phosphorylated ERK2 granules that colocalize with autophagocytosed mitochondria (Zhu et al. 2003). In a neuroblastoma model, expression of either constitutively active (CA) or wildtype ERK2 was sufficient to promote activation of autophagy with CA-ERK2 inducing mitophagy to a greater extent than wildtype (Dagda et al. 2008). Another protein family that plays a prominent role in regulating both autophagy and mitophagy is the Bcl-2 proteins. Inhibition of autophagy occurs via the antiapoptotic members such as Bcl-2, Bcl-XL, and Bcl-w, while proapoptotic BH3-only proteins, such as BNIP3, Bad, Bix, and BimEL can induce autophagy. These proteins seem to play a more prominent role in regulating mitophagy.
3.3 Mitophagy Mitochondria are essential for a number of critical cellular processes. They are also the main source and target of reactive oxygen species (ROS); therefore, it is essential that the pool of mitochondria within a cell remain functional and energetically efficient. Mitochondrial autophagy, or mitophagy, refers to the selective removal of mitochondria by the autophagic machinery and is another method utilized for quality control by promoting turnover (autophagy of dysfunctional mitochondria in conjunction with biogenesis). Mitophagy serves to degrade mitochondria, effectively removing them from the dynamic network. Several questions remain regarding exactly how defective mitochondria are specifically targeted for degradation via autophagy. This section will overview mitophagy and what is known about whether and how mitochondria are selectively targeted for autophagy. It has been known since 1957 that mammalian mitochondria are degraded by autophagy with Clark’s discovery that mitochondria are located in autophagosomes in the kidney of newborn mice (Clark 1957). Since then mitophagy has been documented in a number of different tissues including brain, heart, liver, reticulocytes, and pancreatic b-cells. Mitophagy has been shown to be involved in cellular quality control, differentiation, and disease pathogenesis. Initially, it was thought that autophagy was a nonselective process, arbitrarily engulfing cytosolic components, but this notion is changing with evidence that specific, defective cargo is targeted for degradation. Certain proteins that are involved with targeting mitochondria for sequestration into autophagosomes have been discovered in yeast. While this
3 Mitochondrial Dynamics and Autophagy
79
process remains largely unclear in mammalian cells, potential tags are beginning to be identified, including mitochondrial depolarization and opening of the mitochondrial permeability transition pore (mPTP).
3.3.1 Mitophagy in Yeast Takeshige et al. were the first to show in yeast that an induction of autophagy occurs when yeast are subjected to a stressful environment, such as starvation. This was also the first work to demonstrate that autophagy in yeast was similar to mammalian autophagy. They proposed a mechanism by which autophagy could remove cytosolic components, such as mitochondria, although they believed this to be an unselective process (Takeshige et al. 1992; Goldman et al. 2010). Evidence for selective mitochondrial autophagy was first provided by Campbell and Thorsness using an experimental design that was able to distinguish mitochondria in an acidic compartment. This technique was used to demonstrate increased mitochondrial degradation under conditions such as loss of mitochondrial membrane potential and mtDNA (Campbell and Thorsness 1998). Their work provided a connection between mitochondrial damage and increased degradation, although did not provide direct evidence for mitochondrial quality control via autophagy. Early experimental evidence for this came from Kissova et al. when they demonstrated that knockout of the gene UTH1, which encodes for a yeast outer mitochondrial membrane protein, resulted in a loss of mitophagy, while other kinds of macroautophagy remained intact (Kissova et al. 2004). In addition, autophagy deficient yeast display defects in mitochondrial biogenesis, decreased oxygen consumption and mitochondrial membrane potential, and increased ROS (Zhang et al. 2007). This work highlights the role of mitophagy as a quality control mechanism that is required for maintenance of mitochondrial integrity. Further evidence for this role in quality control is provided by studies showing that mitochondrial dysfunction resulting from loss of specific proteins or pharmacologic treatments also increase mitophagy of damaged mitochondria. Removal of functionally damaged mitochondria helps maintain the mitochondrial network by keeping the system energetically efficient and removing both the major source and target of cellular ROS and, therefore, protects mtDNA. Recently, a large amount of work has gone into identifying ‘mitophagy receptors’ in both yeast and mammalian systems. Since mitophagy is a subset of macroautophagy, it utilizes the basic core autophagic machinery common with autophagy described above. On the other hand, mitophagy does utilize some additional ATG genes that are required for other pathways. Atg11, Atg 20, and Atg24, which are proteins involved in the cytoplasmic to vacuole targeting (Cvt) pathway have been shown to be required for mitochondrial autophagy (Nice et al. 2002; Kanki and Klionsky 2010). This may demonstrate that these proteins are a general requirement for selective autophagy. ATG32 and ATG33 were identified as mitophagy-related genes in yeast by using genomic screens for mutants defective in selective mitochondrial autophagy
80
L. Stiles et al.
(Kanki et al. 2009a; Kanki and Klionsky 2010). Atg32 is an outer mitochondrial membrane protein that has emerged as a mitophagy receptor by interacting with Atg proteins that are essential for autophagosome formation. Atg32 binds to Atg11 during mitophagy and uses it as an adaptor protein to recruit mitochondria to the phagophore assembly site (Okamoto et al. 2009b; Kanki et al. 2009b). In addition, Atg32 has a binding motif (WXXI/L/V) for binding to Atg8/LC3 family members; this binding motif is also present in Atg19 and the mammalian protein p62 (Okamoto et al. 2009a). Okamoto et al. showed through studies using mutations in the WXXI/L/V binding motif of Atg32 that the binding of Atg32 to Atg8 is required for sequestration of mitochondria by the phagophore. Atg33 is also localized to the outer mitochondrial membrane and may detect or present aged mitochondria for selective mitochondrial autophagy when cells have reached the stationary phase (Kanki and Klionsky 2010). While Atg32 and Uth1 have been identified as the main proteins involved with regulating mitophagy in yeast; other proteins that play a role have been established. Nowikovsky et al. demonstrate that knockout of DMN1, the yeast homolog of Drp1, was found to have an inhibitory effect on mitophagy in a strain (mdm38 conditional knockout) known to induce mitophagy. This study also demonstrated that osmotic swelling of mitochondria induces selective mitochondrial autophagy in yeast (Nowikovsky et al. 2007). Another protein that was demonstrated to be required for mitophagy in yeast is Aup1p. This mitochondrial intermembrane space protein is necessary for efficient targeted degradation of mitochondria via autophagy during the stationary phase of yeast (Tal et al. 2007). Interestingly, mitochondrial membrane potential depolarization induced by the oxidative phosphorylation uncoupler, carbonyl cyanide m-chlorophenylhydrazone (CCCP), does not stimulate mitochondrial autophagy in yeast (Kissova et al. 2004; Kanki et al. 2009a), yet mitochondrial depolarization is a necessary, although not sufficient, requirement for mitophagy in mammals.
3.3.2 Mitophagy in Mammalian Cells Mitophagy has been shown to play a key physiological role in a number of different mammalian tissues. While no mammalian homologs of ATG32 and UTH1 genes have been identified, selective removal of mitochondria does occur in mammalian cells and is mediated by mitochondrial membrane potential as well as a number of required proteins. It was first demonstrated in hepatocytes that disturbances in mitochondrial membrane potential by mPTP stimulates degradation of mitochondria via autophagy (Lemasters et al. 1998; Elmore et al. 2001). This work contributed to the knowledge that mitophagy functions to maintain cellular homeostasis by removing damaged mitochondria from healthy cells. It also acts as a mechanism to remove increased levels of ROS generated by dysfunctional mitochondria and keep cells energetically efficient (Goldman et al. 2010). Certain cell-type specific proteins that are required for mitochondrial targeting to the autophagosome have been identified. For instance, the protein Ulk1 has been
3 Mitochondrial Dynamics and Autophagy
81
shown to be necessary for autophagy during erythropoiesis. Reticulocyte maturation is an example of a specialized system that demonstrates the role of autophagic degradation of mitochondria in cellular maintenance and physiology. During the final step of erythrocyte differentiation, mitophagy is utilized to remove reticulocyte mitochondria and other organelles to create a mature red blood cell. It has been shown that Unc51-like kinase (Ulk1) is not necessary for general autophagic activity outside of the reticulocyte, but is required to selectively remove ribosomes and mitochondria during red blood cell differentiation (Kundu et al. 2008). This is in contrast with what was already reported about Ulk1 in previous sections. The discrepancy may be due to the fact that the work showing Ulk1 is a nonessential mechanistic component of mammalian autophagy was done in a Ulk1 conditional knockout where Ulk2 compensation is a possible confounding factor. Interestingly, in the Ulk1 knockout mice, not only are mitochondria not removed by autophagy during reticulocyte maturation but they also maintain their membrane potential (Zhang et al. 2009). Nix is another protein that may be required for red blood cell mitophagy, which is upstream of Ulk1. It is located on the outer mitochondrial membrane and is a member of the Bcl-2 family of proteins, specifically the BH3only proapoptotic subfamily. Nix deficient blood contains a large number of erythrocytes that retain their mitochondria, although in this system ribosomes are cleared, providing evidence that it is a mitophagy specific protein (Zhang and Ney 2008). Nix is required for mobilization of autophagic machinery and mitochondrial depolarization following CCCP treatment (Ding et al. 2010). The mechanism behind how Nix is involved in mitophagy is still controversial, but it may play a role in mitochondrial membrane potential destabilization, which is a trigger for mitophagy. Although, some studies have reported that Nix has a membrane potential independent role in mitophagy. These findings suggest there are multiple pathways that lead to mitophagy in mammals. Nix, also known as Bnip3L, is not the only member of the Bcl-2 family of proteins that has been shown to play a role in mitophagy. Bnip3 is also a member of this family that is hypothesized to trigger autophagy by causing mitochondrial depolarization. Bnip3 has been shown to be activated following ischemia-reperfusion in cardiac myocytes, where it induces autophagy as a protective response to apoptotic signaling (Gottlieb and Carreira 2010). It is important to note that both Nix and Bnip3 play a dual role in autophagy and apoptosis. Autophagy in this system can be both protective or associated with autophagic cell death depending on the conditions (Zhang and Ney 2009). A number of mechanisms have been proposed for how Bnip3 induces autophagy including mitochondria permeability transition, mitochondrial depolarization, and/or inhibition of mitochondrial dynamics machinery.
3.3.3 Mitophagy in Neurons Under normal conditions a very small amount of autophagosomes can be detected in neurons by electron or light microscopy. However inhibition of autophagic
82
L. Stiles et al.
clearance by pharmacologic or genetic tools results in a dramatic accumulation of autophagosomes, many of which contain mitochondria. These findings indicate that not only does mitophagy occur in neurons but also the normal flux from autophagosome formation to degradation is very rapid and efficient. In fact, proper autophagic processing is absolutely crucial for neuronal survival. The dependence on autophagy for clearance of damaged macromolecules is less drastic in dividing cells as cellular debris can be diluted in the daughter cells. This protective mechanism is not an option for long-lived post-mitotic cells. Thus neurons must have functional autophagic clearance mechanisms to avoid the accumulation of hazardous waste material such as damaged mitochondria and protein aggregates. It is not surprising therefore that strong evidence exists linking defects in autophagy with neurodegeneration. To date the clearest evidence demonstrating a causal role of autophagic impairment leading to neuronal loss comes from knockout animal models. Mice with neuronal-specific Atg5 or Atg7 deficiency display massive accumulation of polyubiquitinated protein aggregates and severe neurodegeneration (Hara et al. 2006; Komatsu et al. 2006). It is noteworthy that the neuronal loss and protein aggregates occur without additional stresses used to model neurodegeneration, such as exposure to neurotoxins or protein overexpression (Cuervo 2006). The phenotypes of these mice emphasize the essential role of basal autophagy in maintaining quality control for neuronal maintenance. The importance of autophagy in the human brain is underscored by autophagic abnormalities seen in several neurodegenerative diseases, including Alzheimer’s disease (AD) (Nixon et al. 2005; Nixon 2006) frontotemporal dementia (Lee and Gao 2008a; Ju and Weihl 2010) Parkinson’s disease (Anglade et al. 1997; Dehay et al. 2010), and Dementia with Lewy Bodies (Zhu et al. 2003). The autopsied brains from patients with these chronic diseases exhibit increased numbers of autophagic vesicles, protein aggregates, and dysfunctional mitochondria. In isolation the finding of increased autophagosome number has different viable potential explanations. First, the observed vesicles could result from an increase in activation and thus increased formation of autophagosomes. Alternatively the increased autophagic vesicles could represent a loss of clearance capacity through the lysosome leading to an accumulation of autophagosomes. A third possibility is a combination of increased activation in the presence of impaired degradation. At the time of autopsy the latter possibility seems most probable, as patients tend to be at late stages of a chronic disease progression spanning years to decades. It is likely to be the case in many age-related neurodegenerative diseases that impaired lysosomal degradation capacity leads to the accumulation of intracellular debris, such as damaged mitochondria and protein aggregates. This accumulation in turn signals the activation of autophagy and further increase in autophagosome number. While it is far from clear what comes first in this feed forward scenario, future therapeutics targeting enhancement of autophagic function should consider all stages of autophagosome maturation and seek to improve complete clearance of autophagosomal cargo.
3 Mitochondrial Dynamics and Autophagy
83
3.4 Mitochondrial Dynamics and Mitophagy 3.4.1 The PINK1/Parkin Pathway in Mitophagy and Mitochondrial Dynamics Recently, a large effort has been dedicated to understanding how the PINK1/parkin pathway contributes to the maintenance of cellular and mitochondrial homeostasis. There is evidence showing that this pathway is involved with the regulation of selective mitophagy of damaged mitochondria, as well as mitochondrial function and dynamics. Moreover, improper regulation of the PINK1/parkin pathway, mitophagy, and mitochondrial fusion and fission have been implicated in disease pathology, specifically in Parkinson’s disease. PTEN-induced kinase 1 (PINK1) is a Ser/Thr protein kinase with an N-terminal mitochondrial targeting signal, a putative transmembrane domain, and a C-terminal regulatory domain that governs kinase activity and substrate selectivity (Mills et al. 2008; Chu 2010). More than 50 mutations have been mapped throughout the kinase and C-terminal domain of PINK1, which have differing effects on the activity and stability of the protein (Dagda and Chu 2009). Parkin is a cytosolic E3 ubiquitin ligase. Mutations in parkin have been identified with disease causing mutations often disrupting parkin ligase activity (Lee et al. 2010). Loss-of-function mutations in PINK1 and parkin are the main cause of early-onset autosomal recessive forms of PD (Gasser 2009), which supports a role for these proteins in neuroprotection and cellular quality control. Interestingly, mice that have PINK1 and parkin knocked out display a mild phenotype and do not have the dopaminergic (DA) neuron loss in the substantia nigra observed in humans (Whitworth and Pallanck 2009). These single gene knockout mice display similar functional defects in the dopaminergic system, yet the morphology and numbers of DA neurons are normal (Goldberg et al. 2003; Kitada et al. 2007). PINK1 deficient mice display mitochondrial dysfunction prior to the onset of any neurodegeneration (Gispert et al. 2009). A triple knockout of PINK1, parkin, and DJ-1 also display normal morphology and cell number in the substantia nigra and is insufficient to cause significant nigral degeneration in the mice (Kitada et al. 2009). Again, as yet unknown, compensatory mechanisms may be held responsible. Both PINK1 and parkin play a role in mitophagy, although the mechanism is still not fully understood. It is known that upon selective recruitment of cytosolic parkin to depolarized mitochondria, the dysfunctional units are eliminated via the autophagic machinery (Narendra et al. 2010). PINK1 expression and function is required for this process (Vives-Bauza et al. 2010; Geisler et al. 2010; Vives-Bauza and Przedborski 2010). Overexpression of wild-type PINK1 is sufficient to induce recruitment of parkin to mitochondria, even if mitochondrial membrane potential remains intact. In addition, mutations in either PINK1 or parkin inhibit parkin recruitment to mitochondria and subsequent mitophagy (Vives-Bauza and Przedborski 2010). PINK1 or parkin mutations alone or PINK1/parkin double
84
L. Stiles et al.
mutants display a similar phenotype, indicating that they operate in the same pathway. Interestingly, overexpression of parkin can compensate for loss of PINK1, while the reverse does not occur, suggesting that parkin acts downstream of PINK1 (Clark et al. 2006; Whitworth and Pallanck 2009). Loss of PINK1 leads to alterations in mitochondrial function and morphology in a number of mammalian systems. There seems to be a universal decrease in mitochondrial membrane potential and ATP synthesis in the systems where this has been studied (Exner et al. 2007; Liu et al. 2009a; Chu 2010). The same phenotype is observed with expression of mutated forms of PINK1 (Grunewald et al. 2009; Marongiu et al. 2009). Loss of PINK1 also seems to increase ROS in mammalian cells. An increase in superoxide has been demonstrated in mouse cortical neurons, human dopaminergic neurons (Wood-Kaczmar et al. 2008; Gandhi et al. 2009), and human SH-SY5Y neuroblastoma cells (Dagda et al. 2009), as well as a decrease in glutathione levels in some of these cell lines. There is also evidence for induction of mitophagy or mitochondrial association with lysosomes in a number of these studies. Interestingly, there are also changes in mitochondrial morphology with loss of PINK1, in mammalian systems this generally correlates with an increase in fragmentation (Sandebring et al. 2009). Unraveling the connection between autophagy, the PINK1/parkin pathway, and mitochondrial morphology is critical to further understanding the role of mitochondrial quality control. Although, the mitochondrial morphology phenotype of PINK1/parkin deficiency remains controversial between studies in Drosophila and higher eukaryotes, one thing is clear: loss of PINK1/parkin does lead to alterations in mitochondrial morphology. The PINK1/parkin pathway interacts with components of the mitochondrial dynamics machinery. Much of the work dissecting the connection between PINK1/ parkin and mitochondrial fusion and fission machinery has been done in Drosophila. The expression of mitofusin is inversely correlated with the activity of PINK1 and parkin in Drosophila. On the other hand, loss of PINK1 or parkin does not change the steady-state expression of Drp1 or Opa1, or the subcellular distribution of Drp1 (Poole et al. 2010). Ziviani et al. demonstrated that Mfn is ubiquitinated by parkin when it is recruited to dysfunctional mitochondria (Ziviani et al. 2010). They also show that loss of PINK1 or parkin leads to an increase in the expression of Mfn and an elongated mitochondrial morphology. Additionally, knockdown of Mfn or OPA1 or overexpression of Drp1, rescues the mitochondrial abnormalities in PINK1 or parkin mutants (Poole et al. 2008; Park et al. 2009). There is also evidence that the PINK1/parkin pathway negatively regulates Mfn and OPA1 function and positively regulates Drp1 (Deng et al. 2008). Yang et al. propose that Fis1 acts between PINK1 and Drp1 promoting mitochondrial fission (Yang et al. 2008). All of this experimental evidence suggests that the PINK1/parkin pathway regulates mitochondrial morphology by either promoting mitochondrial fission or inhibiting fusion in Drosophila. This fits with the hypothesized model that the higher the frequency of mitochondrial fission, the higher the probability that dysfunctional units will be segregated and eliminated, as will be discussed in the following sections. These data suggest a scheme where PINK1/parkin promote mitochondrial fission and elimination via mitophagy, therefore providing a connection between this pathway and both mitochondrial dynamics and autophagy.
3 Mitochondrial Dynamics and Autophagy
85
Ubiquitination of Mfn by parkin is hypothesized to promote autophagy of damaged mitochondria. It is thought that the mechanism by which this occurs is that ubiquitination of the outer mitochondrial membrane acts as a recruitment signal for p62/SQSTM1, which is required for PINK1/parkin-mediated mitophagy (Geisler et al. 2010). Although, this could also be mediated by parkin-mediated poly-ubiquitination of the voltage-dependent anion channel 1 (VDAC1), which has been shown to be necessary for PINK1/parkin-directed mitophagy. Ziviani and Whitworth provide additional potential mechanisms for the role of Mfn ubiquitination in mitophagy that focus on the function of Mfn in mitochondrial fusion. For instance, poly-ubiquitinated Mfn may be degraded consequently inhibiting fusion, with the possibility that this mechanism is specific to damaged mitochondria. If Mfn is mono-ubiquitinated, it is unlikely that it will be degraded, but it could still provide a useful regulatory mechanism. An example of this is that ubiquitination may prevent dimerization and therefore tethering of Mfn and in this manner prevents mitochondrial fusion (Ziviani and Whitworth 2010). Interestingly, contradictory mitochondrial morphology findings have been reported in human SH-SY5Y neuroblastoma cells and other mammalian systems. Dagda et al. demonstrate that stable PINK1 knockdown in SH-SY5Y cells results in a fragmented mitochondrial morphology, increased oxidative stress, and an increase in mitophagy that correlates with a 50% reduction in mitochondrial mass, which was assessed by western blotting for mitochondrial proteins (Dagda et al. 2009). Conversely, overexpression of PINK1 lead to an increase in mitochondrial connectivity and an elongated morphology with some abnormally enlarged mitochondria, yet there was no autophagic response to these irregular mitochondria; in fact PINK1 overexpression inhibited 6-hydroxydopamine (6-ODHA)-induced mitophagy. Interestingly, dominant negative Drp1 expression rescued the morphology and autophagy effect in the PINK1 knockdown, leading to more elongated mitochondria and decreased mitophagy (Dagda et al. 2009). This study also shows that autophagy machinery is necessary for mitochondrial fragmentation, which was demonstrated by utilizing siRNA targeting Atg7 and Atg8/LC3B. Knockdown of these proteins inhibited autophagy and reversed the mitochondrial fragmentation observed in PINK1 knockdown cells to levels similar to that in control cells. Decreased PINK1 expression in SH-SY5Y cells causes reduced autophagic flux that corresponds with decreased ATP synthesis (Gegg et al. 2010),which can be rescued by overexpression of parkin. Inducing mitochondrial dysfunction using the electron transport chain uncoupler, CCCP, demonstrated that PINK1 and parkin are required for mitophagy. Gegg et al. show that ubiquitination of Mfn1 and Mfn2 occurs within 3 h of CCCP treatment and that this process may identify mitochondria for degradation via mitophagy. The ubiquitination of these mitochondrial dynamics proteins is inhibited with knockdown of PINK1 or parkin expression, implicating that PINK1 and parkin are essential for mitophagy, specifically for removal of damaged mitochondria. These data point to interdependency between mitochondrial dynamics and autophagy, demonstrating that mitochondrial fusion/ fission machinery is required for PINK1 mediated mitochondrial degradation and suggests that autophagy participates in mitochondrial remodeling.
86
L. Stiles et al.
Loss of PINK1 or parkin in SH-SY5Y cells causes a fragmented mitochondrial morphology (Lutz et al. 2009). Overexpression of Mfn2 and OPA1 or a dominant negative mutation of Drp1 (Drp1-DN) were able to rescue the effects loss of PINK1 or parkin had on mitochondrial morphology and function. Conversely, expression of parkin or PINK1 was able to suppress mitochondrial fragmentation induced by Drp1 expression. Furthermore, Drp1-DN expressing cells that were also knockdown for PINK1 or parkin did not display the expected fragmented mitochondrial morphology phenotype or a decrease in ATP. This implies that mitochondrial alterations in parkin- or PINK1-deficient cells are associated with an increase in mitochondrial fission and relies on mitochondrial dynamics proteins and machinery. In agreement with this research, expression of human mutant PINK1 in a rat dopaminergic cell line leads to fragmented mitochondria via an increased ratio of fission to fusion proteins thereby promoting mitochondrial fission. Mitochondrial division inhibitor (mdivi-1), a small molecule inhibitor of Drp1, rescued both the morphological and functional mitochondrial defects caused by the expression of mutant PINK1 (Cui et al. 2010). Lutz et al. suggest that possible explanations for the difference observed in Drosophila and mammalian cells could be the time points that analysis of PINK1/ parkin deficiency occurred and/or that there could be fundamental differences in the regulation of mitochondrial fusion and fission and mitophagy in mammalian systems (Lutz et al. 2009). Mitochondrial dynamics and mitophagy could also be regulated in a tissue-specific manner. Regardless of the controversial conclusions obtained when examining PINK1/parkin, it is clear that this pathway provides an interesting mechanism that may connect mitochondrial dynamics with mitophagy. The mechanism behind how loss of mitochondrial membrane potential triggers PINK1 signaling, PINK1 triggers parkin recruitment, and parkin is localized to mitochondria remain unknown at this time. Yet, what is known is that PINK1 and parkin affect mitochondrial morphology. It has also been demonstrated that mitochondrial depolarization is critical to the PINK1/parkin pathway and is necessary for mitophagy. The connection between mitochondrial fusion and fission, membrane potential, and mitophagy has been studied extensively in mammalian cells in the context of the lifecycle of a mitochondrion. Currently, interdependence between mitochondrial dynamics, function, and depolarization has been shown to influence selective degradation of damaged mitochondria through autophagy.
3.4.2 The Lifecycle of a Mitochondrion As previously discussed, mitochondria go through continuous cycles of fusion and fission, which is thought to play a role in mitochondrial complementation, allowing for mixing of matrix solutes and metabolites, mtDNA, and mitochondrial membrane components (these occur at different rates with membrane components having the slowest rate). This sharing of proteins and solutes between mitochondria through fusion occurs as a first line of defense in an attempt to recover function in damaged
3 Mitochondrial Dynamics and Autophagy
87
mitochondria. This complementary rescue ensures that dysfunctional mitochondria do not become an energetic strain on the rest of the mitochondrial population. Mitochondrial turnover, which is a balance between mitochondrial degradation and biogenesis, is also required for a healthy mitochondrial network. This allows dysfunctional mitochondrial to be removed by mitophagy while maintaining the population and allowing propagation of the most apt mitochondria. The interplay between mitochondrial dynamics and mitophagy is a key determinant of mitochondrial homeostasis, which can be exemplified by the mitochondrial life cycle. The life cycle of a mitochondrion has been studied by Twig et al. in INS-1 cells, a rat insulinoma cell line, where mitochondrial fission, selective fusion, and autophagy are thought to contribute to mitochondrial quality control, as shown schematically in Fig. 3.3 (Twig et al. 2008a; Mouli et al. 2009). It involves cycles of fusion periods, each followed by fission. Following the fission event, mitochondria enter a solitary state and are available for subsequent fusion events. This solitary state is ~20-fold longer than the fused period and if a mitochondrion maintains a polarized membrane potential during this period, it can re-enter the mitochondrial web by means of a subsequent fusion event with another mitochondrion.
Mitophagy 5 opa1 mfn1 PINK1 Parkin
Fission 2
Fusion
pre-autophagic pool
3
4
Sustained depolarization 1
Transient depolarization opa1
1 1
2
3
4
mfn1
fis1 drp1
PINK1
Parkin
5 Polarized mitochondria
Depolarized mitochondria
Fig. 3.3 The lifecycle of a mitochondrion; the role of fission, fusion, and autophagy in the segregation of dysfunction mitochondria. The mitochondrion shifts between a networked postfusion state (1) and a solitary post-fission state (2). Following a fission event, the daughter mitochondrion may either maintain membrane potential (red mitochondrion), or depolarize (green mitochondrion). If depolarization occurs, the mitochondrion is unlikely to undergo further fusion events for the entire depolarization interval (3). If mitochondrial depolarization is transient and membrane potential is restored, fusion capacity is also restored. However, if mitochondrial membrane potential depolarization is sustained (4), reduction in OPA1 levels and increases in PINK1 activity and parkin translocation follows and elimination by autophagy occurs (5) (Figure courtesy of Twig and Shirihai 2010)
88
L. Stiles et al.
On the other hand, if the daughter mitochondrion loses membrane potential and becomes depolarized, it will remain segregated and it can either be targeted for autophagy or it may repolarize and be recovered by the network. This suggests that mitochondrial fusion is selective for functional mitochondrial units. It is reasonable to consider that fission may merely decrease mitochondrial size making it more accessible for degradation. Although upon further reflection the creation of two dissimilar daughter units argues against this availability theory, given that size will be similar but it is function that becomes divergent. In addition, it has been shown that mitochondrial fusion depends on mitochondrial membrane potential and cannot occur in depolarized mitochondria regardless of size or the close proximity of other polarized, fusion-ready mitochondria (Twig and Shirihai 2010). These metabolically dysfunctional, depolarized mitochondria cannot fuse with other mitochondria and are preferentially targeted for degradation by the autophagosome, although the exact mechanism behind this remains unclear. However, it suggests that fusion itself may be partially responsible by unevenly redistributing components between mitochondria, which with the successive fission event results in two functionally divergent mitochondria. This ability to reorganize mitochondrial components may allow the mitochondrial population to separate and remove damaged units at a faster rate making them less energetically wasteful. The role of depolarization and how it prevents further fusion is in question when examining the life cycle of a mitochondrion. While all of the mitochondria that are targeted for autophagy are depolarized, the timeline of depolarization to engulfment provides further information regarding how autophagy is induced in these cells and whether depolarization is a cause or effect of autophagy. Twig et al. found that mitochondrial depolarization occurs at least 1 h before engulfment, indicating that removal by autophagy is not the explanation for why depolarized mitochondria cannot re-fuse with the network (Twig et al. 2008a). This time gap between depolarization and mitophagy demonstrates that mitochondrial fission is a principal route by which depolarized mitochondria are generated and fusion is selective for polarized units. It is important to note that while mitochondrial depolarization is a necessary prerequisite for mitophagy, depolarization alone is not sufficient to cause mitochondrial autophagy. With the knowledge that a mitochondrion spends a substantial amount of time as a non-fusing, segregated mitochondrion before it is degraded, the question is raised as to what the mechanistic explanation is for the observation that a depolarized mitochondrion cannot go through a subsequent fusion event. It was shown that the underlying mechanism for the membrane potential dependency of fusion is actually an impaired fusion capacity within these mitochondria. Indeed, co-staining mitochondria with mitochondrial matrix targeted photo-activatable green fluorescent protein (mtPA-GFP), to identify non-fusing mitochondria, and TMRE, a mitochondrial membrane potential dependent dye, or an anti-OPA1 antibody provided some mechanistic insight into the membrane potential and fusion state of these mitochondria. Twig et al. show that non-fusing mitochondria are depolarized and display an increase in proteolytic cleavage, or degradation, of the fusion protein, OPA1, with approximately 50% less OPA1 than in wild-type fusing mitochondria (Twig et al. 2008a).
3 Mitochondrial Dynamics and Autophagy
89
Cleavage of OPA1 has been shown to be triggered by reduction in mitochondrial ATP and by mitochondrial depolarization (Griparic et al. 2004; Duvezin-Caubet et al. 2006; Song et al. 2007). This implicates a targeted fusion deficiency as the explanation for a lack of mitochondrial fusion in depolarized mitochondria. The interdependence of mitochondrial dynamics and mitophagy are also revealed by utilizing tools to either knockdown or overexpress mitochondrial dynamics proteins prior to studying autophagy (Table 3.1). Retinal ganglion cells (RGCs) from mice heterozygous for a nonsense mutation in OPA1 display an increase in autophagosomes (White et al. 2009). The authors suggest that this induction of autophagy is due to accumulation of abnormal mitochondria in the RGC layer. Induction of fusion by overexpression of OPA1 using adenovirus in INS1 cells resulted in a decrease in mitophagy by 64%. This was not due to increased mitochondrial size, but to an increase in fusion capacity. Mitochondrial fission is also essential for mitophagy. Stimulation of fission decreases mitochondrial mass in HeLa cells (Frieden et al. 2004; Gomes and Scorrano 2008) and INS1 cells (Park et al. 2008), consistent with the concept of an increase in mitophagy. Overexpression of Fis1 causes cells to accumulate fragmented mitochondria and autophagosomes, with the observation that there is selective autophagy of damaged mitochondria. Using Fis1 mutants, it was demonstrated that induction of punctate mitochondria and autophagic vesicles correlated with mitochondrial dysfunction not fragmentation, indicating that it is function not morphology that determines whether a cell will trigger mitophagy (Gomes and Scorrano 2008). Promoting fission by overexpression of Drp1 stimulates mitochondrial elimination under proapoptotic stimuli (Arnoult et al. 2005). Furthermore, inhibiting fission using either Fis1 RNAi or Drp1-DN results in a reduction in mitochondrial-specific autophagy (Barsoum et al. 2006; Twig et al. 2008a; Gottlieb and Carreira 2010). This reduction in autophagy is mitophagy specific because other forms of autophagy, such as ER autophagy (reticulophagy) remain intact, indicated by no alterations in the levels of ER mass (Twig et al. 2008a). Moreover, pharmacological inhibition of autophagy affects mitochondrial dynamics and metabolic function. Treatment of rat myoblasts with 3MA to inhibit autophagy leads to a decrease in mitochondrial membrane potential, inhibition of mitochondrial fusion (attributed to a decrease in OPA1), and accumulation of ‘giant’ mitochondria (Navratil et al. 2008). These works imply that both fusion and fission play a critical role in mitochondrial turnover and quality control by influencing mitophagy.
3.4.3 Lessons from Simulation Experiments Further support for the potential role of mitochondrial dynamics in mitochondrial quality control comes from simulation experiments from Mouli et al. They measured parameters of fusion and fission that may influence maintenance of mitochondrial function. By using a programmed simulation based on experimental findings they were able to investigate the effects of fusion, fission and autophagy
Fragmentation and perinuclear clustering Fragmentation
Retinal ganglion cells INS1 b -cells
INS1 b -cells
MEFs
Opa1 heterozygous mutated mice Mfn1 overexpression
Mfn1 loss-of function (overexpression of Mfn1 DN) Mfn2 knockout
DJ-1 knockdown
PINK1 overexpression
Increased interconnectivity and elongation Abnormally enlarged mitochondria Fragmentation
Fragmentation
INS1 b -cells
Opa1 overexpression
Human neuronal SH-SY5Y cells Human neuronal SH-SY5Y cells M17 human dopaminergic cell line
Reduction in mitochondrial size with intact fusion ability Increased percentage of opaque mitochondria Mitochondrial aggregation
HeLa cells HeLa cells
PINK1 knockdown
Fragmented, swollen mitochondria Tubular, elongated mitochondria Fragmentation
INS1 b -cells
Drp1K38A (dominant negative Drp1) Drp1 RNAi Drp1 overexpression
Increased general autophagy
Increased autophagic sequestration of depolarized mitochondria Decreased in mitochondrial volume by 50% Autophagic vacuole number remained low
Inhibition of autophagy
Decrease in mitochondrial volume by 40% Unchanged mitochondrial mass
Reduction in autophagosomes containing mitochondria by 75% Decrease in mitophagy (qualitative) Decrease in mitochondrial mass by 70% Reduction in autophagosomes containing mitochondria by 63% An increase in general autophagy
Table 3.1 The effect of manipulations in mitochondrial protein expression on mitochondrial morphology and mitophagy Manipulation Cell type Effect on morphology Effect on mitophagy Fis1 RNAi Elongation Reduction in autophagosomes containing INS1 b-cells mitochondria by 70% Fis1 overexpression HeLa cells INS1 Fragmentation Enhanced autophagosome b -cells formation by 50% Reduce total mitochondrial volume by 50%
Thomas et al. (2010)
Dagda et al. (2009)
Dagda et al. (2009)
Hailey et al. (2010)
Park et al. (2008)
Park et al. (2008)
White et al. (2009)
Twig et al. (2008a)
Parone et al. (2008) Arnoult et al. (2005)
Frieden et al. (2004), Gomes and Scorrano (2008), Park et al. (2008) Twig et al. (2008a)
Reference Twig et al. (2008a)
90 L. Stiles et al.
3 Mitochondrial Dynamics and Autophagy
91
over an extended time period in a large population of mitochondria (Mouli et al. 2009). A model was developed where there is an optimal frequency of fusion and fission events that maintains mitochondrial function, such as respiration, even with a persistent damaging algorithm that should compromise mitochondrial function by inactivating mitochondrial components. In this model, where the extent of fusion and fission contribute to mitochondrial activity, it was determined that autophagy alone was the process by which damaged, “low-activity” mitochondria were removed, working to preserve function, even when this process is nonselective. Indeed, even in the absence of repair mechanisms, mitochondrial dynamics and autophagy may be adequate to restore mitochondrial function, given that fusion allows for redistribution of damaged components that can be removed quickly and preferentially by mitophagy. When mitochondrial activity under selective fusion is considered, especially with high levels of damage, there is a considerable affect on mitochondrial function. Selectivity allows for removal of damaged units by promoting increased fusion frequency of functional mitochondrial. This is accomplished without compromising autophagy of damaged mitochondria. This gives selective fusion a two-fold purpose in maintaining mitochondrial function, first as a means of intramitochondrial complementation and second as a way to segregate damaged mitochondria prior to autophagy (Nakada et al. 2001; Mouli et al. 2009). It also suggests that along with the key element of selective fusion, it is the rate of fission (not just the balance between fusion and fission) that determines the efficacy of quality control mechanisms (fusion, fission, and autophagy). A higher frequency of fission results in an increased probability of dysfunctional mitochondria being isolated and eliminated by mitophagy. This work further explores the interconnected nature of fusion, fission, and autophagy and how the occurrence and frequency of these processes maintains mitochondrial function.
3.4.4 Mitochondrial Motility and Dynamics Mitochondrial movement regulates mitochondrial morphology by controlling the spatial distribution of mitochondria. Mitochondrial fusion requires and in some cases can promote (i.e. transient fusion) mitochondrial motility. In H9c2 cells, there is a similar prevalence of moving and stationary mitochondria within the general mitochondrial population, yet fusion events involve moving mitochondria approximately 90% of the time (Twig et al. 2010). This work demonstrates that mitochondrial motility facilitates fusion. The extent of mitochondrial fusion depends on the location of mitochondria along microtubules, whether they are located on the same or separate microtubules, and the direction in which they are moving (Liu et al. 2009a). Mitochondria move along microtubules via kinesin motors with the assistance of the Miro/ Milton complex. Miro1 and Miro2 are atypical RhoGTPases located on the outer mitochondrial membrane that allow for the kinesin-1 motor to interact with
92
L. Stiles et al.
mitochondria. Milton is an adaptor protein, which connects Miro and kinesin to facilitate mitochondrial motility and trafficking. Miro has two Ca2+–binding EF-hands, which controls calcium-sensitivity (Chen and Chan 2009). Mitochondria are immobilized by high calcium concentrations, which is thought to assist in calcium buffering by mitochondria and localized ATP production, specifically in neurons, which have high energy demands for neurotransmitter release (Liu and Hajnoczky 2009; Stephenson 2010). The connection between mitochondrial motility and mitophagy has not yet been determined, although it has been demonstrated that PINK1 interacts with the Miro/ Milton complex (Weihofen et al. 2009). The interdependence of mitochondrial motility and morphology is beginning to be elucidated. Mfn1 and Mfn2 have been shown to interact with the Miro/Milton complex (Misko et al. 2010). In addition, Mfn2 is necessary for axonal transport of mitochondria in dorsal root ganglia neuronal cultures, which is independent of its role in mitochondrial fusion. Loss of OPA1 has no effect on motility indicating that inner membrane fusion is not required for mitochondrial axonal transport along the microtubule. Overexpression of Miro and Milton causes mitochondrial elongation, clustering and aggregation and inhibits the mitochondrial fragmentation caused by loss of PINK1 (Glater et al. 2006; Saotome et al. 2008; Weihofen et al. 2009). Loss of Miro function leads to suppression of mitochondrial motility and Drp1 mediated mitochondrial fragmentation (Fransson et al. 2006; Saotome et al. 2008; Liu and Hajnoczky 2009). These data provide evidence that mitochondrial motility and dynamics occur in a common pathway and suggest that motility may also influence mitophagy. Figure 3.4 overviews
Fig. 3.4 The role of PINK1 in mitochondrial motility, morphology, and mitophagy. PINK1 has been shown to interact with the mitochondrial motility complex Miro/Milton, yet the exact role PINK1 plays in this complex has yet to be determined. However, it is hypothesized that PINK1 may pay a role in mitochondrial trafficking. A connection between mitochondrial motility and morphology exists, where fusion requires and can promote motility. It has been well established that changes in PINK1 expression affects mitochondrial morphology; in mammalian cells PINK1 promotes fusion and an elongated mitochondrial morphology. PINK1 also promotes mitophagy upon parkin recruitment to the mitochondria. A relationship between mitochondrial dynamics and mitophagy exists where fission followed by selective fusion allows for segregation of dysfunctional mitochondria that can be targeted for mitophagy. Mitochondrial motility, morphology, and autophagy are thought to exert mitochondrial quality control, which determines mitochondrial function. Thus, as PINK1 has been shown to regulate all these processes, it is a solid candidate as a master regulator of mitochondrial quality control
3 Mitochondrial Dynamics and Autophagy
93
the role of PINK1 in mitochondrial motility, morphology, and autophagy, presenting the possibility that PINK1 may play a role in mitochondrial quality control (Whitworth and Pallanck 2009).
3.4.5 Mitochondrial Motility, Dynamics, and Mitophagy as a Quality Control Axis Mitochondrial motility along microtubules is required for mitochondrial fusion (Liu et al. 2009b). The observation that mitochondrial fusion is a membrane potentialdependent process guarantees that dysfunctional organelles will avoid fusion, while intact mitochondria will benefit from complementation. Segregation of dysfunctional mitochondria from the fusing population results in the generation of small, depolarized mitochondria that can be targeted for degradation by mitophagy. This sets up a possible hierarchy of mitochondrial quality control mechanisms with mitochondrial movement at the top, followed by fusion, which utilizes a complementary “rescue” mechanism, followed by fission which provides dissimilar daughter cells and ending with mitophagy as the recipient of the depolarized units. Importantly, the idea of this quality control axis advocates that it is not just the balance between fusion and fission that can contribute to maintenance of the mitochondrial population, but also the absolute rate of events. Specifically, it is thought that the higher the fission frequency, the higher the probability that dysfunctional units will be segregated and eliminated (Twig et al. 2008b).
3.5 When Quality Control Breaks Down: Implications in Aging and Neurodegeneration Mitochondrial quality control is critical for maintenance of a healthy mitochondrial population. Both mitochondrial dynamics and selective mitochondrial autophagy are thought to play key roles in maintaining mitochondrial function and promoting turnover. Therefore, it is not surprising that these processes have been implicated in a number of diseases.
3.5.1 Role of Mitochondrial Dynamics and Mitophagy in Aging Mitochondria have been proposed to play a prominent role in the aging process, namely dysfunctional mitochondrial quality control leads to an accumulation of damaged mitochondria, which could lead to further cellular impairment. ‘Giant’ or swollen mitochondria are often observed in aged cells. These mitochondria are
94
L. Stiles et al.
enlarged with accumulated mtDNA and oxidized proteins, which are indicative of a lack of mitochondrial turnover (Yen and Klionsky 2008). This implicates mitochondrial fusion and fission, as well as mitophagy, as mechanisms of aging. Indeed, mitochondrial dynamics, selective mitochondrial autophagy, ROS, and mtDNA maintenance are all hypothesized to play a role in the aging process (Weber and Reichert 2010). There are a number of other aging theories that have been proposed and even additional mitochondrial-related pathways that are thought to be involved with this process, such as caloric restriction, the insulin signaling pathway/insulin sensitivity, and sirtuins, but these do not strictly fit into the topic of mitochondrial dynamics and autophagy and are beyond the scope of this chapter. Oxidative stress is an interesting starting point when examining the role mitochondria play in the aging process. Mitochondria are both the main source and, due to their close proximity and less efficient DNA proofreading enzymes, target of ROS. The ‘free radical theory of aging’ proposed by Harman in the 1950s is based on the fact that ROS induce mitochondrial dysfunction and mitochondrial dysfunction generates more ROS, leading to a vicious cycle of mitochondrial damage (Harman 1956). It is important to note that not all ROS is deleterious, it also acts as a physiological cellular signal. For instance, at low levels ROS can be a signal to stimulate ROS scavenging pathways, mitochondrial biogenesis, and mPTP, which may lead to mitophagy. As ROS levels and oxidative damage increase, instead of promoting survival of mitochondria they may instead trigger release of factors that initiate apoptosis. Increased ROS levels may also elevate mitochondrial DNA mutations. Mitochondria have increased incidences for DNA mutation compared to genomic DNA due to a number of reasons including being in close proximity to higher levels of ROS and decreased repair mechanisms. Increased accumulation of mtDNA mutations has also been proposed as an aging mechanism and is a cause for heterogeneity in the mitochondrial population. Accumulation of mutated mtDNA is an indication that mitochondrial quality control mechanisms are dysfunctional. It has been hypothesized that certain mtDNA mutations that decrease mitochondrial respiration and therefore ROS production (a seemingly beneficial result in circumstances of mitochondrial damage and high ROS production) may also decrease mitophagy (Lemasters 2005). This provides another mechanism by which impaired mitochondrial dynamics and mitophagy is implicated in the aging process. Mitophagy is known to be upregulated in response to dysfunctional mitochondria and has been proposed to slow the aging process. Specifically, it has been shown that there is an age-related decline in lysosomal systems. Accumulation of damaged mitochondria due to impaired removal/degradation of these organelles is thought to result in decreased cell viability. Therefore, functional selective autophagy of damaged mitochondria is crucial for the preservation of a healthy mitochondrial population and maintenance of cellular integrity. All of the aging pathways described thus far have a common feature in that they converge together to lead to mitochondrial damage and impaired quality control. Mitochondrial dynamics may also play a role in the aging process. Yeast deficient in Dmn1 (homolog of Drp1) have an increased lifespan. It has been demonstrated in P. anserine that mitochondrial fragmentation occurs progressively with age, which
3 Mitochondrial Dynamics and Autophagy
95
was reversed by Dnm1 knockout (Scheckhuber et al. 2007), although this does not occur in mammalian systems where Drp1 knockout is embryonically lethal. Although, this does not rule out the possibility that a small shift in the balance of mitochondrial dynamics could be beneficial to the cellular environment. Additionally, changes in mitochondrial morphology are observed in disease states that are concurrent with aging. It is often difficult to determine whether changes to mitochondrial dynamics are the cause or an effect of pathology, likely it is probably not that simple with a more cyclical mechanism expected. We do know, however, that effective mitochondrial dynamics, including complementation and selective fusion, influence mitophagy and are key determinants of quality control, which helps to maintain a healthy mitochondrial and therefore cellular population.
3.5.2 Mitochondrial-Lysosomal Axis Theory of Aging While essential, the task of degrading mitochondria via autophagy is no easy task. With lipid-rich membranes and several iron containing enzyme complexes, mitochondria represent a challenging substrate for the lysosome. Moreover damaged mitochondria are a serious hazard through their capacity to produce large quantities of ROS. This delicate and dangerous dynamic is especially relevant for neurons and has been elegantly described in the mitochondrial-lysosomal axis theory of aging proposed by Terman and Brunk (Terman et al. 2010). In their theory, high levels of intralysosomal iron combined with hydrogen peroxide leads to peroxidation of cargo in autophagosomes and lysosomes (Kurz et al. 2008b). This oxidative modification renders the cargo resistant to degradation by lysosomal hydrolytic enzymes. A non-degradable polymer of cross-linked protein and lipid residues, known as lipofuscin or ceroid, accumulates in the lysosomes and decreases auto phagic clearance. Impaired mitophagic clearance, in turn exacerbates the situation by allowing more time for reactive oxidative species to escape from damaged mitochondria. Under extreme oxidative stress, damage to the membrane of the lysosome leads to subsequent permeabilization and the pro-apoptotic leakage of lysosomal enzymes into the cytoplasm (Terman et al. 2006; Kurz et al. 2008a). Mechanisms of aging and neurodegeneration in humans are inherently difficult to prove yet there is a rapidly growing body of evidence in support of the mitochondrial-lysosomal axis theory. Examples specific to neurodegeneration come from studies of autopsied brains of patients with Alzheimer’s disease and Parkinson’s disease. Several researchers have documented evidence of aberrant mitophagy in AD (Moreira et al. 2007b; Chen and Chan 2009; Santos et al. 2010) including increased quantities of mitochondrial lipoic acid associated with lipofuscin (Moreira et al. 2007a, b). Nixon and collaborators have documented numerous lysosomal-related abnormalities in sporadic AD suggestive of impaired clearance, including a striking accumulation of autophagosomes and autophagolysosomes within degenerating neurites (Nixon et al. 2008). Further mechanistic support for their interpretations come from studies of presenilin-1, the most common cause of
96
L. Stiles et al.
early-onset familial Alzheimer’s Disease (Lee et al. 2010). Tissues from patients and transgenic animals with presenilin-1 mutations display several lines of evidence indicating impaired autophagic clearance. In relation to PD, Dehay et al. report lysosomal depletion following administration of the neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) which targets mitochondrial complex I (Vila et al. 2010; Dehay et al. 2010). The loss of lysosomes was preceded by a permeabilization of lysosomal membranes due to oxidative damage resulting from increased mitophagy. Supporting their data in toxin models, Dehay et al., also found evidence of lysosomal breakdown and autophagosome accumulation in brain tissue from PD patients. Enhancement of autophagic-lysosomal function through genetic and pharmacologic modifications was protective against the toxicity of MPTP and, most importantly, attenuated the PD-related dopaminergic neurodegeneration. These studies illustrate the lysosomal hazards of mitophagy and point to the great potential for treatments of neurodegenerative conditions through modulation of the mitochondrial-lysosomal axis.
3.5.3 Mitochondrial Dynamics, Mitophagy, and Neurodegeneration All of the factors that have been implicated in aging also play a role in neurodegeneration. It is, therefore, not surprising that neurodegeneration is often a late-onset, age-associated disease. It has even been suggested that aging is a ‘benign’ form of neurodegeneration. Excessive and unbalanced mitochondrial dynamics have been shown to have deleterious effects in a variety of tissues and cell types including, but not limited to, pancreatic b-cells, skeletal and cardiac myocytes, and neurons. Mitochondrial dynamics and mitophagy are required for quality control in neurons, and it has been shown that both are essential for normal neuronal function and disruptions in these processes can lead to disease states. In particular, dysfunctional mitophagy has been implicated and extensively studied in the pathogenesis of Parkinson’s disease, although it has also been associated with Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and Huntington’s disease. Parkinson’s disease is the most common neurodegenerative movement disorder and mutations in PINK1 and PARKIN genes are the most frequent cause of autosomal recessive familial Parkinson’s disease. PD is characterized by degeneration of dopaminergic neurons in the substantia nigra and often by the formation of protein aggregates called Lewy bodies. The primary symptom of PD is a progressive dysfunction in movement, including impairment in motor skills and speech. Interestingly, chemical compounds that inhibit complex I of the electron transport chain (ETC), such as rotenone or MPTP, also cause PD-like symptoms in humans and rodents. Mitochondrial dysfunction has been observed in both human PD and murine animal models of the disease. Deletions and mutations in mtDNA have been found in these models as well as increased oxidative stress. A decrease in mitochondrial respiratory complexes is present in PD models and patients (including sporadic PD
3 Mitochondrial Dynamics and Autophagy
97
patients), specifically a deficiency in complex I expression and activity has been observed. An accumulation of a-synuclein, the major component of Lewy bodies, in mitochondria of dopaminergic neurons may be responsible, at least in part, for the ETC complex deficiency and also increased ROS production. PINK1 deficient mice and Drosophila display age-related decreases in complex I activity and mitochondrial depolarization. Of the 13 ETC subunits encoded for by mtDNA, eight encode for complex I, again implying that mutations or deletions in mtDNA in PD may be responsible for the loss of complex I activity. There is experimental evidence that mitochondrial fusion and fission are altered in animal models of PD. Neurotoxin exposure (such as MPTP) leads to mitochondrial fragmentation and swelling along with increased levels of ROS, mitochondrial dysfunction, and mitophagy. There is also data showing morphological changes in various tissues from PD patients. In brain biopsies from PD patients, heterogeneity in mitochondrial size was observed, as well as mitochondrial swelling. Increased ERK1/2 phosphorylation localized to mitochondria in autophagomes has also been observed in brains of PD patients, which is indicative of an induction of mitophagy and/or impaired clearance of autophagosomes (Zhu et al. 2003; Dagda et al. 2008). Studies of cytoplasmic hybrid (cybrid) cell lines, which contain mtDNA from PD subjects, have shown alterations in mitochondrial respiration and dramatic restructuring of mitochondrial architecture (Esteves et al. 2010), including mitochondrial swelling, changes to cristae structure and the outer mitochondrial membrane. Autophagy and mitophagy dysfunction in PD have been a focus of research in this field. It has been reported that in human PD both increased autophagy and mitophagy are present (Zhu and Chu 2010). Activation of the autophagic response is observed in peripheral blood mononuclear cells (PBMCs) from PD patients, which is hypothesized to be a protective mechanism against abnormal protein accumulation and help prevent or slow a-synuclein aggregation (Prigione et al. 2010). This finding from peripheral tissue may also represent an impairment of flux, with increased signaling for activation of autophagy concurrent with decreased clearance of autophagosomes. Dementia with Lewy Bodies (DLB) patients display elevated levels of neuronal mTOR and reduced Atg7 expression, although this was not observed in brains of PD patients (Crews et al. 2010). The DLB patients also showed increased expression of lysosomal markers in neurons, with the presence of enlarged lysosomes and abundant, abnormal autophagosomes. In addition, alterations in autophagy and/or mitophagy have been reported in other models of PD, such as MPTP and PINK1 or parkin deficiency. A loss in the ability of neurons to clear damaged mitochondria or proteins may be a main mechanism in the pathogenesis of PD. It is evident that PD is associated with impairment in the ability of mitochondria to regulate repair, recovery, and/or recycling of damaged units. Yet these changes to mitochondrial function do not reveal whether the alterations in mitochondrial function and the quality control axis are a cause or consequence of PD. Although, familial PD caused by mutations in PINK1 and parkin suggests that mitochondrial quality control plays a mechanistic role in the early pathogenesis of PD. Additionally, alterations in mitochondrial fusion and fission proteins are known to
98
L. Stiles et al.
be associated with human neurodegenerative disorders. Mitochondrial dysfunction has been implicated in a number of diseases and determining the mechanisms by which these pathways impact disease progression may provide pharmaceutical targets for treatment.
3.5.4 The A9-Dopaminergic Neuron: A Mitochondrial Perfect Storm Selective vulnerability is a common characteristic of many neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, Huntington’s disease and amyotrophic lateral sclerosis. These diseases are marked by a patterned pathology in specific neuronal sub-populations that likely provides a clue to the disease mechanism. Of all the cells in the body, neurons are among the most sensitive to interruptions in mitochondria dynamics, motility, and autophagy. This vulnerability results from extreme energy demands and complex, polarized cell structures, exemplified by neurons that degenerate in forms of parkinsonism, the A9-subtype dopaminergic neurons of the substantia nigra pars compacta (A9-DA). The A9-DA neurons have multiple physical and physiological characteristics that likely render them highly susceptible to loss of function in the mitochondrial network (Fig. 3.5). Nigral A9-DA neurons are examples of extreme physical polarization with somata accounting for less than 1% of cell volume due to massive axonal and dendritic branching (Sulzer 2007). These projection neurons have long, thin, poorlymyelinated axons that terminate in the striatum (Braak et al. 2004;